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Abstract 
Structurally well-defined mesoporous silica materials with tunable pore size and 
narrow pore-size distribution have attracted much attention for their potential applications in 
sensing, drug delivery and gene transfer. A series of mesoporous silica nanosphere-based 
(MSN) nano-devices presented herein were synthesized and utilized for the aforementioned 
applications. 
In terms of sensing applications, we provide a first example in utilization of a multi-
functionalized mesoporous silica material to selectively detect dopamine. The system 
selectivity is regulated by the organic functional groups that are located on the pore surface 
allowing only the target molecules to penetrate into the mesopores to access the sensing 
functionality. A second application, rooted in this work, is the selective detection of amino-
containing neurotransmitters under physiological condition. To serve this purpose we 
developed a fluorescence probe consisting of a poly(lactic acid)-coated, MCM-41 type 
mesoporous silica nanosphere (PLA-MSN) material. By utilizing the PLA layer as a 
gatekeeper to regulate the penetration of molecules in and out of the nano-scale pores, the 
PLA-MSN can selectively recognize dopamine from several structurally similar 
neurotransmitters (tyrosine and glutamic acid). 
Drug delivery applications have been built around a controlled release delivery device. 
In the original conception, the system used surface-derivatized cadmium sulfide (CdS) 
nanocrystals or poly(amido amine) dendrimers (PAMAM) as chemically removable caps to 
encapsulate several drug molecules and neurotransmitters inside the organically functionalized 
MSN mesoporous framework. The caps are covalently attached to the channels openings, with 
a chemically cleavable disulfide bond. The stimuli-responsive release profiles of drug-loaded 
MSN delivery systems were studied by using disulfide reducing molecules, such as 
dithiothreitol (DTT) and mercaptoethanol (ME), as release triggers. A luciferase 
chemiluminescence imaging method was employed to investigate the kinetics and mechanism 
of the ATP release with various disulfide-reducing agents as uncapping triggers in real time. 
By varying the chemical nature of the "cap" and "trigger" molecules in our MSN system, we 
discovered that the release profiles could be regulated in a controllable fashion. 
xvii 
Further, bio-compatible PAMAM dendrimers of low generations, size matched to the 
entrance of the channel of these branched, globular-shaped molecules were utilized in cancer 
drug delivery. The biocompatibility and delivery efficiency of the later MSN system in 
interaction with HeLa cervical cancer cells were demonstrated. The system renders the 
possibility to serve as a universal transmembrane carrier for intracellular drug delivery and 
imaging applications. This is the first uptake study of MCM-41 type mesoporous silicas into 
eukaryotic cells. 
The last application presented in this dissertation is gene delivery. We designed a 
MSN-based gene transfection system, where second generation (G2) PAMAMs were 
covalently attached to the surface of MSNs. The G2-PAMAM-capped MSN material (G2-
MSN) was able to complex with a plasmid DNA (pEGFP-C 1) that is encoding for an 
enhanced green fluorescence protein. The gene transfection efficacy, uptake mechanism, and 
biocompatibility of the G2-MSN system with various cell types, such as neural glia 
(astrocytes), human cervical cancer (HeLa), and Chinese hamster ovarian (CHO) cells were 
investigated. In contrast to other non-viral state-of-the-art gene transfer systems, the 
mesoporous structure of the MSN allows gene regulators small molecule to be encapsulated 
inside the MSN channels. The uniqueness of this gene carrier resides in the utilization of low 
generation PAMAM dendrimers in gene transfection as well as in the ability of the system to 
perform cotransfection of two separate types of genes. This later feature would enable the 
system to be employed in therapeutic gene delivery studies. 
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Chapter 1. Introduction of Mesoporous Silicates MCM-41 
Dissertation Organization 
This dissertation is divided into nine chapters based on chorological order. From 
chapter 2 to 8, each consists of ajournai paper presented with its own abstract, introduction, 
results and discussion, experimental section, conclusions, acknowledgements and references. 
Chapter one presents the thesis organization and chapter nine is a final review of the entire 
dissertation. 
Chapter 2 describes a synthetic method that can fine tune the amount of chemically 
accessible organic functional groups on the pores surface of MCM-41 type mesoporous silica 
nanosphere (MSN) materials by matching the cationic alkylammonium head group of the 
surfactant with various anionic organoalkoxysilane precursors at the micelle-water interface. 
My personal contribution represents 40% of the presented research. 
Chapter 3 describes the design and synthesis of a well-defined, monodispersed 
mesoporous silica nanosphere (MSN) as a fluorescence sensory system which could serve as 
synthetic scaffolds to study the molecular recognition events of biogenic molecules, such as 
dopamine and glucosamine. The characterization, surface modification and molecular 
recognition experiments of MSN are presented. My personal contribution represents 90% of 
the presented research. 
Chapter 4 extends the sensing application of MSN to a poly(lactic acid) coated 
MCM-41-type mesoporous silica nanosphere (PLA-MSN) that can serve as a fluorescence 
sensor system for detection of amino-containing neurotransmitters in neutral aqueous buffer 
while simultaneously provide a biocompatible layer for neuronal interaction. My personal 
contribution represents 40% of the presented research. 
Chapter 5 describes the synthesis and characterization of a site-selective MCM-41 
type mesoporous silica nanosphere-based (MSN) controlled-release delivery system using 
surface-derivatized cadmium sulfide (CdS) nanocrystals as chemically removable caps to 
encapsulate several molecules inside the organically functionalized MSN mesoporous 
framework. In this chapter, the release profiles of several drugs and delivery efficiencies of 
2 
neuroglia cells are also discussed. My personal contribution represents 90% of the presented 
research. 
Chaper 6 extends the application of a MSN type controlled release nano-device by 
replacing caps form CdS nanocrystals to more biofriendly polyamidoamine organic dendimer 
(PAMAM). My personal contribution represents 40% of the presented research. 
Chapter 7 describes a novel polyamidoamine dendrimer-capped mesoporous silica 
nanosphere-based gene transfection reagent. This new gene shuttle, A nano-Trojan Horse, 
provides high transfection efficiencies in several types of cells. The chapter also introduces 
the biocompatibility study of capped-MSNS as well as their cellular uptake behavior. My 
personal contribution represents 50% of the presented research. 
Chapter 8 is presenting an intracellular delivery nano-vehicle based on PAMAM-
dendrimer capped MSNs. The main focus of the chapter is on drug-delivery, achieved on 
HeLa cancer cells by utilizing Doxorubicin-encapsulated MSNs. Furthermore, for 
demonstrating the versatility of coating methodology, this cargo was utilized for condensing 
two different types of DNA on the external surface for co-transfection of different types of 
cells. My personal contribution represents 51% of the presented research. 
The final chapter summarizes the entire dissertation, bringing a final overview of 
each chapter. 
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Chapter 2. Fine-tuning the Degree of Organic Functionahzation of Mesoporous Silica 
Nanosphere Materials via an Interfacially Designed Cocondensation Method 
The paper is in press in Chemical Communications 
Radu, D. R.; Lai, C.-Y.; Huang, J.; Xu S.; Lin, V.S.-Y. 
Department of Chemistry, Iowa State University, Ames, Iowa 50011-3111 
Abstract 
A synthetic method that can fine tune the amount of chemically accessible organic 
functional groups on the pore surface of MCM-41 type mesoporous silica nanosphere (MSN) 
materials has been developed by electrostatically matching various anionic 
organoalkoxysilanes with the cationic cetyltrimethylammonium bromide micelles in a base-
catalyzed condensation reaction of tetraethoxysilane. 
Introduction 
Recent advancements in utilizing organic surfactants or block copolymers as 
structure-directing templates for the syntheses of structurally well-defined mesoporous silica 
materials, such as MCM-41/48,1 SBA-15,2 MSU-n,3 and FSM-16,4 have attracted much 
attention for their potential applications in sensing,5 catalysis,6 and drug delivery.7 
Obviously, the realization of these applications greatly depends on the ability to functionalize 
the interior and exterior surfaces of the mesoporous silicas with various organic functional 
groups. Although a wide variety of synthetic approaches have been pursued and some 
significant progresses has been made, few would argue that the current state-of-the-art 
methods, such as post synthesis grafting8 and organosiloxane/siloxane co-condensation9 
methods, need to be improved in terms of controlling the amount and location of the 
incorporated functional groups on the surface of the mesoporous silica materials. For 
example, functional groups incorporated via the post synthesis grafting method typically 
4 
congregate at the opening parts of porous channels resulting in an inhomogeneous surface 
coverage,10 whereas the amount of functional groups introduced by the 
organosiloxane/siloxane co-condensation method is yet to reach above 25% surface coverage 
without destroying the structural integrity and the long-range periodicity of the synthesized 
materials.9'10 Herein, we report on a new co-condensation method that could generate 
organically functionalized, MCM-41 type of mesoporous silica nanosphere materials while 
controlling the surface concentration of organic functional groups. 
Materials and Methods 
Experimental Section 
Materials. 3 -Mercaptopropionic acid (99+%), 2,2'-dipyridyl disulfide (98%), (3-
mercaptopropyl)trimethoxysilane (MPTES) (95%), 2-mercaptoethanesulfonic acid sodium 
salt (98%), cetyltrimethylammonium bromide (CTAB), tetraethyl orthosilicate (TEOS, 96%) 
and dithiothreitol (DTT) were purchased from Aldrich Chemical Co. (Milwaukee, WI). 
Acetic acid (Glacial), hydrochloric acid (37.4%), sodium hydroxide, ethanol (anhydrous), 
methanol (HPLC grade), tetrahydrofuran (HPLC grade), hexanes (pesticide grade) and ethyl 
ether (anhydrous) were obtained from Fisher Scientific Co. (Pittsburgh, PA). Nanopure water 
was deionized to 18.0 MO-cm in a Bamstead E-pure water purification system and used for 
the synthesis of MSN materials. 
Synthesis of organoalkoxysilane precursors 
2-[3-(trimethoxysilyl)-propyldisulfanyl]-propionic acid, CDSP-TMS, (lb) 
As depicted in Figure 2-1, 2-Carboxyethyl-2-pyridyl-disulfide, compound (la), was 
prepared according to a procedure published by Carlsson et al. In a typical synthesis, 3.75 g 
(17 mmol) of 2,2'-dipyridyl disulfide (Aldrithiol-2) was dissolved in 30 mL of ethanol and a 
solution of 0.87 mL of mercaptopropionic acid in 5 mL ethanol was injected dropwise. After 
20 h of stirring at room temperature, the crude yellow oil product was isolated by rotary 
evaporation. The purified product (1.45 g, yield = 40%) was obtained from an alumina 
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column chromatography (eluent = CHaCla/EtOH 3:2 v/v). The product 1.45 g (6.8 mmol) is 
corresponding to 40% yield. The characterization of compound la is consistent with the 
literature reported data.14 
2-[3-(trimethoxysilyl)-propyldisulfanyl]-propionic acid, compound (lb), was 
prepared by dissolving compound la (1.51 g, 7 mmol) in 30 mL of THF, followed by a 
HOOC^^s,S^x/,Si(OMe)3 
HS^X/Si(OMe)3 
—• 
la 
HOOCx/-\s^Sv^/\/-Si(OMe)3 
lb 
Na03S^^s,Sx/^/Si(0IVIe)3 
2a 
Na03S^xg,S^X/Si(0Me)3 
2b 
Figure 2-1. Schematic representation of the synthesis of organoalkoxysilane precursors 
dropwise addition of MPTMS (1.1 g, 5.6 mmol). The resulting yellow solution was stirred 
under atmosphere for 12 h. After flash evaporation of the solvent, the yellow product was 
purified by silicagel column chromatography using EAJ Hexane in 1:2 ratio as eluent. The 
purified product (1 g) was isolated with a 60% yield. !H-NMR (CDClg), ô 0.76 (t, 2H, 
(%(!)), 1.81 (q, 2H, CHz(2)), 2.71 (t, 2H, CHz(5)), 2.81 (f, 2H, CHz(3)), 2.91 (f, 2H, 
CH%(4)), 3.60 (a, 1H, OCH3); 13C-NMR (D2O), Ô 10.25, 13.69, 23.75, 34.83, 36.98, 42.26, 
180.99. 
2-[3-(trimethoxysilyl)-propyldisulfanyl]-ethanesulfonic acid, SDSP-TMS, (2b) 
As depicted in Figure 2-1, 2,2'-Dipyridyl disulfide (8.82 g, 40.0 mmol) was dissolved 
in 50.0 mL of methanol, followed by an addition of 1.6 mL of glacial acetic acid as catalyst. 
To this mixture, 2-mercaptoethanesulfonic acid sodium salt (3.82 g, 20.0 mmol) in 30.0 mL 
of methanol was added dropwise in 30 min with stirring. The reaction mixture was protected 
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from light and stirred at room temperature overnight, followed by solvent evaporation under 
vacuum. The crude product was purified by dissolving in a small amount of methanol, 
followed by recrystallization in ethyl ether and dried under vacuum to yield compound 2a 
(5.14 g, yield = 94.0%). 'H-NMR (300 MHz; DMSO-d6), ô 2.73 {m, 2H, CH2), 3.02 (m, 2H, 
CH2), 7.24 (d, 1H, ArH), 7.81 (m, 2H, ArH), 8.45 (d, 1H, ArH). 
To synthesize 2-[3-(trimethoxysilyl)-propyldisulfanyl]-ethanesulfonic acid sodium 
salt (2b), compound 2a (1.36 g, 5.0 mmol) was dissolved in 20.0 mL of methanol with 1.0 
mL of glacial acetic acid. To this mixture, (3-mercaptopropyl) trimethoxysilane (0.95 mL, 
5.0 mmol) in 10.0 mL of methanol was added dropwise. The mixture was protected from 
light and stirred under nitrogen at room temperature overnight. The reaction was quenched 
and the solvent was evaporated under vacuum. The solid product was dissolved in a small 
amount of methanol, followed by ethyl ether precipitation. The purified product (5.14 g, 
yield = 74.7%) was collected by filtration and dried under vacuum. 'iI-NMR (300 MHz; D20) 
ô 0.79 (4 2H, CH2(1)), 1.83 (g, 2H, CH2(2)), 2.81 (f, 2H, CH2(3)), 3.03 (A 2H, CH2(5)), 3.27 
(t, 2H, CH2(4)), 3.60 (s, 7H, OCH3). 
Synthesis of MSN materials 
Three organically functionalized mesoporous silica materials, MSN-COOH, MSN-
SO3H, and MSN-SH, were prepared by adding an ethanolic solution (2 mL, 2.24 mmol) of 
CDSP-TMS, SDSP-TMS, and the commercially available MP-TMS, respectively, to an 
aqueous solution (480 mL) of CTAB (2.74 mmol), NaOH (7.00 mmol), and TEOS (22.40 
mmol) at 80°C. The reaction mixture was stirred for 2 h. The solid products were isolated by 
filtration and washed thoroughly with methanol. The surfactant-removed materials were 
obtained by refluxing 1 g of the MSN material in 170 mL of methanolic solution of HC1 (1 M) 
for 12 h. The resulting surfactant-removed material was isolated by filtration, washed 
extensively with methanol, and dried under vacuum. To obtain mesoporous silica material 
with free thiol groups, the surfactant extracted MSN material was added to 100.0 mL of 5% 
NaHCO;(aq) containing a disulfide reducing agent, dithiothreitol (DTT) (1.88 g, 12.2 mmol). 
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The mixture was stirred at room temperature for 4 h. The white product was then filtered and 
washed with water and methanol, following by vacuum drying. 
Characterization of the Organic Functionahzation of the MSN Materials 
1. Powder XRD diffraction patterns of MSN-COOH, MSN-SO3H, and MSN-SH are 
summarized in Table 2-1. The data were collected on a Scintag XRD 2000 X-Ray 
diffractometer using Cu Ka radiation. Low angle diffraction with a 2 6 range of 1 to 10° was 
used to investigate the long-range order of the materials. 
2. Surface area (SA) and Median Pore Diameter (MPD) were measured using a 
Micromeritics ASAP2000 sorptometer. Samples were degassed at 90 °C for 1 h and at 150 
°C for 4 h. Nitrogen adsorption and desorption isotherms of the MSN materials were 
obtained at -196 °C. Specific surface areas and pore size distributions were calculated using 
the BrunauerEmmett-Teller (BET) and Barrett-Joyner-Halenda (BJH) method, respectively. 
3. Particle morphology of these MSN materials was determined by scanning electron 
microscopy (SEM) using a JEOL 840A scanning electron microscope with 10 kV 
accelerating voltage and 0.005 nA of beam current for imaging. For obtaining the 
transmission electron microscopy (TEM) micrograph displayed in the main text, a small 
aliquot was taken from a suspension of MSN in methanol, and placed in a lacey carbon-
coated TEM grid, which was pulled through the suspension and allowed to dry in air. The 
specimen was given no further treatment, as it appeared stable under beam bombardment. 
4. TGA curves were recorded using a TA Instruments TGA 2950 thermogravimetric analyzer 
with a temperature ramp of 5° C/min under continuous flow of nitrogen (100 mL/min). The 
percentage of weigh loss when heating the samples of MSNs in the range of 1-1000°C is 
concluded in Table 2-2. In general, three or four distinct weight loss TGA profiles were 
found, including methanol, organic functional groups, and a small weight loss due to the 
dehydration of the surface hydroxyl groups. 
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5. The 13C spectra shown in the Figure 2-6 confirm the presence of the three organic 
functional groups in the MSN materials before the disulfide bond reductions. Solid-state 13C 
CP-MAS NMR spectra were obtained at 75.47 Mhz on a Bruker MSL300 spectrometer 
equipped with Bruker 4mm rotor MAS probe. Magic-angle sample spinning rate was 
maintained at 10 KHz. The NMR spectra consisted of between 2,000 and 6,000 acquisitions 
with cross polarization times of 3ms and pulse repetition times of 15s. All chemical shifts 
reported are referenced to liquid SiMe^ (TMS). 
Quantification of chemically accessible surface-functionalized thiol coverage 
All experiments were performed in triplicate, by reacting a predetermined amount of 
material (in the range of 20 to 25 mg) with a methanolic solution of excess 2, 2'-dipyridyl 
disulfide (44 mg, 0.2 mmol dissolved in 5 mL methanol)). 
Results and Discussion 
Our method involves the utilization of disulfide-containing organotrimethoxysilanes 
that have different anionic functional groups, such as 3-(3 '-(trimethoxysilyl)-propyl-
disulfanyl)-propionic acid (CDSP-TMS), 2-[3-(trimethoxy-silyl)-propyl-disulfanyl]-
ethanesulfonic acid sodium salt (SDSP-TMS), and mercaptopropyl-trimethoxysilane (MP-
TMS), to electrostatically match with cationic cetyltrimethylammonium bromide (CTAB) 
surfactant micelles in a NaOH-catalyzed condensation reaction of tetraethoxysilane (TEOS) 
as shown in Figure 2-2. We were inspired by the recent reports by Larsen and Magid,11 
where they observed the anionic lyotropic series (citrate < CO32" < SO42" < CH3CO2" < F" < 
OH" < HCO2" < Cl" < NO3" < Br < CH3C6H4SO3") for interaction with the CTAB surfactant 
micelle based on the enthalpy of transfer of the salt from water to solutions of 0.1 M CTAB. 
They concluded that anions less hydrated than Br", such as sulfonate, will be able to replace 
Br and bind tightly to the cetyltrimethylammonium head group of the CTAB molecule 
thereby effectively mitigating the repulsion between these cationic head groups and 
stabilizing the micelle structure. Also, several recent reports12 have also discovered that the 
long-range structure ordering of CTAB-templated mesoporous silicas could be improved by 
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the additions of various anions. The tightly bound (less hydrated) anions, such as acetate and 
BF4", became incorporated in the silicate matrix due to their ability to compete with the 
silicate anions in displacing Br" from the CTAB micelle. 
Figure 2-2. Schematic representation of the utilization of anionic organoalkoxysilane for controlling the 
functionalization of the MSN materials. The MCM-41 type mesoporous channels are illustrated by the parallel 
stripes shown in the TEM micrograph of the MSN-SH material. 
The different electrostatic matching effects of various anionic organoalkoxysilanes, 
such as thiolate-, carboxylate-, and sulfonate-containing organoalkoxysilanes, to CTAB 
micelles in governing the degree of organic functionalization of the MCM-41 type 
mesoporous silica materials are investigated. First, two disulfide-containing 
organotrimethoxysilanes (CDSP-TMS and SDSP-TMS) with carboxylic and sulfonic acid 
groups, respectively, were synthesized via a synthetic approach outlined in Scheme 2-1. 
These two compounds were synthesized via a simple thiol activation of 3-
mercaptopropionic acid and 2-mercaptoethanesulfonic acid sodium salt with 2,2'-dipyridyl 
disulfide followed by a disulfide exchange reaction with mercaptopropyltrimethoxysilane. 
Aqotoua Ph#** *0—y-aa 
CandfoWloo 
Hydfopbabk Cow 
of CTAB Mkdk 
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Three organically functionalized mesoporous silica materials, MSN-COOH, MSN-S03H, 
and MSN-SH, were prepared by adding an ethanolic solution (2 mL, 2.24 mmol) of CDSP-
TMS, SDSP-TMS, and the commercially available MP-TMS, respectively, to an aqueous 
solution (480 mL, 80°C) of CTAB (2.74 mmol), NaOH (7.00 mmol), and TEOS (22.40 
mmol, added at 80°C prior to the addtion of organoalkoxysilanes). The reaction mixture was 
stirred for 2 h. The solid products were isolated by filtration and washed thoroughly with 
methanol. Surfactant-removed materials were obtained with an acid extraction. All three 
materials exhibited spherical particle shape with an average particle diameter of 200 nm 
(Figure 2-2 and 2-3). 
Scheme 2-1 
c-oh 
N S—S N R Compound 1 
/xN/^x^/S|(OMe)3 S^/x^,Si(OMeb HS 
S—0"Na 
MeOH 
Compound lor2 
Compound 2 
MSN-SH MSN-COOH MSN-SO3H 
Figure 2-3. SEM images of MSN-SH (a), MSN-COOH (b) and MSN-SO3H (c). All three materials exhibited 
spherical particle morphology, with an average particle diameter of 200 nm. All images are presented using the 
same magnification (scale bar = 1 pm). 
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The mesoporous structures of these organically functionalized MSN materials were 
determined by nitrogen adsorption-desorption surface analysis (BET isotherms and BJH pore 
size distributions), TEM, and powder X-ray diffraction (XRD) spectroscopy. 
o o 
o C\l 
(/) 
c 0) 
c CI C I 
? § T- CN 
o o T- o t— CM 
1 
20 (Degree) 
Figure 2-4. Powder XRD diffraction patterns of the MSN-SH (green), MSN-COOH (red) and MSN-S03H (blue) 
materials after treatment with disulfide reducing agent (DTT). 
These materials exhibited diffraction patterns characteristic of hexagonal MCM-41 
silicas, including (100), (110), and (200) peaks (Figure 2-4). In addition, all three MSN 
materials exhibited type IV BET isotherms with similar average BJH pore diamerters (Figure 
2-5 and Table 2-1). Hexagonally packed mesoporous channels were clearly observed in the 
TEM micrographs of these MSNs (Figure 2-1). The existence of the organic functional 
groups was confirmed by 13C solid state NMR spectroscopy (Figure 2-6). 
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Relative pressure (P/Po) 
0 60 81 
Pore diameter, (A) 
Figure 2-5. (a) Nitrogen sorption isotherms of the MSN-SH (green), MSN-COOH (red) and MSN-SO3H (blue) 
materials after treatment with disulfide reducing agent (DTT). (b) Pore size distributions of the MSN-SH, MSN-
COOH and MSN-SO3H materials. 
To quantify the amount of chemically accessible functional groups that are 
incorporated and oriented properly on the mesopore surfaces, we chemically converted the 
surface bound organic groups of the MSN-COOH and MSN-SO3H materials to thiol (-SH) 
by treating them with a disulfide reducing agent, dithiothreitol (DTT) as depicted in Figure. 
2-6. 
C2,C3 
C2 CI 
C5 C4 C3 COOH C4 C6 
C5C4C3 C2C1 
MSN-S03H 
6 ppm 
Figure 2-6. Solid state 13C CP-MAS NMR spectra of the MSN-SH (up), MSN-COOH (middle) and MSN-SO3H 
(bottom). 
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Figure 2-7. Schematic representation of the formation of thiol-functionalized mesoporous 
silica material (MSN-SO3H) via disulfide reduction with dithiothreitol (DTT). 
As shown in Scheme 2-2, reactions of the resulting free thiol-functionalized materials 
with the 2,2'-dipyridyl disulfide gave rise to 2-pyidyldithio-derivatized surface functional 
groups along with a 2-pyridothione compound as the side product. 
Table 2-1. Structural properties of the organically functionalized MSN materials. 
SN-SH 
MSN-COOI 
MSN-S03H 43.8 24.4 20.9 
Powder XRD Nitrogen Sorption Isotherms 
Low angle BET BET BJH 
(Silica) (A) 
/ I I <\ J'I /j « « /: V* jitk -fx /'t 
surface area pore volume pore 
|m 1 jft\ ( K\ Vt} (X) "1 10 ^200 
39.8 22.9 19.9 
/g; imug; W 
999 0.793 25.8 
40.5 22.8 20.1 920 0.657 27.3 
0.755 28J 
Nitrogen sorption isotherms of the three MSN materials exhibited a sharp step starting at ca. plp0 = 0.38, as 
shown in Figure 2-5a with reversible type IV isotherms. (The inflection point is attributed to the 
commencement of pore filling from which the pore diameter can be roughly estimated). 
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Given that every surface-bound thiol that reacted with the 2,2'-dipyridyl disulfide 
would yield one 2-pyridothione molecule in solution, the amount of chemically accessible 
surface thiol functionality of these three materials could be quantified by measuring the 
concentration (UV/Vis absorbance) of the 2-pyridothione (Xmax = 343 nm, s = 8,080 M"'cm" 
')13 in the supernatants of these reactions. The results showed that the solution concentrations 
of 2-pyridothione increased in the order of MSN-SH < MSN-COOH < MSN-SO3H, 
indicating that the surface concentration of the chemically accessible thiol functional group 
increases from MSN-SH (0.56 ± 0.01 mmol/g), MSN-COOH (0.97 ± 0.01 mmol/g), to MSN-
S03H (1.56 ±0.01 mmol/g). 
Interestingly, the elemental analyses of these materials showed a decreasing trend in 
the weight % of sulfur and carbon among these materials (MSN-SH > MSN-SO3H > MSN-
2-Pyridothione 
Scheme 2-2 
COOH) as summarized in Table 2-2. 
Table 2-2. Elemental Analysis of the organically functionalized MSNs 
Material C % H % S % 
MSN-SH 13.23 ±0.01 2.74 ±0.01 10.09 ±0.01 
MSN-COOH 8.60 ±0.01 2.33 ±0.01 5.98 ±0.01 
MSN-SO3H 9.79 ±0.01 2.60 ±0.01 7.95 ±0.01 
In spite of a lower loading of organic functional groups in MSN-SO3H, the results 
suggested that the amount of the chemically accessible organic functional groups in MSN-
SO3H is in fact higher than those of MSN-COOH and MSN-SH. Such a difference in the 
loading and spatial orientation of the organic functional groups could be attributed to the 
competition between the anionic species, i.e., Br", silicates, and the anionic 
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organoalkoxysilane precursors (CDSP-TMS, SDSP-TMS and MP-TMS), for the cationic 
surfactants (CTAB). Indeed, the least hydrated sulfonate group-containing SDSP-TMS gave 
rise to the highest loading of chemically accessible organic groups. Furthermore, relative to 
the carboxylate group, the thiolate offered less stabilization of the CTAB micelle aggregates, 
and therefore yielded the lowest loading. 
Conclusions 
Functionalization of mesoporous silica materials is an important prerequisite for 
further utilization of these materials in various applications. In the presented work we studied 
the possibility of gaining control over the amount of chemically accessible functionality on 
the interior or exterior surface of mesoporous silicas. Our results have shown that the 
amounts of chemically accessible organic functional groups present on MCM-41 silica 
particles and consequently on Mesoporous Silica Nanospheres (MSN) by utilizing a modified 
co-condensation reaction can be controlled. This fine-tuning can be achieved by carefully 
designing the matching between the surfactant head groups and the desired organic 
functional group precursors. We concluded that there is a synergy of factors influencing the 
micellar-silica interaction. Among these factors we were investigating: 
a), electrostatic interaction at the micellar rod-precursor head groups interface; 
b). size matching between the cationic head group of the surfactant and the organo-
precursor head-group; 
c). binding affinities between different ionic species and the cationically charged 
CTAB micelle, based on published physical-chemistry studies of binding constants of such 
interactions . 
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Chapter 3. Molecular Recognition Inside of Multifunctionalized Mesoporous Silicas: Toward 
Selective Fluorescence Detection of Dopamine and Glucosamine 
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Abstract 
Organofunctionalized MCM-41 silica pores could serve as synthetic scaffolds to 
mimic enzyme or antibody active sites for specific covalent and/or noncovalent interactions 
with target molecules. Herein, we report the design and synthesis of a fluorescence sensory 
system to study the molecular recognition events of biogenic molecules, such as dopamine 
and glucosamine, inside different functionalized mesoporous silica microenvironments. 
Introduction 
Structurally well-defined mesoporous silica materials, such as MCM-type silicas, with 
tunable pore size and narrow pore-size distribution have attracted much attention for their 
potential applications in adsorption, catalysis, separation, and sensing. Our design strategy 
took advantage of the size-sieving ability of the mesoporous silica framework as the 
supporting matrix to first incorporate an amine-sensitive o-phthalic hemithioacetal (OPTA) 
group on the pore-surface. Only small molecules with amino groups can diffuse into the 
pores and react with the OPTA group to give rise to highly fluorescent isoindole products as 
depicted in Figure 3-1. In contrast to the molecular imprinted micro- and/or mesoporous 
silica materials- where the selectivity was determined by the pore shape and the functional 
group density in each cavity, we prepared multifunctionalized pores to not only capture the 
target substrate molecules covalently but also provide different secondary noncovalent 
interactions. OPTA-derivatized mesoporous silica materials with various surface-bound 
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functional groups allow modulation of our sensory system to enhance the substrate selectivity 
by tuning substrate accessibility and pore hydrophobicity. 
Figure 3-1. Schematic representation of the o-phthalic hemithioacetl (OPTA) functionalized mesoporous silica 
material and their fluorescent detection of amines. (R) siloxy, propyl, phenyl, or pentafluorophenyl groups; Rz-
NH2 ) dopamine or glucosamine). 
Experimental Section 
Materials. 3 -Mercaptopropionic acid (99+%), 2,2'-dipyridyl disulfide (98%), (3-
mercaptopropyl)trimethoxysilane (MPTES) (95%), 2-mercaptoethanesulfonic acid sodium 
salt (98%), cetyltrimethylammonium bromide (CTAB), tetraethyl orthosilicate (TECS, 96%), 
pentafluorophenyltri trimethoxysilane (PFTES) and dithiothreitol (DTT) were purchased 
from Aldrich Chemical Co. (Milwaukee, WI). Acetic acid (Glacial), hydrochloric acid 
(37.4%), sodium hydroxide, ethanol (anhydrous), methanol (HPLC grade), tetrahydrofuran 
(HPLC grade), hexanes (pesticide grade) and ethyl ether (anhydrous) were obtained from 
Fisher Scientific Co. (Pittsburgh, PA). Nanopure water was deionized to 18.0 M£2-cm in a 
Bamstead E-pure water purification system and used for the synthesis of MSN materials. 
Materials and Methods 
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Synthesis of Thiol-functionalized Mesoporpous Silica Material (Ml) 
To synthesize the thiol-functionalized mesoporous silica (Ml), we modified the well 
developed cetyltrimethylammonium bromide (CTAB) surfactant templated co-condensation 
method of tetraethoxysilane (TEOS) and organosiloxane precursors12 by using compound 1 
as the organosiloxane precursor depicted in scheme 3-1. 
Synthesis of compound 1 
NaOaS^x—s. 
SH 
S—S 
HOAc 
 
,Si(OMe)3 Hf 
MeOH NaO; 
la 
,SI(OM@b 
MeOH 
Scheme 3-1 
2,2'-Dipyridyl disulfide (8.82 g, 40.0 mmol) was dissolved in 50.0 mL of methanol; 
1.6 mL of glacial acetic acid was added as catalyst. To this mixture, 2-
Mercaptoethanesulfonic acid sodium salt (3.82 g, 20.0 mmol) in 30.0 mL of methanol was 
added dropwise in 30 min with stirring. The reaction mixture was protected from light and 
stirred at ambient temperature overnight, followed by solvent evaporation under vacuum. 
The crude product was repurified by dissolving in a small amount of methanol, followed by 
ethyl ether precipitation and dried under vacuum to yield compound la. 5.14 g, yield = 
94.0%.  1H-NMR (300 MHz;  DMSO-d6) ,  5  2.73 (m,  2H,  CH 2 ) ,  3 .02 (m,  2H,  CH 2 ) ,  7 .24 (d ,  
1H, ArH), 7.81 (m, 2H, ArH), 8.45 (d, 1H, ArH). 
To synthesize 2-[3-(trimethoxysilyl)-propyldisulfanyl]-ethanesulfonic acid sodium 
salt (1), compound la (1.36 g, 5.0 mmol) was dissolved in 20.0 mL of methanol with 1.0 mL 
of glacial acetic acid. To this mixture, (3-mercaptopropyl)trimethoxysilane (0.95 mL, 5.0 
mmol) in 10.0 mL of methanol was added dropwise. The mixture was protected from light 
and stirred under nitrogen at room temperature overnight. The reaction mixture was 
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quenched and solvent was evaporated under vacuum. The solid obtained was dissolved in a 
small amount of methanol, followed by ethyl ether precipitation. The purified product was 
collected by filtration and dried under vacuum. 5.14 g, yield = 74.7%. 1H-NMR (300 MHz; 
DzO) 8 0.79 (t, 2H, CH2(1)), 1.83 (q, 2H, CH2(2)), 2.81 (t, 2H, CH2(3)), 3.03 (t, 2H, CH2(5)), 
3.27 (t, 2H, CH2(4)), 3.60 (s, 7H, OCH3). 
Synthesis of Ml 
Sodium hydroxide (0.83 g, 20.84 mmol) was dissolved in 80.0 mL (5.0 x 103 mmol) 
of deionized water, and 1.52 g (4.17 mmol) CTAB was added while stirring continuously to 
get a clear solution, and then compound 1 (1.24 g, 3.46 mmol) was added. The reaction 
mixture was stirred at ambient temperature for two hours, followed by dropwise addition of 
TEOS (6.97 mL, 31.27 mmol). The mixture was stirred vigorously at room temperature for 
two days followed by heating at 90°C for one day to improve the structural order. The as-
synthesized Ml was filtered off, and then dried at 90°C under vacuum for 10 h. To remove 
the surfactant template, 3.0 g of as-synthesized Ml was refluxed for 24 hours in 9.0 mL 
37.4% HC1 / 324.0 mL MeOH. To obtain mesoporous silica material with free thiol groups 
(Figure 3-1), the surfactant extracted Ml (0.42 g) was added to 100.0 mL of NaHCOs 5% 
aqueous solution containing a disulfide reducing agent, dithiothreitol (DTT) (1.88 g, 12.2 
mmol). The mixture was stirred at room temperature for 3 hours, then filtered off and washed 
with water. The white powder obtained was dried under vacuum at ambient temperature. 
Solid-State CP-MAS NMR Spectra 
Solid-state 29Si and 13C CP-MAS NMR spectra were obtained at 59.62 MHz and 
75.47 MHz, respectively, on Bruker MSL300 spectrometer equipped with Bruker 4mm rotor 
MAS probe. Magic-angle sample spinning rate was maintained at 4 KHz for 29Si 
measurements, and was increased to 10 KHz for 13C in order to minimize the spin band due 
to the high anisotropic chemical shifts of aromatic carbons. The NMR spectra consisted of 
between 2,000 and 6,000 acquisitions with cross polarization times of 1ms (29Si) and 3ms 
(13C) and pulse repetition times of 10s (29Si) and 15s (13C). All chemical shifts reported are 
referenced to liquid Me^Si (TMS). 
Figure 3-2. Schematic representation of the formation of thiol-functionalized mesoporous silica material via 
disulfide reduction with dithiothreitol. 
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Figure 3-3. (a) Incorporation of the covalently linked organic groups was confirmed by 29Si CP NMR 
spectroscopy which showed distinct resonances for Si atoms in both siloxane [Qx = Si(OSi)x(OH)4.x, x = 2-4] 
and organosiloxane [Ty = RSi(OSi)y(OH)3.y, y = 1-3] environments, (b) 13C CP-MAS NMR spectra of these 
materials further verified the multi-functional nature of the M2, M3, and OPTA-Ml indicating that all the 
organic functional groups were covalently linked to the silica surfaces 
Transmission Electron Microscopy (TEM) Analyses 
The TEM image of thiol-functionalized mesoporous silica (Ml) reveals the hexagonal 
array of uniform channels with the typical honeycomb appearance of MCM-41 type of 
mesoporous materials shown in Figure 3-4. The silica powder was mixed with acrylate 
embedding resin. Then the mixture in an embedding capsule was centrifuged and cured for 
24 hours at 60 °C. The embedded block was microtomed to get thin sections of ca. 60 nm 
thick by using an ultramicrotome (RMC MT6000-XL) with a diamond knife. The floated 
sections were mounted on a 400 mesh Cu grid. The thin sections were observed with a 
transmission electron microscope (Hitachi H9000NA) operating at 300 kV and at 150,000 x 
electron optical magnification. 
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Figure 3-4. TEM image of a representative region of thiol-functionalized mesoporous silica (Ml) after 
surfactant extraction and disulfide reduction. The inset shows the selected area electron diffraction pattern from 
this region. 
BET Nitrogen Adsorption Isotherms and BJH Pore-size distributions 
Surface area (SA) and Median Pore Diameter (MPD) were measured using a 
Micromeritics ASAP2000 sorptometer. Samples were degassed at 90 °C for 1 h and at 150 
°C for 4 h. Nitrogen adsorption and desorption isotherms of the MSN materials were 
obtained at -196 °C. Specific surface areas and pore size distributions were calculated using 
the BrunauerEmmett-Teller (BET) and Barrett-Joyner-Halenda (BJH) method, respectively 
(Figure 3-5). 
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Figure 3-5. BET Nitrogen Adsorption Isotherms and BJH Pore-size distributions of multifunctionalized 
mesoporous materials, from Ml to M4. 
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Fluorescence Detection of Dopamine and Glucosamine with Organo-functionalized 
Amorphous Silicas 
An Amorphous silica material (O.lg) with a 200 m2/g BET surface area was 
purchased from Aldrich and treated with 3-mercaptopropyltrimethoxysilane (0.9 mL, 4.7 
mmol) in a 10 mL of toluene solution. The reaction mixture was refluxed over night under 
nitrogen. The resulting thiol-grafted silica was filtered and washed thoroughly with toluene, 
ethanol, and deionized water. The product was then filtered and dried under vacuum for 12 h. 
Propyltrimethoxysilane (0.85mL, 4.7 mmol) and phenyltrimethoxysilane (0.9 mL, 4.7 mmol) 
were grafted separately to the thiolfunctionalized silica to yield two different multi­
functionalized silicas, S2 (propyl- and thiol-derivatized silica) and S3 (phenyl- and thiol 
derivatized silica), respectively. The incorporation of all these organic groups was also 
confirmed by 13C CP-MS solid-state NMR spectroscopy (same as Figure 3-3). The amounts 
of chemically accessible thiol groups (S2: 0.08 mmol/g; S3: 0.1 mmol/g) of these 
multifunctionalized silica materials were determined by the aforementioned method.13 The 
CHNS elemental analyses of these materials indicated that the surface coverage of the propyl 
and phenyl groups are 0.054 mmol/g (S2) and 0.075 mmol/g (S3), respectively. 
Results and Discussion 
To synthesize these multifunctionalized mesoporous silica materials, we first 
prepared a thiol-functionalized MCM-41 silica (Ml) via a modified synthetic method of the 
well-developed surfactant templated co-condensation reaction.5 The unoccupied silica pore 
surface of the Ml was further functionalized with propyl, phenyl, and pentafluorophenyl 
groups via postsynthesis grafting procedures- using propyltrimethoxysilane, 
phenyltrimethoxysilane, and pentafluorophenyltriethoxysilane7 to yield three other 
multifunctionalized organomesoporous silica materials, M2, M3, and M4, respectively.8 The 
characterization of these materials is summarized in Table 3-1. 
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Table 3-1. Characterization of Multifunctionalized Mesoporous Silicas 
B J I l  p u r e  dk ' t iuvaih 
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M2 VV) 2u.(i U 
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M4 y i i )  2 i i . 7  1 . 2  
a See experimental section for the adsorption isotherms and pore size distributions, b Chemically accessible 
thiol densities were determined by measuring the solution concentration of the side product (pyridine-2-thione) 
generated from the reaction of the pore-surface thiols with 2,20-dipyridyl disulfide.9 c Measured by CHNS 
elemental analyses. 
Phthalic dicarboxaldehyde (o-phthalaldehyde, OP A) was introduced to suspensions of 
these thiol-containing multifunctionalized mesoporous silicas in a neutral buffer solution to 
form the amine-sensitive o-phthalic hemithioacetal-derivatized materials, OPTA-MX (X - 1 
to 4). Incorporation of the OPTA groups was confirmed by 13C CP-MAS NMR spectroscopy 
(see experimental section). The resulting OPTA-silica powder was dispersed in buffer for the 
fluorescence sensing experiments of dopamine or glucosamine. In contrast to the reported 
results of multi-functionalized mesoporous silicas, Figure 3-6a,b shows that the reaction rates 
of the nonporous silica surface-bound OPTA groups with dopamine and glucosamine are 
almost the same. Despite of the different surface phenyl groups), the fluorescence intensity of 
all three materials (OPTA-SX, X = 1 to 3) increased rapidly and reached their plateaus within 
5 min. Also, in the concentration studies, all OPTA-SX (X = 1 to 3) amorphous silica 
materials showed similar changes of fluorescence intensity with the increasing concentration 
of dopamine or glucosamine (Figure 3-6c,d). 
28 
OP I V SI  
M 
I 
e 4 M M 
e S 
I 
0 40 50 60 
Time (min) Time {mitt,) 
6.2-
L2 
1.(1-
•OH 
S 
Figure 3-6. Kinetic measurements of the fluorescence detection of dopamine (a) and glucosamine (b) with 
OPTA-derivatized amorphous silicas grafted with secondary functional groups, such as silanol (SI: solid line), 
propyl (S2: dotted line), and phenyl (S3: dashed line) groups. Fluorescence increase of OPTA-SX (X = !:•; 2: 
? ; 3: A) as a function of dopamine (c) and glucosamine (d)concentrations. 
In contrast to the instaneous completion of the homogeneous reaction of 2-
mercaptoethanol, OP A, and dopamine or glucoseamine to form a highly fluorescence 
isoindole, the reactions of dopamine (30 t* M) with all four of our OPTA-derivatized 
mesoporous silicas exhibited slower reaction rates (Figure 3-1a). For OPTA-Ml, the increase 
of fluorescence intensity at the emission Amax of isoindole (440 nm) reached a plateau 
indicating the completion of the reaction in about 10 min. In contrast to the dopamine 
experiment, OPTA-Ml treated with 600 f*M glucosamine took about 2 h for the reaction to 
proceed to completion (Figure 3-7b). The reaction rate of glucosamine is at least 1 order of 
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magnitude slower than that of dopamine. Since dopamine and glucosamine are similar in 
their sizes and reactivities toward OPTA in homogeneous solutions,10'11 the large difference 
in reaction rates between dopamine and glucosamine could not be explained by the size-
sieving effect of these functionalized mesoporous materials. Conceivably, the significantly 
slower reaction rates of glucosamine could be attributed to a strong dipolar interaction 
between the abundant hydroxy groups of glucosamine with the pore surface silicates leading 
to a slower diffusion process within the pores. In addition, as the silicate walls are 
functionalized with increasingly hydrophobic substituents (OPTA-MX, X = 2 to 4), the 
diffusion rates for both dopamine and glucosamine are slowed (Figure 3-7a,b). The 
fluorescence intensity of these OPTA-derivatized mesoporous silicas treated with dopamine 
and glucosamine also varies dramatically depending on the pore environment (Figure 3-7c,d). 
In our study of dopamine binding, the measured fluorescence intensity of OPTA-Ml 
increased with the increasing concentration of dopamine, but for the more hydrophobic 
OPTA-MX (X = 2 to 4) materials, the change of fluorescence intensity was smaller than that 
of OPTA-Ml. The reaction rates of dopamine binding are clearly slower in these materials. 
Furthermore, the OPTA-M4/dopamine binding gives a significantly higher increase of 
fluorescence intensities at all concentrations in comparison with that of OPTA-M3 and 
OPTA-M4. This observation strongly suggested that the pentafluorophenyl-functionalized 
mesopores of the OPTA-M4 were more reactive and preferred by dopamine compared to the 
propyl- and phenyl-fimctionalized pores of the OPTA-M2 and OPTA-M3 materials. Since 
both the average pore sizes and the surface coverage of the thiol functionality of these 
materials (MX, X = 2 to 4) are very similar (Table3-1), the large difference in binding 
behaviors is not likely due to the slight variation in the amount of chemically accessible thiol 
groups or the pore size of the functionalized mesopores of these materials. Compared with 
the phenyl-fimctionalized OPTA-M3, the better %-a donor/acceptor type of stacking effect 
between the catechol rings of dopamine molecules and the pentafluorophenyl moieties of the 
OPTA-M4 silica could induce a faster and more favorable diffusion of dopamine to enter 
their functionalized mesopores. The hydrophobic propyl-functionalized OPTA-M2 material 
discourages the intercalation of dopamine. The same fluorescence study for glucosamine 
binding to OPTA-Ml at various concentrations showed similar large increases in 
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fluorescence intensity (Figure 3-7d). In contrast to dopamine binding, the propyl-, phenyl-, 
and pentafluorophenyl-functionalized OPTA-MX (X = 2 to 4) materials showed only similar 
small increases of fluorescence intensities with increasing glucosamine concentrations. These 
data further support the possibility that the nonaromatic glucosamine molecules could not 
easily diffuse into either the propyl-, phenyl-, or pentafluorophenyl-functionalized mesopores 
to react with the OPTA groups due to the hydrophobic environment inside the pores. 
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Figure 3-7. Kinetic measurements of the fluorescence detection of dopamine (a) and glucosamine (b) with 
OPTA-dervatized mesoporous silicas grafted with secondary functional groups, such as silanol (Ml: solid line), 
propoyl (M2: dotted line), phenyl (M3: dashed line), and pentafluorophenyl (M4: dash-dotted line) groups. 
Fluorescence increase of OPTA-MX (X ) = 1 (•); 2 (O); 3 (?); 4 (A) as a function of dopamine (c) and 
glucosamine (d) concentrations. 
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Conclusions 
In this study, we have demonstrated that selective molecular recognition of two 
multifunctional molecules with similar sizes and functionalities can be achieved not by shape 
recognition but by creating a multifunctionalized mesopore as the "active site" with 
ombinations of covalent (isoindole formation) and noncovalent interactions (hydrophobic 
and a-is interactions). The presented selectivity was not observed in the amorphous silica 
systems grafted with the same organofunctionalities, such as propyl and phenyl groups. 
Unlike the large difference in the increases of fluorescence intensity in the cases of dopamine 
and glucosamine binding to the OPTA-derivatized mesoporous silicas with different 
secondary functional groups, such as propyl and phenyl groups, the presence of the same 
hydrophobic functional groups here apparently did not significantly perturb the kinetic 
profiles of dopamine/glucosamine reacting with the amorphous silicas decorated with the 
same functional groups (see Figure 3-6). These results support our hypothesis that the multi-
functionalization of a material with size and structurally well-defined, meso-scale pores is an 
important prerequisite for further developing new types of sensors or catalysts with highly 
selective molecular recognition sites within a rigid scaffold that could mimic biological 
active sites. Therefore, we envision that these multifunctionalized mesoporous silicas could 
serve as new materials for developing highly selective sensors and catalysts. 
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Abstract 
Selective functionalization of the exterior and interior surface of structurally uniform 
mesoporous materials, such as MCM- or SBA-type of silicas with different organic moieties2 
allows precise regulation of the penetration of selective molecules with certain sizes and 
chemical properties into the nano-scale pores. Herein, we report the synthesis and 
characterization of a poly(lactic acid)-coated, MCM-41 type mesoporous silica nanosphere 
(PLA-MSN) material that can serve as a fluorescence sensor for selective detection of amino-
containing neurotransmitters under physiological condition. By utilizing the PLA layer as a 
gatekeeper to regulate the penetration of molecules in and out of the nano-scale pores, we 
investigated the molecular recognition events between several structurally simple 
neurotransmitters, i.e., dopamine, tyrosine, and glutamic acid and a pore surface-anchored o-
phthalic hemithioacetal (OPTA) group. 
Introduction 
Synthesizing molecular receptors that can differentiate various extracellular amino 
acid-based neurotransmitters has long been a research challenge. For example, dopamine 
and glutamic acid are two essential neurotransmitters that are often simultaneously 
exchanged between various neural cells.1 Despite their importance in understanding 
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interneuronal chemical communication, to the best of our knowledge, no synthetic molecular 
receptor has been reported in the literature that can distinguish dopamine from glutamic acid. 
In this chapter, we extend our sensor design strategy from providing a secondary interaction 
between similar targets to study the molecular recognition events to coating a poly(lactic acid) 
layer on MCM-41 type mesoporous silica nanosphere (PLA-MSN) to regulate the diffusion 
of detecting amino-containing neurotransmitters under physiological condition. 
Experimental Section 
Preparation of materials 
5,6-Epoxyhexyltriethoxysilane was purchased from Gelest, methanol and toluene 
were purchased from Fisher, and all other chemicals were purchased from Aldrich. All 
chemicals were used as received without further purification. Figure 4-1 illustrates schematic 
representation of the mesoporous silica nanosphere (MSN) materials functionalized with 
mercaptopropyl (Thiol-MSN) and bifunctionalized with dihydroxyhexyl/mercaptopropyl 
(DH-MSN). 
Figure 4-1. Schematic representation of a surface of MSN materials: Thiol-MSN (a) and DH-MSN (b). 
Synthesis of DH-MSN 
5,6-Epoxyhexyltriethoxysilane (EHTES, 1.0 mmol) was added to a toluene 
suspension (80.0 mL) of thiol-MSN (1.0 g). The reaction mixture was refluxed overnight 
under nitrogen. The resulting material was filtered, washed extensively with toluene and 
methanol and dried under vacuum for 3 h at 25 °C. The 5,6-epoxyhexyl-grafted thiol-MSN 
Materials and Methods 
OH 
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material (1.50 g) was refluxed in a 162 mL methanol solution of hydrochloric acid (1.57 M) 
for 12 h to remove the CTAB template. The HCl methanol solution also converted the thiol-
MSN with epoxyhexyl groups to the desired 5,6-dihydroxyhexyl-coated thiol-MSN material 
(DH-MSN). The surfactant-removed DH-MSN (1.00 g) was treated with 80 mL 
water/methanol (1/7) solution of sodium bicarbonate (0.042 g) for 4 h at room temperature to 
remove any unreacted, physisorbed EHTES. The purified material was dried under vacuum 
for 6 h at 60 °C. 
Synthesis of PLA-coated thiol-MSN 
The purified DH-MSN material (0.68 g) was sonicated for 30 min in 10.0 mL 
anhydrous THF to disperse the particles uniformly. Z-Lactide (0.36 g, 2.50 mmol) was mixed 
with tin(II)-2-ethylhexanoate (Sn(Oct)z, 0.16mL, 0.50 mmol), in 15 mL anhydrous THF. The 
lactide/catalyst solution was added to the DH-MSN THF solution by injection under N%. The 
reaction mixture was stirred for 72 h under N% at 80°C to produce the PLA-coated thiol-MSN. 
Synthesis of OPTA-SS material 
A fumed amorphous silica material (0.2 g) with a 200.0 m2/g BET surface area was 
added to a 20.0 mL toluene solution of 3-mercaptopropyltrimethoxysilane (0.88 mL, 4.68 
mmol). The reaction mixture was refluxed over night under nitrogen. The resulting thiol-
grafted solid silica was filtered and washed thoroughly with toluene, ethanol, and de-ionized 
water. The product was isolated by filtration and dried under vacuum for 12 h. Chemically 
accessible thiol density was determined by measuring the solution concentration of the side 
product (pyridine-2-thione) generated from the reaction of the surface thiols with 2,2'-
dipyridyl disulfide in THF.1 The surface-bound thiol functionality was then converted to o-
phthalic hemithioacetal (OPTA) by reacting 85.0 mg of material with 170.0 mg (126.0 mmol) 
of phthalic dicarboxaldehyde (o-phtal aldehyde, OP A) in 10 mL methanol for 5 h. After 
filtration, the material was extensively washed with methanol and dried under vacuum. 
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Material Characterization 
Solid state NMR was used to characterize the mesoporous silica nanosphere (MSN) 
materials functionalized with mercaptopropyl (Thiol-MSN) and bifunctionalized with 
dihydroxyhexyl/mercaptopropyl (DH-MSN). The expected structures of these materials are 
illustrated in Figure 4-1. In addition, a PLA-coated sample (PLA-MSN) prepared from DH-
MSN, was examined. The samples were also analyzed by powder X-Ray diffraction and by 
measurements of nitrogen adsorption/desorption isotherms (see following Sections). 
Experimental conditions 
Solid-state nuclear magnetic resonance (NMR) of 29Si and 13C was used to (i) confirm 
the functionalization of MSN materials, (ii) determine their average molecular formulae, and 
(iii) provide evidence for polymerization of the lactide. The spectra were obtained at 9.4 T on 
a Varian/Chemagnetics Infinity spectrometer equipped with a doubly-tuned 5-mm magic 
angle spinning (MAS) probe. A sample rotation rate of 9 kHz was used in all experiments. 
The method of variable amplitude cross polarization (CP) between 'H and the observed, 
diluted nuclei (13C or 29Si) was used to increase the sensitivity.2 During each CP period, the 
!H rf magnetic field was ramped between 16 and 40 kHz using 2.4 kHz increments, whereas 
the 29Si (or 13C) rf field was maintained at a constant level of 36 kHz. The *H rf magnetic 
fields of 83 kHz and 60 kHz were used for initial excitation and during continuous wave 
(CW) decoupling, respectively. The measured values of 1H longitudinal relaxation time TiH 
did not exceed 1 s, which allowed for repetition time of 1.2 s to be used in the CPMAS 
experiments. In the 1H—>13C CPMAS experiments, 6,000 free induction decays (FID's) were 
typically acquired using two different contact times of 0.4 or 1.5 ms. The !H—> 29Si CPMAS 
experiments used a contact time of 1 ms and 36,000 scans. All spectra were referenced to 
SiMe4. In spite of long relaxation times of 29Si nuclei, the direct polarization (DPMAS) 
method was used for quantitative measurements of various silicon groups. During these 
measurements a 90° excitation pulse of 2.1 fxs was followed by acquisition of the 29Si FID 
under CW !H decoupling at 65 kHz. The saturation recovery experiment, carried out with 
MCM-41 samples functionalized with allyl and 3-isocyanatopropyl groups, yielded the 
values of 7iSl on the order of 50 to 65 s for T" groups and 30 to 45 s for Qn groups.3 Thus, a 
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delay of 300 s between the scans was used to allow for full restoration of the equilibrium 
magnetization of 29Si spins. An acquisition of 270 FID's yielded the relative intensities of 29Si 
resonances with an accuracy of ± 3%. 
Powder X-Ray Diffraction 
Powder XRD experiments were performed on a Scintag XDS 2000 diffractometer 
using a Cu Km radiation source. Low angle diffraction with a 28 range of 1 to 10 " was used 
to investigate the long-range order of the materials. 
Nitrogen adsorption/desorption isotherms 
The surface area and median pore diameter were measured using N% 
adsorption/desorption measurements in a Micromeritics ASAP 2000 BET surface analyzer 
system. The data were evaluated using the Brunauer-Emmett-Teller (BET) and Barrett-
Joyner-Halenda (BJH) methods to calculate the surface area and pore volumes/pore size 
distributions, respectively. Samples were prepared by degassing at 90 * C for 1 h and then at 
150 3 C for 4 h. 
Particle size distribution and scanning electron micrograph of PLA-MSN 
Particle morphology of these materials was determined by scanning electron 
microscopy (SEM) using a Hitachi S4700 FE-SEM system with 10 kV accelerating voltage 
and 0.005 nA of beam current for imaging. 
Transmit ion electron micrograph of PLA-MSN 
For transmission electron microscopy (TEM) studies, a small aliquot was taken from 
a suspension of methanol and placed in a lacey carbon-coated TEM grid, which was pulled 
through the suspension and allowed to dry in air. Thin sections of samples embedded in 
epoxy resin were obtained with ultramicrotomy (60-80 nm). The resulting sample was 
examined with a Philips model CM-30 TEM operated at 300 kV. The specimen was given no 
further treatment, as it appeared stable under beam bombardment. 
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HPLC analysis of the competitive detection of PLA-MSN system in a mixture of dopamine 
and glutamic acid 
PLA-MSN nanoparticles (2 mg) were introduced to a pH 7.4 PBS buffer (10 mM) 
solution of dopamine (0.5 mM) and glutamic acid (10 mM) at 25°C. After 10 min of mixing, 
the suspension was centrifuged and the individual concentrations of dopamine and glutamic 
acid in the supernatant were analyzed by HPLC. All analyses were performed on a Hitachi 
LC/3DQMS HPLC system with a reverse phase CIS column (SUPELCOSIL LC-18-T 250 
mm x 4.6 mm, ID 5gm packing, Aldrich). The UV absorption peak at 210 nm was used for 
the quantitative analyses of Glutamic acid and Dopamine. Flow rate of mobile phase was 1 
mL/min. The mobile phase eluent consisted of a mixture of 0.1M potassium dihydrogen 
phosphate adjusted to pH 6.0 (solvent A) and methanol (solvent B). The elution gradient 
program was as follows: 0 min 100% A, 0% B, 9min 100%A, 0%B; llmin, 70%A, 30% B; 
17 min 70% A, 30% B; 18 min 100% A, 0% B. Finally, an additional 7 min was allowed for 
the column to return to the initial condition and re-equilibrate. The column temperature was 
set at room temperature and the injection volume of samples was 25 j_lL for all analyses. 
Results and Discussion 
We synthesized a mercaptopropyl-functionalized mesoporous silica nanosphere 
(thiol-MSN) material with average pore diameter of 2.5 nm via our previously reported 
method.3"'4 As outlined in Figure 4-2, 5,6-epoxyhexyltriethoxysilane (EHTES) was grafted 
onto the exterior surface of the thiol-MSN-containing cetyltrimethylammonium bromide 
(CTAB) surfactants inside the mesopores. 
The resulting material was refluxed in a methanol solution of hydrochloric acid to 
remove the CTAB template and to convert the thiol-MSN with epoxyhexyl groups to a 5,6-
dihydroxyhexyl-coated thiol-MSN material (DH-MSN).5 Incorporation of the 5,6-
dihydroxyhexyl group was confirmed by 29Si and 13C CP- and DP-MAS NMR spectroscopy 
(see below) and the surface coverage was measured to be 43% (2.1 mmol/g). 
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Figure 4-2. Schematic representation of the synthesis of PLA-coated MSNbased fluorescence sensor system for 
detection of amine-containing neurotransmitters, i.e., dopamine, glutamic acid, and tyrosine (R-NH2). (5,6-
epoxyhexyltriethoxysilane ) EHTES, cetyltrimethylammonium bromide(CTAB) surfactant = 
Figure 4-3 shows the 13C and 29Si spectra acquired for Thiol-MSN, DH-MSN and 
PLA-MSN samples. The carbon chemical shifts §c corresponding to thiol, DH, and PLA 
functional groups are listed in Table 4-1, while Table 4-2 includes the chemical shifts ô& of 
T" and Q" silicone groups. In addition, Table 4-2 shows the relative concentrations of silicon 
groups, molecular formulae, and molar concentrations of organic functionalities obtained 
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from the 29Si DPMAS measurements. The 13C NMR results demonstrated that the 
functionalization of mesopores was accomplished as intended. Only relatively small amounts 
of secondary and/or unreacted species were detected, as discussed below. The spectra were 
processed, deconvoluted and integrated using SpinSight NMR software by 
Varian/Chemagnetics. The observed resonances were assigned based on chemical shifts 
found in the liquid state spectra of the analogous compounds. Thus, the 13C peaks at around 
11 and 27 ppm in thiol-MSN (Figure 4-3a) were assigned to carbons CI and the 
superposition of C2 and C3, respectively, in the thiol functional group.4 Small quantities of 
two additional species were also detected in this sample. The resonance at around 50 ppm 
was assigned to methoxy groups =SiOCH3,4 while the two resonances at 23 and 42 ppm 
could represent the C2 and C3 carbons in disulfide functionality (^SiCHiCHiCHzS)?/ The 
CI carbon in disulfide yielded a peak at around 11 ppm, which overlapped with CI in thiol. 
In the l3C spectrum of DH-MSN (Figure 4-3a) the resonances representing thiol and disulfide 
functionalities were found in approximately 2:1 ratio. Five additional resonances were 
identified at around 72, 69, 55, 36, and 30 ppm. The peaks at 72, 69, 36, and 30 ppm 
represent carbons C5, C6, C4, and C3 of DH functionality.6 The resonances from CI and C2 
carbons of DH, expected at positions around 23 (C2) and 10 (CI) ppm, overlap with those 
from disulfide and thiol groups.6 The small resonance at 55 corresponds most likely to CH2 
carbon of =SiOCH2CH3 group, in which case the CH3 carbon would overlap with the 
resonance at around 13 ppm. It is also possible, however, that the peak at 55 ppm is due to 
C5 carbon in unreacted EH groups.7 Spectrum (c, Figure 4-3) of PLA-MSN exhibits all 
resonances found in spectra (a) and (b) along with several new peaks representing the PLA 
coating, as shown in the last two columns of Table 4-1. It is also noted that the relative 
concentration of CTAB in all samples was below our detection limit of approximately 3%. 
Table 4-1. Summary of 13C CPMAS NMR data 
Thiol Sr disulfide Sr DU S,- PLA-MSN Sr 
C I  I I I  CI 11.1 CI 12.7 ( II; 16.4 
02 27.3 C2 23.2 C2 23.2 17.0 
C3 27.3 C3 42.4 C3 29.7 CM 70.1 
C4 36.5 75.9 
C5 71.7 CO 170.1 
C6 68.9 171.5 
174.7 
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Table 4-2. Summary of 29Si CPMAS NMR DATA 
Relative concentration of silicon groups SC Average molecular formula 
,, q2 q) Q4 
(-58ppm) (-67ppm) (-93ppm) f-!02ppm) (-112ppm) 
Thiol-MSN 4 15 3 29 49 37*2.7) (SiO:WlI,OWC;ll,Sh, 
DH-MSN 3 l(, 1 24 56 4.1(2.1) (Si0n)WH3()WC]H„SrC»ll,402)„ 
PLA-MSN 3 16 1 24 56 43 
(a) SC - sur'-xe covvnev cn'cu'ucd using following equation: St I I: l'id" • P' ' Qr t Qj). Isloic that NMR data represent 
the SC's of i,k ^ ltiu util Ki Wording to outNî adsorption ravusutetiMiK tl'.v external Mittatv uv1 w the suuliul MSN's was 
approximate l\ Mi°o 11 js k m i « ce coverage of internal po;v- in I liku-MSN is In fiist l | | , lo htplu* I hi v.iltks ii parentheses 
represent (h<_ i toi 11-. ul or_> u.n. uoups in miuol/g. 
CPMAS »Si DPMAS CPMAS 
(b) DH-MSN 
wVl / w V. 
200 im iso 
rjMrry.yTTf,pMrT|Tr uny .yy^y 
-20 -40 -80 -80 100 -120 140 180 -20 -40 -00 -*0 «100 -1Z) -140 -100 0 
Figure 4-3. 'H-^13C CPMAS (a-c), 29Si DPMAS (d-f) and 'H->29 SiCPMAS (g-i) spectra collected for Thiol-
MSN (a,d,g), DH-MSN (b,e,h) and PLA-MSN (c,f,i) samples. Following contact times (in ms) were used to 
collect the CPMAS spectra: 0.4 (a,b), 1.5 (c), and 1.0 (g-i). 
The assignments of 29Si NMR, which are also shown in Figure 4-3, spectra (d) and 
(g), are well established in the literature.3,4'8'13 The following silicone groups were found: T2 
(at -58 ppm), T3 (-67 ppm), Q2 (-93 ppm), Q3 (-102 ppm), and Q4 (-112 ppm). Surface 
coverage (SC), calculated using equation: SC = (T2 + T3)/(T2 + T3 + Q2 + Q3), expresses 
amount of surface silicone atoms bonded to an organic group per total number of surface 
silicone atoms. Note that the 29Si CPMAS spectra are not quantitative; they were merely used 
to facilitate the deconvolution of less intense resonances measured using DPMAS NMR. 
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The vacuum-dried DH-MSN material (0.68 g) was sonicated for 30 min in 10 mL of 
anhydrous THF to disperse the particles uniformly. L-Lactide (0.36 g, 2.50 mmol) was mixed 
with a catalyst, tin(II) 2-ethylhexanoate (Sn(Oct)2, 0.16 mL, 0.50 mmol), in 15 mL of 
anhydrous THF. The lactide/catalyst solution was added to the DH-MSN THF suspension via 
injection and stirred at 80 # C for 72 h to yield the PLA-coated thiol-MSN material. The 
crude solid product was further purified by a method previously published by Langer's 
group.7 As shown in Figure 4-4, the average thickness (ca. 11 nm) of the PLA layer was 
determined by transmission electron microscopy (TEM). The chemically accessible thiol 
density (0.22 mmol/g) of the purified PLA-MSN was measured by our previously published 
method.3a 
Figure 4-4. Transmission electron micrograph (TEM) of an ultramicrotomed PLA-MSN material. The layer of 
PLA can be visualized by the rim of amphorous structure surrounding the MCM-41-type of MSN core with 
mesopores packed in a hexgonal symmetry. 
The mercaptopropyl functionality was then converted to the amine-sensitive OPTA 
group by reacting 85.0 mg of PLA-coated thiol-MSN with 170.0 mg (1.26 mmol) of phthalic 
dicarboxaldehyde (o-phthalaldehyde, OP A) in 10 mL of methanol solution for 5 h. After 
filtration, the resulting material (PLA-MSN) was thoroughly washed with methanol and dried 
under vacuum. The morphology, particle size distribution, and the structure of organic 
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functionalities of PLA-MSN were scrutinized by XRD, SEM, TEM, N2 sorption isotherms 
(From Figure 4-5 to 4-7 and Table 4-3). 
5 É 
k» 
ta 
Thiol-MSN 
DH-MSN 
PLA-MSN 
n 1 1 i 1 1 1 
2 3 4 5 6 7 8 
2 0 (Degree) 
Figure 4-5. Powder X-Ray diffraction patterns of thiol-MSN, DH-MSN, and PLA-MSN. All three materials 
exhibit the typical diffraction patterns of MCM-41 type mesoporous silica with hexagonal symmetry. 
Table 4-3. Powder X-Ray diffraction results 
Powder XRD Diffraction 
t/;o»(Â) fini (A.) 
Thiol-MSN 
DH-MSN 
PLA-MSN 
20.26 
23.30 
22.64 
11.50 10.00 
11.84 9.74 
11.50 9.63 
The N2 sorption isotherms of thiol-MSN material were published in our previous 
papers.9 The details of nitorgen sorption analyses of the DH-MSN and PLA-MSN materials 
are outlined below (Table 4-4). 
Table 4-4. Nitrogen sorption isotherms. 
Vj(k>ih! BET " BËT BÏÏÏ 
' 
c Surface Area (m~/g) Pore volume (inL/g) Average Pore Diameter (A) 
DH-MSN 904.38 0.53 23.0 
PLA-MSN 633.95 0.34 20.5 
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Figure 4-6. BET nitrogen adsorption/desorption isotherms and BJH pore size distributions of DH-MSN (solid 
line) and PLA-MSN (dashed line) materials. The BET isotherms of both DH-MSN and PLA-MSN materials 
didn't exhibit any hysteresis, which suggested the absence of the xerogel layer. 
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Figure 4-7. Particle size distribution (a) and scanning electron micrograph (b) of PLA-MSN. Polydispersity of 
PLA-MSN is approx. 160 nm (half width at half maximum of the particle size distribution). 
To examine the gatekeeping effect of the PLA layer in our PLA-MSN system, we 
prepared and characterized an amorphous silica material grafted with the same OPTA 
functionality (OPTA-SS) as a control system.6 The surface coverage of the OPTA group was 
determined to be 0.08 mmol/g.2a'4 Both the OPTA-SS and our PLA-MSN materials were 
dispersed in pH 7.4 PBS buffer (10 mM) for the fluorescence-sensing experiments of 
neurotransmitters. In the case of OPTA-SS, dopamine, tyrosine, and glutamic acid (230 MV1 
each) reacted with the surface-bound OPTA groups rapidly, as evidence by the fluorescence 
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emission data shown in Figure 4-8a. It is noteworthy that both tyrosine and glutamic acid 
reacted to the OPTA-SS with very similar rates and therefore could not be distinguished. In 
contrast, the reactions of these analytes (230 |uM) with our OPTA-derivatized PLA-MSN 
exhibited significantly different and lower reaction rates (Figure 4-8b), by a factor of 4, 10, 
and 57, respectively. In the case of dopamine, the lower reaction rate could be attributed to 
the additional diffusional penetration through the PLA layer into the OPTA-functionalized 
mesopores. Clearly, the reaction rates of tyrosine and glutamic acid were further slowed by 
the gatekeeping effect of the PLA layer on these two analytes. In addition, our study (Figure 
4-8c) showed that the fluorescence intensity of OPTA-SS increased similarly with the 
increasing concentrations of all three neurotransmitters. However, in the case of the PLA-
MSN (Figure 4-8d), the dopamine binding gave the most significant increase of fluorescence 
intensities at all concentrations. We also note that a similar set of kinetic and titration 
experiments performed on the DH-MSN material (without PLA) showed no evidence of the 
gatekeeping effect.6 To examine the substrate selectivity of our PLA-MSN system in the 
presence of a mixture of neurotransmitters, PLA-MSN nanoparticles (2 mg) were introduced 
to a pH 7.4 PBS buffer 10 mM) solution of dopamine (0.5 mM) and glutamic acid (10 mM) 
at 25 "C. 
o 3 N w » a 
Timi (min.) 
* 
if* 1** If" 
M M *  M % 
a 
1 4 « |« |if* 
Figure 4-8. Kinetic measurements of the fluorescence detection of dopamine (s), tyrosine ( ), and 
glutamic acid ( ) with OPTA-SS (a) and PLA-MSN (b). Fluorescence increase of OPTA-SS (c) and 
PLAMSN (d) as a function of dopamine (b), tyrosine (O), and glutamic acid (4) concentrations. The 
fluorescence intensities were measured 5 min after the introduction of every concentration of each 
neurotransmitter. 
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After 10 min of mixing, the suspension was centrifuged, and the individual 
concentrations of dopamine and glutamic acid in the supernatant were analyzed by HPLC 
(Figure 4-9).6 
Glutamic acid Donaminc 
0 2 4 6 8 10 12 14 
Time (min.) 
Figure 4-9. HPLC chromatographs of the solution containing dopamine (0.5 mM) and glutamic acid (10 mM) 
before (blue) and after (red) the introduction of PLA-MSN. 
Given that the signal transduction mechanism of the PLA-MSN system is based on 
the covalent capture of substrates by the surface-bound OPTA groups, the different degrees 
of concentration decrease of these two analytes in solution would represent the selectivity of 
the PLA-MSN system. Despite the initial 20:1 concentration ratio between glutamic acid and 
dopamine, the results showed a 96% decrease of dopamine concentration, whereas only a 2% 
decrease of the concentration of glutamic acid was observed (Table 4-5).6 
Table 4-5. HPLC analysis of dopamine and glutamic acid before and after the introduction of PLA-MSN. 
Dopamine 
1 ntegrated Peak Retention time 
Area (min) 
Glutamic acid 
Integrated Peak Retention time 
Area (min) 
Before 
introduction of 
PLA-MSN 
403270 10.54 140508 2.67 
After 10 min of 
mixing with 
PLA-MSN 
16499 10.72 138267 2.67 
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The observed large difference in the rates of diffusion is most likely due to the 
different electrostatic, hydrogen bonding, and dipolar interactions between these 
neurotransmitters and the PLA layer in pH 7.4 buffer solutions. The isoelectric points (pis) of 
dopamine, tyrosine, and glutamic acid are 9.7, 5.7, and 3.2, respectively, whereas the pi of 
PLA is typically below 2.0,8 which means the dopamine will be positively charged and the 
others will be negatively charged under our experimental conditions. Similar effects of pi 
have also been reported previously.9 For example, Blanco et. al reported that proteins with 
low pi values, such as bovine serum albumin (pi = 4.6) were released faster from a PLGA-
based polymer than those with high pis, such as lysozyme (pi = 11.2).9a 
Conclusions 
We report on the synthesis and characterization of a poly-(lactic acid)-coated, MCM-
41-type mesoporous silica nanosphere (PLA-MSN) material as a fluorescence probe. By 
utilizing the PLA layer as a gatekeeper to regulate the penetration of molecules in and out of 
the nanoscale pores, we successfully select the molecular recognition events between several 
structurally simple neurotransmitters, i.e., dopamine, tyrosine, and glutamic acid and a pore 
surface-anchored o-phthalic hemithioacetal (OPTA) group 
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Abstract 
An MCM-41 type mesoporous silica nanosphere-based (MSN) controlled-release 
delivery system has been synthesized and characterized using surface-derivatized cadmium 
sulfide (CdS) nanocrystals as chemically removable caps to encapsulate several 
pharmaceutical drug molecules and neurotransmitters inside the organically functionalized 
MSN mesoporous framework. We studied the stimuli-responsive release profiles of 
vancomycin- and adenosine triphosphate (ATP)-loaded MSN delivery systems by using 
disulfide bond-reducing molecules, such as dithiothreitol (DTT) and mercaptoethanol (ME), 
as release triggers. The biocompatibility and delivery efficiency of the MSN system with 
neuroglial cells (astrocytes) in vitro were demonstrated. In contrast to many current delivery 
systems, the molecules of interest were encapsulated inside the porous framework of the 
MSN not by adsorption or sol-gel types of entrapment but by capping the openings of the 
mesoporous channels with size-defined CdS nanoparticles to physically block the 
drugs/neurotransmitters of certain sizes from leaching out. We envision that this new MSN 
system could play a significant role in developing new generations of site-selective, 
controlled-release delivery nanodevices. 
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Introduction 
Several attractive features, such as stable mesoporous structures, large surface areas, 
tunable pore sizes and volumes, and well-defined surface properties of the organically 
functionalized MCM-type mesoporous silica materials1 have made them ideal for hosting 
molecules of various sizes, shapes, and functionalities. Therefore, developing new 
mesoporous silica-based carrier systems for controlled-release delivery of drugs,2 biocides, 
genes, or even proteins3 in vitro or in vivo is of keen interest. 
Many important site-selective deliveries, e.g., deliveries of highly toxic antitumor 
drugs, such as Taxol, require "zero release" before reaching the targeted cells or tissues. 
However, the release of encapsulated compounds of many current drug delivery systems 
typically takes place immediately upon dispersion of the drug/carrier composites in water.4 
Also, the release mechanism of many biodegradable polymer-based drug delivery systems 
relies on the hydrolysis-induced erosion of the carrier structure.5 Such systems typically 
require the use of organic solvents6 for drug loading, which could sometimes trigger 
undesirable modifications of the structure or function or both of the encapsulated molecules, 
such as protein denaturation and aggregation. Herein, we report the synthesis of a novel 
MCM-41 type mesoporous silica-based controlled-release delivery system that is stimuli-
responsive and chemically inert to the matrix-entrapped compounds. The system consists of a 
2-(propyldisulfanyl)ethylamine functionalized mesoporous silica nanosphere (MSN) material 
with an average particle size of 200.0 nm and an average pore diameter of 2.3 nm. As 
depicted in Figure 5-1, the mesopores of the MSN material were used as reservoirs to soak 
up aqueous solutions of various pharmaceutical drug molecules and neurotransmitters, such 
as vancomycin and adenosine triphosphate (ATP). The openings of the mesopores of the 
drug/neurotransmitter-loaded MSN material were then capped in situ by allowing the pore 
surface-bound 2-(propyldisulfanyl)ethylamine functional groups to covalently capture the 
water-soluble mercaptoacetic acid-derivatized cadmium sulfide (CdS) nanocrystals7 via a 
literature-reported amidation reaction.8 The resulting disulfide linkages between the MSNs 
and the CdS nanoparticles are chemically labile in nature and can be cleaved with various 
disulfide-reducing agents, such as dithiothreitol (DTT) and mercaptoethanol (ME). 
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Figure 5-1 Schematic representation of the CdS nanoparticle-capped MSN-based drug/neurotransmitter delivery 
system. The controlled-release mechanism of the system is based on chemical reduction of the disulfide linkage 
between the CdS caps and the MSN hosts. 
Hence, the release of the CdS nanoparticle caps from the drug/neurotransmitter-
loaded MSNs can be regulated by introducing various amounts of release triggers. In this 
study, we investigated the stimuli-responsive release profiles, the biocompatibility with 
neuroglial cells (astrocytes) in vitro, and the delivery efficiency of vancomycin and 
adenosine triphosphate (ATP) encapsulated inside the CdS-capped MSN system. 
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Materials and Methods 
Experimental Section 
Materials. Cadmium nitrate tetrahydrate (99.99%), sodium sulfide, mercaptoacetic acid, 3-
mercaptopropyltrimethoxysilane (MPTMS), n-cetyltrimethylammonium bromide (CTAB), 
tetraethyl orthosilicate (TEOS), 2-aminoethanethiol hydrochloride, l-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC), dithiothreitol (DTT), and 
aldrithiol-2 were purchased (Aldrich) and used as received. Vancomycin hydrochloride and 
adenosine triphosphate disodium salt (ATP) were obtained from Sigma and used without 
further purification. Nanopure water (18.1 MHz) prepared from a Bamstead E-pure water 
purification system was employed throughout. PBS buffer (10.00 mM, pH 7.4) solutions with 
the total ionic strength of 0.06 M were prepared and used as the solvent for all the loading 
and release experiments of vancomycin and ATP. 
CdS Nanoparticle Preparation 
Synthesis of Mercaptoacetic Acid-Derivatized Cadmium Sulfide (CdS) Nanoparticles. 
The synthetic procedures were modified from the previous literature report by Alivisatos and 
co-workers.7 Mercaptoacetic acid (2.15 x 10"3 mol, 150.00 mL) was added to an aqueous 
solution (270.00 mL) of cadmium nitrate tetrahydrate (3.00 * 10"4 mol), forming a turbid 
blue solution, followed by adjusting the solution pH to 11 with 0.01 M NaOH. Sodium 
sulfide (1.50 X 10"4 mol) was dissolved in 10.0 mL of H2O and rapidly added to the cadmium 
nitrate solution with vigorous stirring. The reaction mixture was protected from light and 
stirred for 10 min. It was concentrated to about one-tenth of its original volume using a rotary 
evaporator, and anhydrous methanol was added until the precipitate formed, yielding the 
mercaptoacetic acid-capped, water-soluble cadmium sulfide nanoparticles (CdS). 
Synthesis of MCM-41-Type Mesoporous Silica Nanosphere with 2-
(Propyldisulfanyl)ethylamine Functionality (Linker-MSN) 
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The MSN material was synthesized by derivatization of a mercaptopropyl-
fimctionalized mesoporous silica nanosphere material (thiol-MSN) prepared by the following 
procedures: n-Cetyltrimethylammonium bromide (CTAB, 1.00 g, 2.74 x 10"3 mol) was first 
dissolved in 480 mL of Nanopure water. NaOH(aq) (2.00 M, 3.50 mL) was added to CTAB 
solution, followed by adjusting the solution temperature to 353 K. TEOS (5.00 mL, 2.57 x 
10"2 mol) was first introduced dropwise to the surfactant solution, followed by the dropwise 
addition of MPTMS (0.97 mL, 5.13 x 10"3 mol). The mixture was allowed to stir for 2 h to 
give rise to white precipitates (as synthesized thiol-Sphere). The solid product was filtered, 
washed with deionized water and methanol, and dried in air. To remove the surfactant 
template (CTAB), 1.50 g of as-synthesized thiol-Sphere was refluxed for 24 h in a solution of 
9.00 mL of HCl (37.4%) and 160.00 mL of methanol followed by extensive washes with 
deionized water and methanol. The resulting surfactant-removed thiol-MSN material was 
placed under high vacuum to remove the remaining solvent in the mesopores. The chemically 
accessible thiol group surface coverage of the thiol-MSN material was quantified to be 7.64 
x 10"4 mol/g by our previously published method.93 The purified thiol-MSN material (1.00 g) 
was treated with a methanol solution (60.00 mL) of 2-(pyridyldisulfanyl)ethylamine (PDEA) 
(9.12 x 10~4 mol), which was synthesized via a literature procedure,10 at room temperature for 
24 h under vigorous stirring to undergo the desired disulfide bond exchange reaction. The 
resulting MSN material with 2-(propyldisulfanyl)ethylamine functionality was filtered and 
washed with methanol and dried in air. 
Loading of Vancomycin and ATP into the Mesoporous Framework of Linker-MSN and the 
Capping of the Mesopores with Mercaptoacetic Acid-Functionalized CdS Nanoparticles 
The purified linker-MSN material (100.00 mg) was incubated in the aforementioned 
PBS buffer solution (0.60 mL, pH 7.4) of ATP or vancomycin (3.00 pmol in both cases) for 
24 h. The mercaptoacetic acid-functionalized CdS nanoparticles (0.15 mmol) were dissolved 
in 2.00 mL of PBS buffer with vancomycin or ATP (0.01 mmol in both cases). l-[3-
(Dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) (57.50 mg, 0.30 mmol) 
was added to the CdS/drug solution. The reaction mixture was allowed to stir for 24 h, 
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followed by centrifuging the suspension at 12 000 rpm for 3 min. The resulting precipitates 
(ATP- or vancomycin-loaded, CdS-capped MSNs) were isolated and dried under vacuum. 
DTT-Induced Drug/Neurotransmitter Release Study 
CdS-capped MSN with vancomycin or ATP (10.00 mg) material was dispersed in 
1.50 mL of PBS buffer (pH 7.4), followed by repeating wash/sonication/centrifugation cycles 
for five times to remove physisorbed, uncapped vancomycin or ATP molecules on the 
exterior surface of the material. The purified MSN/drug composite was redispersed in 3.50 
mL of PBS buffer (pH 7.4). Aliquots were taken every 4 h over a time period of 12 h from 
the MSN/water suspension and injected to an analytical HPLC system (Hitachi LC/3DQMS 
with a reverse phase CI 8 column (Vydac), 0.4 cm x 25 cm) to monitor the leaching of the 
mesoporous channel encapsulated vancomycin or ATP molecules. After 12 h, dithiothreitol 
(DTT, 18.50 mM) was added to the suspension to cleave the disulfide linkage between the 
CdS nanoparticle and the MSN. The kinetic profiles of the DTT-induced release of 
vancomycin and ATP were monitored by following two literature-reported HPLC separation 
conditions.20 The peaks/areas at 280 and 258 nm were monitored/integrated for the 
quantitative analysis of amounts of released vancomycin and ATP, respectively. 
Instrumental Methods, Conditions, and Parameters for the Structure Characterizations of 
Linker-MSN and CdS-Capped MSN Materials 
Powder XRD diffraction data were collected on a Scintag XRD 2000 X-ray 
diffractometer using Cu Ket radiation. Nitrogen adsorption and desorption isotherm, surface 
area (SA), and median pore diameter (MPD) were measured using a Micromeritics 
ASAP2000 sorptometer. Sample preparation included degassing at 130 °C for 1 h. Nitrogen 
adsorption and desorption isotherms of these materials were obtained at -196 °C. Specific 
surface areas and pore size distributions were calculated using the Brunauer-Emmett-Teller 
(BET) and Barrett-Joyner-Halenda (BJH) method, respectively. Particle morphology of these 
materials was determined by scanning electron microscopy (SEM) using a JEOL 840A 
scanning electron microscope with 10 kV accelerating voltage and 0.005 nA of beam current 
for imaging. For transmission electron microscopy (TEM) studies, a small aliquot was 
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removed and placed between two clean glass slides. Slides were squeezed between fingers 
and rubbed back and forth to break up larger clumps. The resulting powder was washed into 
a Petri dish with acetone. The mixture was stirred and ultrasonically agitated. While still in 
suspension a lacey carbon-coated TEM grid was pulled through the suspension. The grid was 
allowed to dry in air and then examined in an Amray 1845 FE-SEM followed by examination 
with a Philips model CM-30 TEM operated at 300 kV. The specimen was given no further 
treatment, as it appeared stable under beam bombardment. The preparation for the 
microtomed samples included embedding into a derivation of EPON epoxy resin using 
EmBed 812. This mixture was centrifuged and cured for 24 h at 60 °C. The embedded block 
was microtomed to obtain thin sections of 60-80-nm thickness by using a Reichert Ultracut S 
ultramicrotome with a diamond knife (Diatome). The floated sections were mounted on a 400 
mesh Pd-coated Cu grid. The TEM images of these microtomed samples were recorded using 
a Philips model CM-30 TEM operated at 300 kV at 69 000 to 340 000 electron optical 
magnification. 
Experimental Methods and Conditions for Controlled-Release Studies of CdS-Capped, ATP-
Encapsulated MSN with Neuroglia Cells (Astrocytes) in Vitro 
Wistar rats, raised at Iowa State University, were used for these experiments. Animal 
care and experimental protocols were in accordance with the guidelines and approval of the 
Iowa State University Committee on Animal Care. 
Cell Cultures 
Enriched primary astrocyte cultures from neonatal (Po to P3) rat cerebral cortex were 
prepared as previously described.15a Briefly, freshly dissected cortical tissues from three 
animals were incubated 50 min at 37 *C in 2.00 mL of Earle's balanced salt solution (BBSS; 
Gibco-Invitrogen Co.) containing papain (1.54 mg/mL; Sigma-Aldrich Co.). After incubation, 
tissue was rinsed with BBSS solution and incubated for 5 min in trypsin-inhibitor solution (1 
mg/mL; Gibco-Invitrogen Co.). After being rinsed, once with BBSS solution and once with 
culture medium (consisting of a-minimum essential medium (x-MEM; Gibco-Invitrogen Co.) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco-Invitrogen Co.) 
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and 1.00 mL of penicillin-streptomycin solution (Sigma-Aldrich Co.) per 100 mL, the tissue 
was mechanically dispersed in culture medium by triturating through a fire-polished glass 
pipet. The cell suspension was transferred to sterile 15-mL centrifuge tubes and spun at 
1000g for 10 min. Cell pellets were resuspended in culture medium (x-MEM supplemented 
with 10% heat-inactivated FBS and 1.00 mL of penicillin-streptomycin solution per 100.00 
mL) and plated in culture flasks. Cells were maintained at 37 " C in a humidified 5% 
COa/95% air atmosphere. Culture medium was changed every 2 to 3 days. When mixed 
cultures reached confluence (9-12 days), the flasks were shaken (260 rpm) for 90 min to 
remove microglia and dividing type I astroglia. After shaking the cells, medium was replaced, 
and the flasks were incubated for 1 h to equilibrate with CO% in the fresh medium. Cultures 
were then shaken overnight (12-18 h) at 260 rpm at 37 * C. Cultures enriched in type I 
astroglia were obtained by trypsinizing (0.25%; Sigma-Aldrich Co.) attached cells for 5 min. 
Trypsin was inactivated by adding ot-MEM supplemented with the 10% heat-inactivated FBS 
(serum contains protease inhibitors). Cells were plated on poly-L-lysine-coated coverslips 
(10.00 mg/mL; MW 100 000; Sigma-Aldrich Co.) at a density of 3.00 * 104 cells/cm2. All 
experiments were performed on cells that had been in culture for 2-4 days after replating. 
Characterization of Glial Cultures 
An antibody against glial fibrillary acidic protein (GFAP) was used to identify 
astrocytes following the procedure described in the subsequent Immunocytochemistry 
section. We confirmed that glial cultures were neuron-free by using antibodies against the 
tubular protein MAP-2. In astrocyte-enriched cultures immunoreactivity for MAP-2 was 
absent, while neurons were immunopositive in parallel cultures that contained neurons. 
Immunocytochemistry 
After fixation with 4% paraformaldehyde (Fisher Chemical) for 30 min at room 
temperature, cells were incubated for 30 min in a 50% goat serum solution containing 1% 
bovine serum albumin (BSA; Sigma-Aldrich Co.) and 100.00 mM L-lysine (Sigma-Aldrich 
Co.), to block nonspecific binding, and 0.4% Triton X-100 to permeabilize the membrane. 
Immunocytochemistry was performed using antibodies raised against glial fibrillary acidic 
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protein (GFAP; 1:5000; Sigma-Aldrich Co.) and microtubule associated protein (MAP-2; 
1:2000; Sigma-Aldrich Co.). Positive controls were established with these antibodies using 
cortical glia and neurons. Negative controls were established by omitting the specific 
antiserum. Antibody visualization was accomplished by the employment of the biotinylated 
secondary antibody, the Vectastain ABC kit (Vector) and the nickel-enhanced 3-3'-
diaminobenzidine method.21 Cells were dehydrated in graded alcohol, cleaned in xylene, and 
sealed with acrytol on glass slides as shown in Appendix B. 
Intracellular Calcium Imaging 
The effect of experimental manipulation on the intracellular calcium concentration 
([Ca2+]i) of cultured cells was evaluated by ratiometric imaging techniques.17 Cells were 
loaded with Fura 2-AM (5.00 FM; Molecular Probes) for 40-60 min at 37 0 C; 1.00 |iL of 
25% (w/w) of Pluronic F-127 (Molecular Probes) was mixed with every 4.00 nM of AM 
ester to aid solubilization of the ester into aqueous medium. Coverslips containing glial cells 
were washed with normal Hepes-saline solution and further incubated for 10 min at 37 9 C to 
allowed ester hydrolysis of Fura 2-AM. Normal Hepes-saline solution contains (in mM): 
NaCl 140.00, KC1 5.00, MgCl2 2.00, CaCl2 2.00, and HEPES (Sigma-Aldrich Co.) 10 (pH 
7.4). All image processing and analysis were performed using an Attofluor system with Zeiss 
microscope. Background subtracted, rationed images (340/380 nm) were used to calculate 
the [Ca2+]i according to a literature-reported method.19 Calibration was performed in situ 
according to the procedure provided by the Attofluor, using the Fura-2 Penta K+ salt 
(Molecular Probes) as a standard. Using wavelengths of 340 and 380 nm, Fura 2-AM was 
excited, and the emitted light was collected at 520 nm. 
Results and Discussion 
To prepare the MSN material fimctionalized with a chemically labile linker that can 
covalently capture the CdS nanoparticles, we first synthesized a mercaptopropyl-derivatized 
mesoporous silica nanosphere material (thiol-MSN) via our recently reported co-
condensation method.9 As illustrated in Figure 5-2, the surfactant-removed thiol-MSN 
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material was treated with a methanol solution of 2-(pyridyldisulfanyl)ethylamine, which was 
synthesized via a literature procedure,— at room temperature for 24 h under vigorous stirring 
to yield the MSN material with 2-(propyldisulfanyl)ethylamine functionality (linker-MSN). 
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Figure 5-2. Synthesis of 2-(propyldisulfanyl)ethylamine functionalized mesoporous silica nanosphere (linker-
MSN) material. 
As depicted in Figure 5-3 a, b, c, and e, the spherical particle shape and the MCM-41 
type of hexagonally packed mesoporous structure of the linker-MSN material are confirmed 
by scanning and transmission electron microscopy (SEM and TEM, respectively). The N% 
adsorption/desorption isotherms of the material further revealed a BET isotherm typical of 
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MCM-41 structure (type IV) with a surface area of 941.0 m2/g and a narrow BJH pore size 
distribution (average pore diameter = 2.3 nm). The linker-MSN (100.0 mg) was used as a 
chemically inert host to soak up the aqueous solutions of vancomycin (3.0pmol) and ATP 
(15.5 nmol). 
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Figure 5-3. (a) BET nitrogen adsorption/desorption isotherms of the thiol-MSN material before and after 
covalent encapsulation of the mercaptoacetic acid-functionalized CdS nanoparticles. (b) BJH pore size 
distributions for the thiol-MSN and CdS-capped MSN nanocomposite materials. The decrease in surface area 
and the disappearing of the maximum peak in BJH pore size distribution plot indicate that the mesopores of 
MSN are capped by the CdS nanoparticles. 
TEM investigations of the CdS-capped MSN also provided direct evidence of the 
CdS distribution both on and in the organically functionalized MSN material. As shown in 
Figure 5-4d, where the mesopores (porous channels) are represented by the alternating black 
and white stripes, the CdS nanoparticles are clearly visible on the outside edge and inside the 
mesopores of the MSN depicted by the lighter areas (indicated by the arrowheads). As 
opposed to these features observed in the case of CdS-capped MSN, the TEM micrograph of 
the linker-MSN (Figure 5-4c) prior to the CdS "capping" showed smooth edges and nice 
contrasts between the mesoporous channels and the silica matrix. Furthermore, compared 
with the periodically well-organized hexagonal array of mesopores represented by the bright 
dots shown on the TEM micrograph of the linker-MSN orientated along the pore axis (Figure 
5-4e), an additional layer of CdS nanoparticles on the outside of the MSN material and a 
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large area of disordered hexagonal array of mesopores indicated by the arrows in Figure 5-4f 
were observed in the case of CdS-capped MSN material. 
Figure 5-4. SEM (a and b) and TEM (300 kV) micrographs of the linker-MSN (c and e). The MCM-41 type of 
mesoporous channel structure of the nanospheres is visualized with the parallel stripes (c) and the hexagonally 
packed light dots (e) shown in the micrographs. The TEM micrographs (d and f) of the CdS-capped MSN 
clearly exhibit aggregations of CdS nanoparticles on the exterior surface of MSN material represented by dots 
in the areas indicated by black arrows in (d). A large area (left side of the MSN particle indicated by the blue 
arrow) displaying light dots packed in a disordered symmetry and an area (green arrow) where the mesopores 
are hexagonally arranged represent the CdS nanoparticle-capped and uncapped areas of MSN particle shown in 
(f), respectively. The TEM micrographs (d-f) were measured on ultramicrotomed samples with section 
thickness of 60-80 nm. 
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In contrast to the "disordered" area, a small area with mesopores that are packed with 
a hexagonal symmetry was also noticed on the micrograph. These different areas could be 
attributed to the fact that most, but not all, mesopores are capped with the CdS nanoparticles. 
To design a chemically removable cap, we synthesized a mercaptoacetic acid-coated, 
photoluminescent CdS nanocrystal material with an average particle diameter of 2.0 nm via a 
literature-reported procedure.7 As illustrated in Figure 5-1, the water-soluble CdS 
Nanocrystals with mercaptoacetic acid groups were covalently captured and formed amide 
bonds by reacting with the mesopore surface-bound 2-(propyldisulfanyl)ethylamine linkers 
of the MSN/drug composite material in aqueous solutions. The resulting reaction suspensions 
were centrifuged, and the CdS-capped MSN/drug composite materials along with the 
unreacted CdS nanoparticles were filtered. The concentrations of the free vancomycin and 
ATP molecules in the filtrate were then determined by HPLC. The calculated concentration 
decreases of solution vancomycin and ATP were attributed to the amounts of mesopore-
encapsulated vancomycin (2.5 Fmol) and ATP (4.7 Fmol) per 100.0 mg of linker-MSN 
material. These numbers correspond to ca. 83.9 and 30.3 mol % loading efficiency, 
respectively. 
The successful incorporation of CdS nanoparticles to the MSN matrix was confirmed 
by various spectroscopy methods.11 As shown in Figure 5-5a, the covalent immobilization of 
the surface-functionalized CdS nanoparticles to the linker-MSN material reduced the 
intensity of the powder X-ray diffraction (XRD) peaks. Such a reduction of scattering 
contrast between the pores and the framework of the MCM-41 materials due to the pore-
filling effect has been reported previously in the literature.12 Compared with the d\w value of 
the linker-MSN material, a small increase in that of CdS-capped MSN was observed. The 
increase of the dioo values may be attributed to the covalent linkage induced pore-filling 
effect between the CdS nanoparticles and the mesoporous silica matrix. Figure 5-5b showed 
the high-angle XRD diffraction patterns of the linker-MSN and the CdS-capped MSN 
materials within the 20 range of 10° - 70°. In contrast to the low-intensity diffuse peak of 
noncrystalline silica observed in the linker-MSN material (Figure 5-5b), two additional peaks 
are detected in the CdS-capped MSN sample. As depicted in Figure 5-5b, these two peaks are 
attributed to the diffraction of (111) and (220) lattice planes of the CdS nanoparticles 
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attached to the mesoporous silica.13 To further confirm that these CdS nanoparticle "caps" 
were indeed covalently linked to the mesopore surface-bound linker groups, the 13C solid-
state CP-MAS NMR spectra of both the CdS-capped MSN and the linker-MSN were 
carefully compared and the existence of the covalent linkage between the CdS and MSN 
materials was clearly observed as shown in the Appendix B.11 
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Figure 5-5 Low (a) and high (b) angle powder X-ray diffraction patterns (XRD) of the linker-MSN material 
before (solid line) and after (dashed line) the immobilization of CdS nanocrystals. (# is the diffuse peak of 
noncrystalline silica.) 
Table 5-1. Structural parameters of the thiol-MSN and the CdS-capped MSN materials 
Powder XK1) \ilmucii Sorption Isoihcmis 
Ixm angle High angle Bhl HI I IUH 
(CdS)(A) siu.jLCjiA: pmvxohime ixxciliameter 
* L i !< • f/1 III 4lW ^All (1)1 'g) ( iTti.i'g) (À) 
Ihtol-MSN 38.6 22.4 19.3 - - 941.2 0.582 23.0 
I US-capped 
36.7 - - 3.2 1.9 342.3 0.203 
As shown in Figure 5-6a, the CdS-capped MSN drug/neurotransmitter delivery 
system exhibited less than 1.0% of drug release in 10 mM PBS buffer solutions (pH 7.4) over 
a period of 12 h. The result suggested a good capping efficiency of the CdS nanoparticles for 
encapsulation of the vancomycin and ATP molecules against the undesired leaching problem. 
Addition of disulfide-reducing molecules, such as DTT and ME, to the aqueous suspension 
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of CdS-capped MSNs triggered a rapid release of the mesopore-entrapped 
drug/neurotransmitter. Within 24 h, the release reached 85% of the total release seen in 3 
days of vancomycin and ATP after the introduction of 18.5 mM DTT (Figure 5-6a). 
Interestingly, the rates of release of vancomycin and ATP showed similar diffusional 
kinetic profiles, indicating the lack of interaction between these released molecules and the 
mesoporous silica matrix. However, 53.8% (1.6 mnol) of the encapsulated vancomycin was 
released after 3 days of the DTT-induced uncapping of the mesopores, while only 28.2% (1.3 
/*mol) of the entrapped ATP molecules was able to diffuse away. Such a large difference 
between the portion of vancomycin and ATP released from the MSN material implied that 
ATP molecules were more strongly physisorbed to the organically functionalized 
mesoporous channels than the vancomycin molecules. On the basis of several reports in the 
literature,14 vancomycin has an isoelectric point (pi) of 8.3 and therefore is cationically 
charged under our experimental condition (pH 7.4). Conversely, ATP is anionic in pH 7.4 
aqueous solutions. Given that the surface of the linker-MSN material is decorated with the 2-
(propyldisulfanyl)ethylamine functionality, which is cationic (ammonium cation) at pH 7.4, 
the attractive electrostatic interaction between the ATP molecules and the linker-
functionalized mesopores could be attributed to the stronger physisorption of ATP, whereas 
the repulsive electrostatic interaction between vancomycin molecules and the linker-
derivatized mesopores disfavor the surface adsorption of vancomycin. 
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Figure 5-6. The DTT-induced release profiles of Vancomycin (-•-) and ATP (- -) from the CdS-capped 
MSN system: (a) % release over time, (b) The DTT concentration-dependent releases. Released analyte 
concentrations were measured with CdS-MSNs (2.3 mg) in pH 7.4 PBS buffers (0.8 mL) after 24 h of the DTT 
additions. 
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These results suggested that perhaps only those molecules that are not in direct 
contact with the pore surface, i.e., nonphysisorbed molecules, could be released under our 
experimental conditions. Furthermore, in both vancomycin and ATP cases, the amount of 
drug release after 24 h of the addition of DTT showed similar DTT concentration 
dependencies (Figure 5b), indicating the rate of release is dictated by the rate of removing the 
CdS caps. To demonstrate the biocompatibility and utility of our controlled-release delivery 
system for selective stimulation of certain cell types, ATP-loaded MSNs were introduced 
into an established astrocyte culture. It has been previously shown that ATP molecules evoke 
a receptor-mediated increase in intracellular calcium in astrocytes,15 which is an important 
regulatory mechanism for many intercellular communications and cooperative cell 
activities.16 Astrocyte type-1 cultures were obtained from neonatal rats by following 
previously published protocol17 to ensure the absence of neurons that complicate 
experimental interpretation. Phase-contrast microscopy indicated that cultures were indeed 
enriched in type-1 astrocytes and devoid of neurons. Immunocytochemistry experiments on 
these cells demonstrated that all the cultures are more than 95.0% immunopositive for glial 
fibrillary acidic protein (GFAP) and lacked MAP-2 immunoreactivity.18 The observed results 
further confirmed that these cultures are indeed type-1 astrocytes and not neurons. To 
determine the effect of ATP on cultured astrocytes, we used ratiometric-imaging 
techniques17'19 to monitor the glial calcium levels. Cells were loaded with the membrane-
permeant Ca2+-chelating fluorescent dye (Fura-2 AM),19 which is a widely used and highly 
sensitive indicator of intracellular calcium concentration ([Ca2+]i). The ATP-induced 
increases of [Ca2+]i (calcium transients)19 represented by the color changes (increases of 
fluorescence) of the pseudocolor images of the cells were detected using an Attofluor system 
with Zeiss microscope. 
To measure the effect of ATP released from the MSN system, astrocytes cultured in 
the presence of surface immobilized, CdS-capped MSNs with ATP molecules encapsulated 
inside of the mesoporous channels were first loaded with Fura-2 AM and then placed in a 
flow cell with a volume of 50.0 mL and a flow rate of 200.0 RL/min in a flow direction from 
the top to the bottom of the images shown in Figure 5-7. As shown in Figure 5-7a and c, 
perfusion application of ME (1 mM for 5 min) resulted in a drastic decrease in the 
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fluorescence intensity of CdS at the areas of the ATP-loaded MSN piles (MSN-1 and MSN-2) 
indicating the CdS caps have been released and diffused away from the surface-bound MSNs. 
Furthermore, we observed a pronounced increase in intracellular [Ca2+]; represented 
by the color change of the pseudocolor images of Cell-1 and -2 (Figure 5-7a) and the 
corresponding upward shift of the red and blue curves of those two cells in the time course 
plot (Figure 5-7c). The observations suggested that the ATP molecules released from the 
mesoporous silica nanospheres located at the MSN-1 pile have reached their receptors on the 
cell surface of those astrocytes (for example, Cell-1 and -2) located at the downstream areas 
of the flow and thereby triggered the corresponding ATP receptor-mediated increase in 
intracellular calcium concentration. It is interesting to note that only the cells that were 
situated at the downstream areas relative to the MSN-1 pile (Figure 5-7a) are stimulated by 
the perfusion application of ME. Throughout the whole period of ME application, no obvious 
color changes could be observed in the pseudocolor images of those astrocytes that were 
located at the upstream areas, such as Cell-5, as shown in Figure 5-7a. The result indicated 
that the intracellular calcium concentrations of those "upstream" astrocytes relative to the 
MSN-1 pile were not affected by the perfusional introduction of ME. Given that the flow 
direction is from the top to the bottom of these images, such a phenomenon could be 
attributed to the fact that the ATP molecules released from the immobilized piles of MSNs 
by the perfusion application of ME could not diffuse against the flow to reach and stimulate 
the "upstream" astrocytes (Cell-5). 
To confirm that the increase of [Ca2+]; was not induced by the ME or the CdS 
released from the MSNs, two control experiments were performed. First, we obtained an 
enriched astrocyte type-1 culture via the same protocol but without the presence of MSNs. 
As shown in Figure 5-8, the perfusion application of ME (1.0 mM for 5 min) to these cells 
showed no increase in [Ca2+];. A high concentration of ATP (100.0 MM) was later introduced 
to these ME-treated astrocytes. All cells responded to the ATP application with obvious 
increases in [Ca2+]i. Clearly, the ME application did not stimulate the calcium channel 
activity of these astrocytes to create any noticeable increase in [Ca2+];. Also, such ME 
treatments did not cause any obvious damage to these cells and they could still respond 
normally to ATP stimulation. 
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Figure 5-7. Effect of ATP release from CdS-capped MSNs on astrocytes, (a) Top panels show the pseudocolor 
images of astrocytes loaded with Fura-2 at resting level (top left panel) and after the application of ME (top 
right panel). The yellow arrows indicate the flow direction of HEPES buffer (pH 7.4). (b) Left bottom panel 
shows the fluorescence of cells and CdS at 520 nm (\x = 380 nm). (c) Right bottom graph is a time course of 
astrocytes and CdS-capped MSN fluorescence prior to and after the application of ME. (Black bar represents 
the application time period of ME). 
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Figure 5-8 (a) Images showing that application of ME on an astrocyte culture loaded with the intracellular Ca2+-
chelating fluorophore (Fura 2-AM) without the presence of MSN failed to produce any [Ca2'], response of 
astrocytes, (b) Pseudo-color image of astrocytes taken after the ME application showed no increase or decrease 
in [Ca2+]j of the cells, (c) The same cells responded to the perfusion application of 100.0 f*M ATP indicated by 
the increase of fluorescence intensity of the pseudo-color image of astrocytes, i.e., [Ca2+]i increases. 
To determine the effect of CdS nanoparticles on the [Ca2+]; of astrocytes under our 
experimental conditions, we cultured the enriched type-1 astrocytes in the presence of CdS-
capped MSNs without ATP encapsulation. Perfusion application of 100.0 f*M ATP only 
increased the fluorescence intensity ([Ca2+], increased) of the areas where the astrocytes are 
located, whereas the fluorescence intensity of those of CdS-capped MSNs stayed constant as 
depicted in the pseudo-color images of the culture before (Figure 5-9a) and after (Figure 5-9b) 
the ATP application. This result showed that apparently the astrocytes responded normally to 
ATP stimulation in the presence of CdS-capped MSNs. The culture of astrocytes and CdS-
capped MSNs was then subjected to the same ME application. As shown in Figure 8b and c, 
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no detectable changes in [Ca2+]i were observed in the areas of astrocytes, but drastic 
decreases of fluorescence could be noticed easily in those areas of CdS-capped MSNs 
indicating the release of CdS caps upon ME application. 
MEappocadon 
MSN', 
ATPapplicaùoa 
Figure 5-9 Pseudo-color images of an astrocyte culture in the presence of random piles of CdS-capped MSNs 
with empty mesoporous channels (no ATP encapsulation) before (a) and after (b) the application of ATP (100.0 
MM). An increase in [Ca2+]i of the astrocytes (lower square, red) located adjacent to a pile of MSNs (upper 
square, yellow) upon the perfusion application of ATP was observed (d, lower curve). The result suggested that 
the astrocytes are responsive to ATP stimulation. Interestingly, significant decrease of the fluorescence intensity 
(c and d, upper curve) of the pile of MSNs (upper square, yellow) was observed upon the perfusion application 
of ME due to the uncapping of CdS (diffusing away from the area of interest). Concurrently, the adjacent 
astrocytes did not show any detectable response during the application of ME. 
Conclusions 
In conclusion, we have demonstrated that the organically functionalized MCM-41 
type of mesoporous silica nanosphere material can be used as a novel controlled-release 
delivery carrier that are stimuli responsive. Given that the loading and release mechanism of 
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the MSN system is based on the capping and uncapping of the openings of the mesopores 
with CdS nanoparticles, no chemical modification of the molecules of interest is needed. In 
addition, the biocompatibilty and stability of the MSN material allow us to utilize such a 
system to investigate various intercellular chemical/neurochemical interactions in vitro. We 
envision that this MSN system could play a significant role in developing new generations of 
site-selective, controlled-release delivery, and interactive sensory nanodevices. 
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Appendix A 
Immunocytomchemistry 
Appendix A (A) Stimulatory effect of ATP on cultured astrocytes. Panel illustrates bright field 
(left image) and phase contrast (right image) images of GFAP immunostained cortical astrocytes.(B) Panels 
illustrate pseudocolor images of baseline (a), ATP-induced increase (b), andrecovered (c) ratio in fluorescence 
of free and bound Fura-2. Images a taken at the time indicated on time course graph in lower panel. Black bar 
represents the duration of perfusion application of ATP 10 ^iM. In resting conditions, the cytoplasmic calcium 
level of glia was 91 ± 2 nM (n =136, in three separate experiments). Perfusion application of ATP (10 |iM) for 
60 seconds reliably raised the cytoplasmic level of free calcium in all cells tested. The increase of intracellular 
calcium reached the peak of 207 ± 7 nM (n = 136, in three separate experiments) in about 10 seconds after the 
onset of ATP application and was sustained for several minutes. Space bar =100 |iM. 
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Appendix B. Solid state 13C CP-MAS NMR spectra of the surfactant-removed linker-MSN (below) and CdS-
capped MSN (above). 
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Chapter 6. Real-Time ATP Imaging of Tunable Release from a MCM- 41-type Mesoporous 
Silica Nanosphere-Based Delivery System 
A paper submitted to Chemistry of Materials 
Gruenhagen, J.A.; Lai, C.-Y.; Radu, D R.; Lin, V.S.-Y.; Yeung, E.S. 
Ames Laboratory-USDOE and Department of Chemistry, Iowa State University, Ames, Iowa 
50011-3111 
Abstract 
We designed a mesoporous silica nanosphere (MSN) material with tunable release 
capability for drug delivery applications. Adenosine 5-triphosphate (ATP) molecules were 
encapsulated within the MSNs by immersing dry nanospheres in aqueous solutions of ATP 
followed by capping of the mesopores with chemically removable caps, such as CdS 
nanoparticles and poly(amido amine) dendrimers (PAMAM), via a disulfide linkage. We 
employed luciferase chemiluminescence imaging to investigate the kinetics and mechanism 
of the ATP release with various disulfide-reducing agents as uncapping triggers. By varying 
the chemical nature of the "cap" and "trigger" molecules in our MSN system, we discovered 
that the release profiles could indeed be regulated in a controllable fashion. 
Introduction 
Nanomaterial1 research has attracted much attention recently for their potential 
applications in electronics,2"4 electro-optics,5 biosensors,6"8 etc. One particularly interesting 
application is the development of novel nanomaterials-based drug delivery systems. 
Traditionally, responsive polymer systems have been employed in such devices.9'10 For 
example, degradable polymers are synthesized in the presence of the drug molecule of 
interest.11 The resulting polymer/drug composite materials usually exhibit slow rates of drug 
release under normal conditions. Upon stimulation, the degradation of polymer matrix is 
accelerated, and the release of drug molecules is thereby enhanced. Drug delivery polymers 
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that are responsive toward several types of stimulants, such as temperature, pH, and 
magnetic/electric field, have been reported in the literature.12"15 
In addition to polymer-based drug delivery systems, the organically functionalized 
MCM-type mesoporous silica materials16,17 offer several attractive features, such as stable 
mesoporous structures, large surface areas, tunable pore sizes and volumes, and well-defined 
surface properties, that are ideal for encapsulation of pharmaceutical drugs,18"21 proteins,22"26 
and other biogenic molecules.27 We have recently reported the synthesis and characterization 
of a unique drug delivery system, which is based on a mesoporous silica nanosphere (MSN) 
material and surface-derivatized CdS nanocrystals.27 In contrast to many current polymer-
based delivery systems, the molecules of interest were encapsulated inside the porous 
framework of the MSN not by adsorption or sol-gel types of entrapment, but by covalently 
capping the openings of the mesoporous channels with size-defined CdS nanocrystals to 
physically block the drugs from leaching out. Drug molecules loaded into the pores were 
released by the addition of disulfide bond-reducing molecules as "uncapping triggers". The 
rate of release was controlled by the concentration of the trigger molecules. Prior to 
uncapping, the CdS-capped MSN system exhibited negligible release of drug molecules. The 
"zero release" feature along with the ability to tune the rate of release by varying stimulant 
concentrations are important prerequisites for developing delivery systems for many site-
specific applications, such as delivery of highly toxic anti-tumor drugs, hormones, and 
neurotransmitters to certain cell types and tissues. To investigate the release mechanism and 
kinetics, we monitored the dithiothreitol- (DTT) and mercaptoethanol- (ME) triggered release 
of ATP and vancomycin from the CdS-capped MSN system utilizing high performance liquid 
chromatography (HPLC).27 While successful, HPLC was only sensitive enough to detect 
drug release on the hour timescale, which cannot provide the detailed temporal profile of 
release. 
To gain further insight on how the release mechanism and kinetics can be fine tuned 
by the chemical nature of the "cap" and "trigger" molecules in our MSN system, we report 
herein on the synthesis and characterization of a new adenosine triphosphate (ATP) loaded 
MSN material capped with poly(amido amine) dendrimers (PAMAM).28"30 As depicted in 
Scheme 6-1, a highly sensitive method of ATP chemiluminescence imaging was used to 
monitor the release of ATP from MSN materials capped with PAMAM dendrimers or CdS 
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nanoparticles that are triggered by three different disulfide reducing agents, i.e., DTT, ME, 
and tris(2-carboxyethyl)phosphine (TCEP),31 in real time. The imaging method was based on 
our previously reported luminescence imaging assay by detecting the ATP-induced 
chemiluminescence of luciferase in situ?2 Through use of an intensified charge-coupled 
device (iCCD) camera attached to a microscope, real-time imaging of release of ATP from 
glial cells with a detection limit of 10~8 M was achieved.33 By using this highly sensitive and 
selective imaging method, we investigated the effects of the aforementioned uncapping 
triggers in regulating the magnitudes and kinetics of ATP release from the two MSN 
materials capped with CdS nanoparticles and PAMAM dendrimers. 
Materials and Methods 
Experimental Section 
Firefly luciferase (from Photinus pyralis) was obtained from R&D Systems 
(Minneapolis, MN). All other chemicals were from Aldrich (Milwaukee, WI) and Sigma (St. 
Louis, MO) and used as received. Low ionic strength HEPES buffer contained 10 mM 4-(2-
hydroxyethyl)-1 -piperazineethanesulfonic acid (HEPES), 5 mM KC1, and 5 mM NaCl (pH = 
7.75). Chemiluminescence imaging solution was comprised of low ionic strength HEPES 
buffer with 100 |_ig/mL firefly luciferase and 205 pM D-luciferin. Nanopure water (18.1 
MHz) prepared from a Bamstead E-pure water purification system was employed throughout. 
PBS buffer (10 mM, pH 7.4) solutions with the total ionic strength of 0.06 M were prepared 
and used as the solvent for all the loading experiments. 
Loading of ATP into the mesoporous framework of linker-MSN and the capping of the 
mesopores with mercaptoacetic acid-functionalized CdS nanoparticles 
2-(Propyldisulfanyl)ethylamine-functionalized MSN (linker-MSN) and 
mercaptoacetic acid-derivatized cadmium sulfide (CdS) nanoparticles were synthesized and 
purified as described previously.27 The purified linker-MSN material (100 mg) was incubated 
in a 10 mM PBS buffer (0.60 mL, pH 7.4) solution of ATP (5 mM) for 24 h. The 
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mercaptoacetic acid-functionalized CdS nanoparticles (0.15 mmol) were dissolved in 2 mL of 
the aforementioned PBS buffer with ATP (5 mM). 1 -[3-(Dimethylamino)propyl]-3-
ethylcarbodiimide hydrochloride (EDC, 57.5 mg, 0.30 mmol) was added to the CdS/ATP 
solution. The resulting solution of CdS was then added to the MSN/ATP suspension. The 
reaction mixture was stirred at room temperature for 24 h. The suspension was centrifuged at 
12 000 rpm for 3 min. The precipitates (ATP-loaded, CdS-capped MSNs) were isolated and 
dried under vacuum. Previous to each ATP imaging experiment, ATP-loaded MSN (10 mg) 
was redispersed in 1.5 mL of PBS buffer (pH 7.4), followed by repeating 
wash/sonication/centrifugation cycles for five times to remove physisorbed ATP molecules 
from the exterior surface of the material. 
Loading of ATP into the mesoporous framework of linker-MSN and the capping of the 
mesopores with G2.5 or G4.5 PAMAM dendrimers 
The purified linker-MSN material (100 mg) was incubated in the aforementioned PBS 
buffer solution (0.7 mL, pH 7.4) of ATP (5 mM) for 24 h. The G2.5 and G4.5 PAMAM 
dendrimers were purchased from Aldrich as 10% and 5% w/w methanol solutions, 
respectively. In a typical experiment, 2 mL of G2.5 or G4.5 PAMAM dendrimer-containing 
methanol solution was first evaporated, followed by the addition of 2 mL of PBS buffer 
containing EDC (30 mg, 0.16 mmol) to re-dissolve and activate the PAMAM dendrimers. 
The resulting PAMAM solution was then added to the MSN with ATP (5mM) suspension. 
The reaction mixture was stirred at room temperature for 24 h. The resulting precipitates 
(ATP- loaded, G2.5 or G4.5-capped MSNs) were isolated and purified via the same washing 
procedures described above. 
Scanning and transmission electron microscopy 
Particle morphology of these materials was determined by scanning electron 
microscopy (SEM) using a JEOL 840A scanning electron microscope with 10 kV 
accelerating voltage and 0.005 nA of beam current for imaging. For transmission electron 
microscopy (TEM) studies, a small aliquot of ATP-loaded MSN was placed between two 
clean glass slides. Slides were rubbed back and forth to break up larger clumps. The resulting 
powder was washed into a petri dish with acetone. The mixture was stirred and ultrasonically 
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agitated. While still in suspension, a lacey carbon-coated TEM grid was pulled through the 
suspension. The grid was allowed to dry in air and then examined in an Amray 1845 FE-SEM 
followed by examination with a Philips model CM-30 TEM operated at 300 kV with 69 000 
to 340 000 electron optical magnification. The specimen was given no further treatment, as it 
appeared stable under beam bombardment. 
ATP imaging 
ATP imaging was performed on the stage of an inverted microscope (Axiovert 100 
TV, Zeiss, Germany). Chemiluminescence signal was collected with a Zeiss Apochromat 
20X microscope objective (NA = 0.75) and detected with an iCCD (EEV 576 x 384 pixels 
CCD chip, Roper Scientific, Trenton, NJ) attached to the camera mount of the microscope. 
Nanosphere bulk samples were incubated in imaging solution for at least four hours prior to 
conducting experiments. The nanospheres were centrifuged down and the supernatant was 
replaced with fresh imaging solution. Images were collected at a frequency of 0.80 Hz with 
1000 ms exposure times. All experiments were performed at room temperature. 
Data presentation/analysis 
Chemiluminescence signal was obtained and processed with Winview32 software 
(Roper Scientific). The number of pixels over a threshold value was tabulated for each 
particle and each frame of data. The ATP concentrations were calculated from a calibration 
curve obtained with the identical imaging parameters. Displayed images are the average of 50 
frames for clarity. 
Results and Discussion 
Characteristics of end-capped mesoporous silica nanospheres 
The synthesis and characterization of ATP-loaded, CdS-capped MSN material (CdS-
MSN) were described in our previous report.27 (see Scheme 6-1). 
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Scheme 6-1. 
As shown in Figure 6-1A, the G4.5 PAMAM dendrimer-capped MSN (PAMAM-
MSN) material consists of spherical-shaped nanoparticles with an average particle diameter 
of 200 nm. 
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Figure 6-1. SEM (A) and TEM (B, C) micrographs of PAMAM dendrimer-capped MSN. The channel structure 
is revealed as the hexagonally packed dots shown in B. The lines traversing the entire particle in C are the pores, 
as viewed perpendicular to the pore axis. Also visible is the PAMAM dendrimer coating along the entire 
perimeter of the particle. 
The MCM-41 type of mesoporous channel structure of the PAMAM-MSN was 
visualized with the linear pores (2.3 nm in diameter) traversing their entire length and the 
hexagonally array of mesopores shown in the transmission electron micrographs (Figure 6-IB 
and C). An even layer of G4.5 dendrimers coated on the exterior surface of MSN material 
was clearly observed in the TEM micrographs (Figure 6-1B and 6-1C). As shown in Figure 
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6-2, the presence of the PAMAM dendrimers and ATP molecules in our MSN delivery 
system was also confirmed by the solid state CP- and DP-MAS 13C, 31P, and 29Si NMR 
spectroscopy described in our prior reports.27,34-37 
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Figure 6-2. Solid state 13C CPMAS (A), 31P CPMAS (B), 29Si DPMAS (C), and 29Si CPMAS (D) spectra of 
ATP-loaded MSN material capped with G2.5 PAMAM dendrimers. 29Si CPMAS spectrum was acquired by 
using 1 ms contact time. * are spinning side bands. 
Chemiluminescent imaging of ATP release was chosen for the following reasons: (1) 
The method is extremely sensitive since luciferase has a luminescence efficiency of 0.88.38 
(2) The reaction kinetics of luciferase catalyzed ATP chemiluminescence are exceedingly 
rapid.39 (3) The luciferase enzyme employed in ATP imaging measures approximately 5.5 x 
6.5 x 8.1 nm in size40 and therefore cannot enter the uncapped pores of the nanospheres. This 
ensures that any detected chemiluminescence must result from release of ATP from the 
MSNs. (4) There is no interference from the fluorescent MSNs. 
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Compatibility of ATP imaging and the MSN-based drug delivery system 
Though detection of ATP via firefly luciferase-catalyzed chemiluminescence is highly 
specific for ATP, experiments were conducted to ensure that the uncapping molecules did not 
interfere with the detection scheme. Excessive concentrations of these agents could diminish 
the activity of firefly luciferase. 
As depicted in Figured- 3A, the chemiluminescence from injection of a 66 nM ATP 
standard was four times lower for luciferase containing 500 pM ME than for luciferase 
without ME. In our previous report,27 1 mM ME was employed to remove the CdS caps 
from their nanospheres. Thus, it was not a suitable uncapping agent for use with our detection 
scheme. As illustrated in Figure 6-3a, addition of 10 mM DTT to luciferase imaging solution 
also caused a significant reduction in chemiluminescence from injected ATP standards. In 
this case, however, the reduction in signal was only by a factor of 2. Previous experiments 
demonstrated that DTT concentrations of 0.1-10 mM were effective in uncapping the CdS-
capped nanospheres.27 Therefore, further experiments were conducted to determine if lower 
concentrations of DTT also interfered with detection of ATP. In Figure 6-3B, DTT 
concentrations of 20 mM, 10 mM, and 5 mM showed progressively less interference with the 
detection of ATP chemiluminescence. Finally, 1 mM DTT did not interfere with our 
detection scheme significantly. Thus, DTT was employed as the uncapping agent in our 
initial experiments. 
Based on work by Whitesides and coworkers,31 TCEP is a biocompatible disulfide 
bond-cleaving molecule and is widely used in cell cultures. Thus, we also examined the 
effect of TCEP as an uncapping trigger. As shown in Figure 6-3 A, 5 mM TCEP did not cause 
any significant interference with the detection of injected ATP standards. Since only 100 pM 
TCEP was necessary to induce significant uncapping of the nanospheres,27 this compound 
was applicable for our experiments. 
In Figure 6-3A, the control experiment (no uncapping agent present) provides a 
calibration curve for the detection of ATP from luciferase-catalyzed chemiluminescence. The 
limit of detection was calculated to be 0.5 nM ATP, and the signal was linear over three 
orders of magnitude (0.5-66 nM ATP; R2 = 0.9997). 
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Figure 6-3. Effect of disulfide-cleaving molecules on chemiluminescence signal. Chemiluminescence signal 
from ATP standards was collected as detailed in the experimental section. (A) ATP standards were injected into 
imaging solution containing 5 mM TCEP (v), 10 mM DTT (a), 1 mM ME (X), and imaging solution only (X). 
(B) ATP standards were injected into imaging solution containing DTT concentrations of 20 mM ([~îh 10 mM 
( X ) ,  5  m M  ( v ) ,  1  m M  ( a ) ,  a n d  0  m M  ( X ) .  
Detection of release of encapsulated ATP from CdS-MSN 
Prior to the release experiments, the MSN particles were first thoroughly rinsed with a 
high ionic strength buffer to remove most of the physisorbed ATP. The nanospheres were 
then bathed in the imaging solution containing luciferase for 4 h, where the remaining 
physisorbed ATP was broken down enzymatically into ADP and inorganic phosphate. Prior 
to uncapping with DTT, the purified MSN generated no significant ATP release. In contrast, 
upon addition of 10 mM DTT, significant levels of ATP were released from the MSNs. 
Figure 6-4A depicts nine frames of chemiluminescence data obtained from a representative 
experiment. The optical image shows an aggregate of MSNs in the lower right region. The 
maximal ATP release was observed 129 s after stimulation, as illustrated in the signal profile 
in Figure 6-4B. 
The magnitude of the ATP signal rose quickly in an initial burst and then quickly 
decreased again. The rate of signal decline slowed greatly approximately 3-4 min after 
stimulation, and the magnitude of release approached pre-stimulation levels 8-10 min after 
stimulation. As previously observed via HPLC, the majority of the ATP which is released is 
detected in the first hour after stimulation with DTT.27 The results here suggest that in fact 
the majority of release occurs in the first few min after uncapping. 
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Figure 6-4. Release of encapsulated ATP from MCM-type mesoporous nanospheres. Chemiluminescence signal 
from ATP release was collected as detailed in the experimental section. (A) 1st frame—optical image of CdS-
capped MCM-type mesoporous nanosphere aggregate. Other frames—chemiluminescence images depicting 
release of encapsulated ATP from the nanospheres stimulated with 5 mM DTT. (B) Time course for release of 
ATP from (A). Arrow indicates point of stimulation. 
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The initial peak in the signal likely represents release of a pool of free ATP near the 
opening of the pores. Additionally, the release following the initial burst (3-10 min) is likely 
associated with diffusion of free ATP from the center of the particle through the pores to the 
extracellular solution. Finally, the very low-level release detected previously over a period of 
days would correspond to release of physisorbed ATP from within the pores. Given that the 
mesopore surface was functionalized with 2-(propyldisulfanyl)ethylamine groups, the 
electrostatic adsorption of ATP within the pores would be expected. The combined data 
obtained by HPLC and ATP chemiluminescence imaging describe the complete release 
profile for the MSNs. The results further illustrate how these two methods complement one 
another. 
Comparison of uncapping of MSNs by DTT and TCEP 
As TCEP was the most compatible reducing agent for use with our detection system, 
it was also utilized for uncapping ATP-loaded CdS-MSNs. Surprisingly, the amount of ATP 
released was attenuated while the temporal maximum of release was extended compared to 
stimulation of identical MSN material with DTT, as illustrated in Table 6-1. These results 
indicate that TCEP cannot cleave the disulfides bonds securing the CdS caps to the MSNs as 
quickly as can DTT. Several explanations can be proposed for this phenomenon. First and 
foremost, since the reducing power of DTT is greater than that of TCEP,31 the rate of 
disulfide cleavage for the linkers is likely slower for TCEP than DTT. Thus the rate of CdS 
nanocrystal release and subsequent ATP release would be delayed. Another possible 
explanation of this phenomenon is the charge of TCEP. The CdS nanocrystals are derivatized 
with carboxylic acid moieties and are thus negatively charged across their entire surface. 
TCEP is also negatively charged while DTT is neutral in charge in the imaging solution. 
Therefore, DTT can more easily diffuse into the nanosphere structure to reach and cleave the 
disulfide linkers. Finally, since TCEP is larger than DTT, its diffusion through the CdS 
nanocrystal caps could be sterically hindered. The actual basis for the attenuated release of 
ATP in the case of TCEP stimulation likely is a combination of the above. Further 
investigation of the stimulant diffusion and reaction kinetics would be necessary to pinpoint 
the reason. 
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Table 6-1. Characteristics of release of encapsulated ATP from CdS-capped MCM-type mesoporous 
nanospheres for various reducing agents. 
Uncapping Agent Release Maximum (min) Release Maximum (nM ATP) 
5 mM DTT 1.8 ± 0.8 32.1 ^ M.N 
5 mM TCEP X.O ± 2.3 4.5 ± O.K 
Effect of DTT concentration on release of encapsulated ATP from CdS-MSN 
We examined the effect of varying the concentration of uncapping agent on the 
magnitude of ATP release. DTT concentrations from 5 ^M to 5 mM were added to CdS-
MSNs. The 5 mM DTT was employed to ensure complete uncapping of the nanospheres, 
though it decreased the luminescence efficiency as demonstrated above. This was 
compensated for by employing the calibration curve for imaging solution containing 5 mM 
DTT to determine the ATP concentration. As depicted in Figure 6-5, the magnitude of ATP 
release varied with DTT concentration. 5 mM DTT induced release of 32.9 ±1.6 nM ATP 
compared to only 8.0 ± 2.9 nM ATP for 5 p,M DTT. 
|
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Figure 6-5. Effect of uncapping agent concentration on the magnitude of release of encapsulated ATP from 
MCM-type mesoporous nanospheres. Chemiluminescence signal from ATP release was collected as detailed in 
the experimental section. 
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Thus the lower concentrations of DTT were unable to completely uncap all of the 
MSN pores or, at least, were unable to uncap all of the pores simultaneously. These results 
27 
corroborate those obtained previously with HPLC. 
Release of ATP from PAMAM-MSN 
To investigate the influence of different capping moieties on the release kinetics, the 
release of ATP from MSNs capped with PAMAM dendrimers was also studied. Two types of 
PAMAM dendrimers (generations 2.5 and 4.5) have been successfully attached to cap the 
pores of the linker-functionalized MSN. When stimulated with 5 mM DTT, release of ATP 
was detected from both types of PAMAM-MSNs. The release profiles are displayed in Figure 
6 for generation 2.5 and generation 4.5 PAMAM-MSNs. These release profiles were 
smoothed by averaging the release for all 50 frames of each imaging file. 
Also depicted in Figure 6 is the release profile previously shown in Figure 6-4B for DTT 
stimulation. For comparison purposes, this profile was processed identically to those for 
dendrimer-MSNs. Upon stimulation with DTT, the generation 2.5 PAMAM-MSN showed 
no immediate release of ATP. Only after 20-30 min was a small amount of release observed 
from the nanospheres. This ATP release slowly increased to a maximum approximately 1.5 h 
after stimulation and slowly decreased back towards baseline levels. For nanospheres with 
generation 4.5 dendrimer caps, release occurred more quickly. ATP signal began 5 min after 
the addition of DTT, and maximum release was observed 11 min after stimulation. For both 
types of dendrimer-capped nanospheres, the maximum amount of release was smaller and the 
time required was longer than those of CdS-MSNs. 
Apparently, the PAMAM dendrimer caps are more flexible than the CdS nanocrystal 
caps. After forming one link to the nanosphere, it is possible that a dendrimer can flex 
slightly and form additional bonds to the opening of the MSN pore. The CdS nanocrystals, on 
other hand, are solid particles and perhaps lack flexibility and therefore may form fewer 
bonds to the nanosphere. Hence, in the case of PAMAM-MSN, more disulfide bonds would 
need to be broken in order to release the dendrimer caps upon stimulation. Additionally, with 
more bonds formed, the dendrimer caps would be held tighter to the nanosphere allowing less 
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room for the reducing agents to diffuse into the pores to reach the disulfide linkers. In fact, 
the generation 2.5 PAMAM is smaller in size than the 2.3 nm diameter pores of the MSN. 
Ï 25 
100 120 140 
Figure 6-6. Release of encapsulated ATP from dendrimer-capped MCM-41-type mesoporous nanospheres. 
Chemiluminescence signal from ATP release was collected as detailed in the experimental section. Plots depict 
release stimulated with 5 mM DTT at time = 2 min for generation 2.5 PAMAM dendrimer-capped particles 
(•), generation 4.5 PAMAM dendrimer-capped particles (A) and CdS nanocrystal-capped particles (solid 
line). 
Therefore, these dendrimers could diffuse into and bind inside the pores. Thus, each 
pore could be bound by more than one generation 2.5 dendrimer capping molecule. This 
would decrease the rate of capped ATP release significantly, as was observed in our 
experiments. Upon further examination of Figure 6-6, it appears that the total released ATP 
from the PAMAM-MSN is actually greater than that of the CdS-MSN. As observed via TEM 
images in an earlier report,27 the capping efficiency for CdS nanocrystals is only 57%. In 
contrast, the dendrimer-capped particles have a capping efficiency of nearly 100%. This 
indicates that though the nanospheres were loaded with the same concentration of ATP, the 
dendrimer-capped particles contain more ATP than the CdS-capped particles. Thus, more 
ATP is present to be released upon introduction of DTT. 
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Conclusions 
Real-time imaging of ATP release via luciferase-catalyzed chemiluminescence is a 
highly sensitive and selective method. We applied this imaging technique to the study of ATP 
release from mesoporous silica nanospheres end-capped with CdS nanocrystals and PAMAM 
dendrimers. The kinetics revealed a pulse-type release from CdS-capped particles upon 
uncapping. In contrast, the dendrimer-capped nanospheres exhibited release of ATP in a more 
gradual and plateau-like profile. Understanding the release mechanisms and release kinetics 
of these systems will aid in the development of more advanced particle designs. By varying 
the capping molecules as well as the uncapping triggers, we envision that the release profile 
of a drug of interest can be fine-tuned depending on whether a high concentration, one-time 
drug release or a lower level, continuous drug release treatment is desired. 
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Abstract 
We synthesized a MCM-41 type mesoporous silica nanosphere (MSN) based gene 
transfection system, where second generation (G2) PAMAMs were covalently attached to the 
surface of MSN. The G2-PAMAM-capped MSN material (G2-MSN) was used to complex 
with a plasmid DNA (pEGFP-Cl) that is encoding for an enhanced green fluorescence 
protein. The gene transfection efficacy, uptake mechanism, and biocompatibility of the G2-
MSN system with various cell types, such as neural glia (astrocytes), human cervical cancer 
(HeLa), and Chinese hamster ovarian (CHO) cells were investigated. 
Introduction 
Recent reports in the literature have demonstrated that polyamidoamine (PAMAM) 
dendrimers can serve as non-viral gene transfection reagents.1 However, only those 
PAMAMs of high generations (G > 5) have been shown to be efficient in gene transfection.13 
The required procedures for the synthesis and purification of these high G PAMAMs are 
usually tedious and low-yield. In contrast, the low G PAMAMs (G < 3) are nontoxic and 
easy to be synthesized. Despite the benefits, the smaller molecular sizes and the limited 
surface charges of the low G PAMAMs prohibit efficient complexation with plasmid DNAs 
in solution due to the entropy penalty.13 Herein, we report a novel gene transfection system, 
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where second generation (G2) PAMAMs were covalently attached to the surface of a MCM-
41 type mesoporous silica nanosphere (MSN)2 material as depicted in Figure 7-1. 
Experimental Section 
Synthesis of ICP-MSN 
iV -Cetyltrimethylammonium bromide (CTAB, 1.00 g, 2.74 mmol) was dissolved in 
480 mL of nanopure water. Sodium hydroxide aqueous solution (2.00 M, 3.50 mL) was 
introduced to the CTAB solution and the temperature of the mixture was adjusted to 353 K. 
Tetraethoxysilane (TEOS, 5.00 mL, 22.4 mmol) was added dropwise to the surfactant 
solution under vigorous stirring. The mixture was allowed to react for 2 h to give rise to a 
white precipitate. This solid crude product was filtered, washed with deionized water and 
methanol, and dried in air to yield the as-synthesized MSN. To remove the surfactant 
template (CTAB), 1.50 g of the as-synthesized MSN was refluxed for 24 h in a methanolic 
solution of 9.00 mL of HC1 (37.4%) in 160.00 mL methanol. The resulting material was 
filtered and extensively washed with deionized water and methanol. The surfactant-free MSN 
material was placed under high vacuum to remove the remaining solvent from the mesopores. 
MSN (1.00 g) was refluxed for 20 h in 80.00 mL of anhydrous toluene with 0.25 mL (1.00 
mmol) of 3-isocyanatopropyltriethoxysilane to yield the 3-isocyanatopropyl-functionalized 
MSN (ICP-MSN) material. 
Figure 7-1. Schematic representation of a non-viral gene transfection. 
Materials and Methods 
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Synthesis of G2-MSN without Texas Red 
The purified ICP-MSN (0.15 g) was added to anhydrous ethanol (3.00 mL). A 
second-generation (G2) polyamidoamine dendrimer (PAMAM, 2.00 mL, 0.11 mmol) was 
then added to the ICP-MSN ethanol solution. The amino groups of the G2-PAMAM were 
allowed to react with the ICP functional groups present on the surface of MSN for 20 h at 
room temperature to yield the G2-PAMAM-capped MSN material (G2-MSN). The resulting 
G2-MSN material was filtered and washed thoroughly with ethanol, methanol and acetone 
and dried under high vacuum. 
Synthesis of Texas Red-loaded G2-MSN 
The purified ICP-MSN (0.15 g) was added to an anhydrous ethanol solution (3.00 mL) 
of Texas Red™ (5.00 mM, Molecular Probe). The solution mixture was stirred at room 
temperature for 20 h to allow the Texas Red to be encapsulated by the ICP-MSN. A second-
generation (G2) polyamidoamine dendrimer (PAMAM, 2.00 mL, 0.11 mmol) was then 
added to the ICP-MSN/Texas Red solution. The amino groups of the G2-PAMAM were 
allowed to react with the ICP functional groups present on the surface of MSN for 20 h at 
room temperature to yield the Texas Red-loaded, G2-PAMAM-capped MSN material (Texas 
Red-loaded G2-MSN). The resulting G2-MSN material was filtered and washed thoroughly 
with ethanol, methanol and acetone and dried under high vacuum. To ensure the complete 
removal of Texas Red molecules physisorbed on the exterior surface of the G2-MSN, a 
Soxhlet extraction in ethanol was performed for 20 h. The resulting solid was filtered and 
dried in air. 
Characterization of ICP-MSN and G2-MSN 
Powder X-Ray Diffraction 
Powder XRD experiments were performed on a Scintag XDS 2000 diffractometer 
using a Cu Kx radiation source. Low angle diffraction with a 28 range of 1 to 10 *"' was used 
to investigate the long-range order of the materials. 
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Nitrogen adsorption/desorption isotherms 
The surface area and median pore diameter were measured using N% 
adsorption/desorption measurements in a Micromeritics ASAP 2000 BET surface analyzer 
system. The data were evaluated using the Brunauer-Emmett-Teller (BET) and Barrett-
Joyner-Halenda (BJH) methods to calculate the surface area and pore volumes/pore size 
distributions, respectively. Samples were prepared by degassing at 90 * C for 1 h and then at 
150 9 C for 4 h. 
Solid-state 13C CP-MAS NMR 
Solid-state 13C CP-MAS NMR spectra were obtained at 75.47 MHz on a Broker 
MSL300 spectrometer equipped with Broker 4mm rotor MAS probe. Magic-angle sample 
spinning rate was maintained at 10 KHz for 13C in order to minimize the spin band due to the 
high anisotropic chemical shifts of aromatic carbons. The NMR spectra consisted of 5,000 to 
20,000 acquisitions with cross polarization times of 3 ms (13C) and pulse repetition times of 
15 s (13C). All chemical shifts reported are referenced to liquid Me^Si (TMS). 
Scanning and Transmission Electron Micrographs (SEM and TEM) of G2-MSN 
Particle morphology of these materials was determined by scanning electron 
microscopy (SEM) with 10 kV accelerating voltage and 0.005 nA of beam current for 
imaging. For transmission electron microscopy (TEM) studies, a small aliquot was taken 
from a suspension of methanol and placed in a lacey carbon-coated TEM grid, which was 
pulled through the suspension and allowed to dry in air. Thin sections of samples embedded 
in epoxy resin were obtained with ultramicrotomy (60-80 nm). The resulting sample was 
examined with a Philips model CM-30 TEM operated at 300 kV. The specimen was given no 
further treatment, as it appeared stable under beam bombardment. 
Gene Transfection Experiments of DNA-coated G2-MSNs 
Human cervical cancer (HeLa) and Chinese Hamster Ovarian (CHO) cell lines were 
obtained from American Tissue Culture Collection (ATCC). HeLa and CHO cells were 
maintained in T75 flasks using DMEM (Dulbbecco's modified Eagle's medium) 
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supplemented with 10% CS serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 (J,g/(J,L 
streptomycin, and 1 ng/|aL gentamycin. All cells were passaged every 2-3 days. A red-
shifted variant of GFP expressed from pEGFP-Cl (Clontech, Palo Alto, CA) was used as 
reporter protein. All plasmids were amplified in the E. coli strain DH5a and purified 
according to the manufacturer's protocol (Qiagen, USA). The isolated DNA was 
resuspended in Tris-EDTA (pH 8.0) at a concentration of 1 ja,g/p,L. 
HeLa cells were first seeded onto 24-well plates (6 x 104 cells per well, in 0.6 mL 
growth medium) and 6-well plates (2 x 105 cells per well, in 1.5 mL growth medium) 24 h 
prior to the experiment. The former plating (24-well) was used for transfection efficiency 
measurements. The 6-well plating was used for imaging studies. 
In a typical transfection experiment, 1 |ig of plasmid DNA encoding GFP was added to 10 
jag of G2-MSN suspension obtained by dispersing the nanosphere material in 30 juL of 
HEPES buffer solution (10 mM HEPES, pH 7.4). The complex mixture was incubated for 2 
h at 4 °C. A solution of 30 \iL of 100 mM CaCl^(aq) was added to the G2-MSN-DNA 
complex solution and allowed to incubate for another 2 h. The 50 mM Ca2+ was to 
enhance/stabilize the complexation between DNA and G2-MSN and protect the surface-
bound DNA from enzymatic degradation as described in recent literature. The entire 60 pL 
of the G2-MSN-DNA suspension was added to cells cultured on 24-well plates. Given that 
each well contained 0.6 mL DMEM, the addition of the suspension resulted in a final Ca2+ 
concentration of 4.5 mM. After incubation for 4 hours at 37 °C, the transfection mixture 
containing residual G2-MSN-DNA complexes was removed by washing the transfected cells 
with PBS buffer and cultured with DMEM supplemented with 10% calf serum (CS) and 
antibiotics. The cultures were maintained for 2 days to monitor gene expression. The 
transfected cells were then washed with PBS buffer and cultured with DMEM + 10% calf 
serum (CS) medium and antibiotics for 2 days for gene expression analysis or image studies. 
To compare the transfection efficiency of our G2-MSN system with other commercially 
available transfection reagents, three different reagents, PolyFect®, SuperFect® (Qiagen, 
Valencia, California) and Metafectene® (Biontex, Germany), were used to transfect the 
aforementioned cell types under the same experimental condition. First, 8 and 5 |aL of the 
stock solutions of PolyFect® (2 mg/mL) and SuperFect® (3 mg/mL), respectively, were 
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added to a 30 \xL of serum-free medium (DMEM) containing 1 p,g DNA. The solutions were 
incubated at room temperature for 15 min to allow the formation of stable complexes 
between DNA molecules and transfection reagents. The complexes were then added to a 
culture of HeLa cells in a 24 well plate with a cell density of 6 x 104 cells/well that contained 
350 jil of pre-warmed DMEM + 10% CS medium and antibiotics. After 4 h of incubation, 
the transfection medium was discarded and replaced with fresh growth medium (DMEM + 
10% CS medium and antibiotics). The cells were evaluated for expression of the enhanced 
green fluorescent protein (EGFP) by flow cytometry after 48 h post-transfection. 
For Metafectene®, the protocol involved the addition of 5 jaL stock solution of 
Metafectene® (lmL stock solution was used as received from Biontex, Germany) to a 30 pL 
of serum-free medium (DMEM) containing 1 pg DNA. This solution was incubated at room 
temperature for 15 min to allow complex formation before the addition to the cells. The 
complexes were added to the aforementioned HeLa cell wells that contained 350 pL of pre-
warmed, serum-free DMEM. After 4 h of incubation, the transfection medium was discarded 
and replaced with fresh growth medium (DMEM + 10% CS medium and antibiotics). Cells 
were evaluated for expression of the enhanced green fluorescent protein (EGFP) by flow 
cytometry after 48 h post-transfection. 
Stability Studies of pEGFP-Cl DNA and G2-MSN-DNA Complex after Bam HI treatment 
DNA was released from the G2-MSN particles by vigorous agitation in 2 M NaCl at 
50 °C for 30 min. The supernatant was collected by micro-centrifugation at 14000 rpm at 4 
°C for 15 min. After ethanolic precipitation, the DNA was resuspended in TE buffer and 
loaded in the gel. 
Flow Cytometric Analysis of Transfection Efficiencies of G2-MSN and Other Reagents 
Flow cytometric measurements were performed immediately after collection of 
cultured cells. All cells were trypsinized and resuspended in 0.5 mL of PBS before the 
F ACS analysis. Positive and negative control experiments utilizing cultures of untransfected 
cells (HeLa cells only) and "mock"-transfected cells (cells incubated with MSNs without 
pEGFP-Cl plasmid) were measured with an EPICS-ALTRA flow cytometer (Beckman 
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Coulter, Miami, FL), using a 488 nm laser for GFP excitation. GFP fluorescence was 
detected using PMT2 in conjunction with a 525 nm band-pass filter. An electronic gate was 
set around cells based on the forward and side scatter properties of the population, and a 
minimum of 10,000 gated events per sample were collected and stored in list mode files. 
Data analysis was performed with FlowJo software (Tree Star, Ashland, OR). Scatter-gated 
events are displayed herein as single parameter histograms of logarithmic GFP fluorescence. 
All experiments were performed in quadruplicate. Untransfected cells were used for 
background calibration. The average transfection efficiencies of different transfection reagent 
systems on HeLa cells were summarized in Table 7-3. 
Confocal Microscopy Imaging of Transfected Cells 
HeLa cells were grown on coverslips in a 6-well culture plate. All of the samples 
were washed three times with PBS buffer and fixed with formaldehyde in PBS (3.7 %). The 
samples were excited by an argon laser (Xex = 488 nm) and the images were subject to a 
longpass filter Qj= 515 nm). Images were captured on an inverted Nikon Eclipse microscope 
connected to a Prairie Technologies (Middleton, WI) Scanning Laser Confocal Microscope 
controlled by Prairie Technologies software. Images were analyzed using Metamorph 
software (Universal Imaging, West Chester, PA). 
Transmission Electron Micrographs of G2-MSN transfected Cells 
To study the endocytosis of G2-MSN-DNA complexes, post-transfection cells on 
coverslips were fixed at selected time-points with 2% glutaraldehyde and 2% 
paraformaldehyde in PBS buffer, pH 7.2, at 4°C for 48 h. The samples were then washed in 
PBS followed by washing in 0.1M cacodylate buffer, pH 7.2, and post-fixed in 1% osmium 
tetroxide in 0.1M cacodylate buffer for 1 hour at room temperature. The samples were then 
washed briefly in dH^O and dehydrated through a graded ethanol series and cleared using 
ultra pure acetone and infiltrated and embedded with EPON epoxy resin (EmBed 812, 
Electron Microscopy Sciences, Ft. Washington, PA). Coverslips were embedded by inverting 
the slips (cell side down) onto upright beem capsules and polymerized at 60°C for 24 hours 
and 70°C for 24 h. The coverslips were removed from the resin with liquid nitrogen. Thin 
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sections were made using a Reichert Ultracut S ultramicrotome (Leica, Deerfield, IL) and 
collected onto copper grids and stained with 4% uranyl acetate in 50% methanol followed by 
Sato's lead stain. Images were collected using a JEOL 1200 EXII scanning and transmission 
electron microscope (Japan Electron Optics Laboratory, Peabody, MA.) at 80kV with a 
Megaview III digital camera and SIS Pro software (Soft Imaging System, Corp., Lakewood, 
CO). 
Cell Growth Studies 
To further demonstrate the in vitro biocompatibility of the G2-MSN, growth studies 
were performed for HeLa and CHO cells. Two series of experiments were designed for both 
types of cells: one series studied the natural cells growth (without MSNs) and the other was 
monitored after MSNs application. All experiments were performed in triplicate. To ensure 
enough space and media for cell growing, the cells were seeded in T-25 flasks. In the 
experiments without MSNs, 18 flasks were loaded with the same amount of cells for each 
cell type. After allowing 24 h for cell adhesion, the cells were analyzed everyday (3 flasks 
per day) for 6 days. The cells were trypsinized and counted by using a Guava ViaCount® 
assay (Guava Technologies, Inc, USA). In the experiments with G2-MSNs, the cells were 
seeded for 24 h prior to the incubation with MSNs at 0.1 mg/mL concentration in DMEM + 
10% CS (calf serum) and antibiotics for 4 h. After the 4 h incubation, the cells were washed 
twice with PBS buffer and incubated for another 6 days. The aforementioned cell counting 
procedures were followed. All experiments were performed in triplicate (3 flasks /day). 
During the 6-day growth period, the cells were periodically examined under a phase contrast 
microscope. The cells were added with fresh media every other day or upon pH fluctuations 
(Phenol Red dye was used as pH indicator). The doubling times of the cell density of HeLa 
cells without and with MSNs were calculated from the semilog plots to be 20 h and 24 h, 
respectively. The doubling times of CHO cells without and with MSNs were calculated to be 
21 h and 24 h, respectively. (R2> 97 % in the case of HeLa cells, whereas R2 > 97.6 % for 
CHO cells) 
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Results and Discussion 
The G2-PAMAM-capped MSN material (G2-MSN) was used to complex with a 
plasmid DNA (pEGFP-Cl) that codes for an enhanced green fluorescence protein.3 We have 
investigated the gene transfection efficacy, uptake mechanism, and biocompatibility of the 
G2-MSN with neural glia (astrocytes), human cervical cancer (HeLa), and Chinese hamster 
ovarian (CHO) cells. 
Cndocy&Ml# 
Nuc*$w$ 
Green Fluoreacant Protein# 
Figure 7-2. Schematic representation of a non-viral gene transfection system based on a Texas Red. (TR)-
loaded, G2-PAMAM dendrimercapped MSN material complexed with an enhanced green fluorescence protein 
{Aequorea victoria) plasmid DNA (pEGFP-Cl). 
In contrast to other recently reported silica nanoparticle-based gene transfer systems,4 
the mesoporous structure of the MSN allows membrane impermeable molecules, such as 
pharmaceutical drugs and fluorescent dyes, to be encapsulated inside the MSN channels.2,5 
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The system renders the possibility to serve as a universal transmembrane carrier for 
intracellular drug delivery and imaging applications. To the best of our knowledge, no uptake 
study of MCM-41 type mesoporous silicas into eukaryotic cells have been reported before. 
To construct the G2-MSN gene transfer system, a MSN material with an average particle size 
of 250 nm (avg. pore diameter = 2.7 nm) was synthesized via our previously reported 
method.2 3-Isocyanatopropyltriethoxysilane (0.25mL, 1 mmol) was grafted onto the pore 
surface of the MSN (1 g) in 80 mL of toluene for 20 h to yield the isocyanatopropyl-
functionalized MSN (ICP-MSN) material. To visualize the interaction of MSNs and cells, we 
prepared a G2-MSN material loaded with a fluorescent dye (Texas Red™). ICP-MSN (0.15 g) 
was added to an anhydrous ethanol solution of Texas Red™ (5mM), and stirred for 20 h. The 
amine-terminated G2-PAMAMs were used as caps to encapsulate Texas Red molecules 
inside the porous channels of ICP-MSN. An ethanol solution of G2-PAMAM (0.11 mmol) 
was added to the MSN/Texas Red solution for 20 h to form urea linkage between amines of 
PAMAM and ICP groups of MSN (Figure 7-1,2 inset). The structure of G2-PAMAM-capped, 
Texas Red-encapsulated MSN were scrutinized by XRD, SEM, TEM, Na sorption isotherms, 
and 1 3C CP-MAS NMR spectroscopy and also summaried in the following (Figure 7-3 to 5)6  
(A 
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Figure 7-3. Powder X-Ray diffraction patterns of purified ICP-MSN, G2-MSN, and Texas Red-loaded G2-
MSN materials. Both ICP-MSN and G2-MSN materials exhibit the typical diffraction patterns of MCM-41 type 
mesoporous silica with hexagonal symmetry. The changes in the Tex Red-loaded G2-MSN diffraction pattern 
might be caused by pore filling effect. 
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Table 7-1. Powder X-Ray diffraction patterns 
Sample 
Powder XRD Diffraction 
ti^ioo (Â) d\ 10 (A) <^200 (Â) 
ICP-MSN 40.88 23.61 21.05 
G2-MSN 40.88 2148 21.05 
Tex Red-loaded 
G2-MSN 
39.41 — 
— 
ICP-MSN 
G2-MSN 
Relative Pressure ( P/Pq) 
Figure 7-4. BET nitrogen adsorption/desorption isotherms (a) and BJH pore size distributions (b) of MSN, ICP-
MSN, G2-MSN, and Texas Red-loaded G2-MSN materials. The BET isotherms of ICP-MSN and G2-MSN 
materials didn't exhibit any hysteresis indicated that there was no xerogel formation on the exterior surface of 
the MSN upon surface functionalization. 
To study the complexation between the pEGFP-Cl DNA and G2-MSN in different 
weight ratios at physiological pH, agarose gel electrophoresis (0.8%, 45 mM TBE buffer) of 
pEGFP-Cl in the presence of G2-MSNs was performed for 3.5 h at 155 V. Figure 7-7a 
shows the electrophoretic shifts for pEGFP-Cl in the absence (lane 2) of G2-MSN and 
presence of increasing amounts (lane 3-8) of G2-MSN. The results demonstrated that the G2-
MSN could bind with plasmid DNA to form stable DNA-MSN 1:5, as illustrated by the 
retention of pEGFP-Cl around the sample wells (lane 6-8). 
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Figure 7-5. 13C solid state CP-MAS NMR spectra of the ICP-MSN (top) and G2-MSN (bottom) materials. 
Propyl-carbamic acid impurity from the hydrolyzed isocyanopropyl groups of the ICP-MSN was also observed 
in the spectrum of ICP-MSN. 
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Table 7-2. BET and BJH parameters 
Sample 
Nitrogen Sorption Isotherms 
BET Surface Area BET Pore Volume BJH Pore diameter 
(m2/g) (mL/g) (A) 
MSN 959 0.865 27.3 
ICP- MSN 842 0.755 27.2 
G2-MSN 568 0.481 22.6 
Texas Red-loaded 
G2-MSN 
167 0.190 18.8 
Scanning and Transmission Electron Micrographs (SEM and TEM) of G2-MSN 
Figure 7-6. SEM (a) and TEM (300 kV) micrographs of the G2-MSN (b). The spherical shape of the silica 
particles is illustrated in the SEM image (a). The MCM-41 type of mesoporous channel structure of the G2-
MSN is visualized by the parallel stripes shown in the micrograph (b). 
Similar to the high G PAMAMs with large numbers of positive surface charges, each 
G2-MSN particle was covered with numerous covalently anchored G2PAMAMs. Thus, the 
resulting polycationic G2-MSN could complex with the polyanionic pEGFP-Cl efficiently 
without paying a large entropy penalty as in the case of free G2 PAMAMs complexing with 
plasmid DNAs.la To examine whether the G2-MSN are efficient in protecting pEGFP-Cl 
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DNA against enzymatic cleavage, a restriction endonuclease (BamH I, 2 units) was 
introduced to the DNA and the stable G2-MSN-DNA complexes containing 1 p.g of DNA. 
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Figure 7-7. Complexation of G2-MSN with pEGFP-Cl DNA (GFP). (a) Electrophoretic gel shifts of GFP in the 
absence (lane 2) and increasing amounts of G2-MSN (lane 3-8). (b) Electrophoretic gel shifts of GFP 
complexed with la and uncapped MSN (MSN). Lane 2 is undigested free GFP, whereas lane 3 is the GFP 
digested with BamH I endonuclease. Lane 4-6 are GFP complexed with different ratios of G2- MSN and treated 
with BamH I. Lane 7 and 8 are the GFP complexed with uncapped MSN untreated and treated with BamH. I 
respectively. 
The samples were incubated for 2 h at 37 °C, followed by deactivation of enzyme at 
70 °C for 15 min. As shown in Figure 7-7b, free pEGFP-Cl (lane 2) was digested and 
cleaved by BamH I, whereas the DNAs when complexed with MSNs (lane 4-6) were not 
cleaved by the enzyme under the same condition. We also extracted the pEGFP-Cl from the 
BamH I treated G2-MSN-DNA complex with 2 M NaCl(aq). The electrophoretic shift of the 
extracted DNA was the same as that of the free pEGFP-Cl suggested that the G2-MSN-DNA 
complex could protect DNA from enzymatic degradation.6 Interestingly, pEGFP-Cl DNA 
was digested by BamH I in the presence of MSN without PAMAM caps (Figure 7-7b, lane 8). 
The result indicated that the G2-MSN-DNA complex could protect pEGFP-Cl DNA 
from enzymatic degradation (Figure 7-9). 
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Figure 7-8. Electrophoretic gel shifts of stability Studies of pEGFP-Cl DNA and G2-MSN-DNA Complex after 
Bam HI treatment. Lanes 1 and 6: DNA marker (k DNA). Lanes 2 and 5: Undigested free plasmid DNA 
(pEGFP-Cl). Lane 3: Free plasmid pEGFP-Cl after digestion with BamH 1 (2 U/|ig DNA). Lane 4: The 
pEGFP-Cl extracted from the BamH 1 (2 U/jag DNA) treated G2-MSN-DNA complex with 2 M NaCl(aq). 
(a) 
Figure 7-9. Fluorescent microscopy images of HeLa cells treated with G2-MSN-DNA complexes that have first 
been exposed to BamH I. (a) HeLa cells with green fluorescent proteins expressed, (b) Phase contrast image of 
the same region of interest. 
To investigate the transfection efficacy of our system, G2-MSNs without Texas Red 
(10 ng) were mixed with 1 \xg of pEGFP-C1.6 The MSN/DNA suspension (60 ^iL/well) was 
further added to the cells on 24-well plates (6 x 104 cells per well, in 0.6 mL growth medium) 
and incubated for 4 hours at 37°C. The cells were then washed with PBS buffer and cultured 
with DMEM + 10% calf serum (CS) medium and antibiotics for 2 days. The transacted cells 
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were trypsinized and resuspended in 0.5 ml of PBS for direct flow cytometric analysis to 
evaluate the expression of GFP. Control experiments utilizing cultures of untransfected cells 
and "mock"-transfected cells (cells incubated with MSNs without pEGFP-Cl) were 
measured with an EPICS-ALTRA flow cytometer. As shown in Figure 7-10 and Table 7-3, 
significant GFP-expression was observed. To compare the transfection efficiency of G2-
MSN with other commercial transfection reagents, we conducted pEGFP-Cl transfection 
experiments on HeLa cells with PolyFect, SuperFect, and Metafectene under the same 
experimental conditions.6 Flow cytometry analyses on the 48 h post transfection cells showed 
efficiencies of 35 ± 5% (G2-MSN), 15 ± 2% (PolyFect), 10 ± 2% (SuperFect), and 16 ± 2% 
(Metafectene).6 
Table 7-3. Transfection Efficiencies of different transfection reagents on HeLa cells. 
Transfection Reagent Population (%) X mean Intensity 
G2-MSN 35 ±5 129 ± 13 
PolyFect® 15 ±2 312 ± 4 
SuperFect® 10 ±2 250 ±50 
Metafectene® 16 ± 2 248 ± 20 
The transfection enhancement of the G2-MSN could be attributed to the particle 
sedimentation effect as previously reported by Luo et al.4a,d To examine the mammalian cell 
membrane permeability, Texas Red-loaded G2-MSNs were introduced to GFP-transfected rat 
astrocytes. The confocal fluorescence micrograph (Figure 7-1 lb) clearly illustrated that the 
G2-MSNs (red fluorescent dots) entered into the cytoplasm of a green fluorescent neural glia 
cell. 
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Figure 7-10. Flow cytometry analysis of the transfection of pEGFP in HeLa cells with G2-MSN. The flow 
cytometry histograms show distribution of events on the green (FL1) channel, (a) Nontransfected control 
experiment: HeLa cells (dashed line) and HeLa cells treated with pEGFP-Cl DNA (solid line), (b) "Mock" 
transfection control experiment: HeLa cells (dashed line) and HeLa cells treated with MSNs without DNA 
(solid line), (c) G2-MSN transfection results: HeLa cells (dashed line) and HeLa cells treated with pEGFP-Cl 
DNA-coated G2-MSNs. HeLa cells transfected different commercially available transfection reagents (d), (e), 
and (f). 
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Figure 7-11. Fluorescence confocal micrographs of cells transfected by pEGFP-C 1-coated G2-MSN system (a) 
GFP transfected HeLa cells showing cross-sections through a cell layer. Orthogonal images indicated the 
monolayer packing of cells, (b) Texas Red-loaded G2-MSNs inside a GFP-transfected rat neural glia cell 
(astrocyte). 
Transmission electron micrographs of the posttransfusion cells also provided direct 
evidence that a large number of G2-MSN-DNA complexes were endocytosed by all three 
types of cells (Figure 7-12). It is noteworthy that many subcellular organelles, such as 
mitochondria and Golgi, were observed with MSNs nearby as shown in Figure 7-12b, c and d. 
Given the fact that these organelles disappear rapidly upon cell death, the result strongly 
suggested that the MSNs were not cytotoxic in vitro. 
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Figure 7-12. TEM micrographs of G2-MSN-DNA complexes (black dots) endocytosed by Chinese hamster 
ovarian (CHO) (a), human cervical cancer (HeLa) (b), and neural glia (astrocytes) (c) cells. Subcellular 
organelles, e.g., mitochondria and Golgi, were observed with MSNs nearby (b) and (c). The measured distance 
between channels (d) (including the pore walls) is consistent with the BJH average pore diameter of 3-4 nm 
from N2 sorption isotherms of the MSN material alone, zooming in image taken from neural glia cells.. 
To further investigate the biocompatibility of G2-MSN, we compared the cell growth 
profiles of HeLa cultures without and with G2-MSNs (O.lmg/mL). The numbers of cells 
from cultures with and without G2-MSNs were counted daily for 6 days.6 The doubling times 
of the cell density of HeLa cells without and with MSNs were calculated from the semilog 
plots to be 20 h and 24 h, respectively. The doubling times of CHO cells without and with 
MSNs were calculated to be 21 h and 24 h, respectively. (R2> 97 % in the case of HeLa cells, 
whereas R2 > 97.6 % for CHO cells) 
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Figure 7-13. Cell growth of (a) HeLa and (b) CHO cells in the presence of G2-MSN (gray bars) and in the 
absence of G2-MSN (black bars). 
Shown in Figure 7-13, the slopes of the cell growth curves from those cultures with 
and without G2-MSNs were very similar indicated that the increase of numbers of cells was 
not hindered by the presence of G2-MSNs. We envision that the G2-MSN material could 
serve as a new transmembrane delivery system for many biotechnological applications. 
Conclusions 
The mesoporous structure of the MSN material shows exogeneous biomolecules such 
as DNA or membrane impermeable molecules, such as pharmaceutical drugs and fluorescent 
dyes, to be encapsulated inside the MSN channels. The system renders the possibility to 
serve as a universal transmembrane carrier for intracellular therapeutic gene therapy, drug 
delivery and imaging applications. 
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Abstract 
Silica mesoporous nanomaterials have been utilized in various applications. For 
applying these materials in biology, they have to fulfill several prerequisites: a) narrow size 
distribution within a safe size-range defined from 100 nm to 1 |im for biocompatibility 
reasons; b) versatility in exterior particle surface modifications for receptor targeting 
purposes or simply for improving particles biocompatibility; c) high chemical and thermal 
stabilities for increased feasibility. We are reporting on a intracellular delivery nano-vehicle 
that successfully responded to all these prerequisites and further proved pluripotency in 
biological applications. In the present work, the mesoporous silica nanospheres (MSNs) have 
been utilized for: drug delivery by encapsulating Doxorubicin inside the mesopores and 
controlled release of the drug in HeLa cancer cells and for transfection of different types of 
cells such as cancer cell lines: HeLa human cervical cancer and CHO Chinese hamster 
ovarian cells as well as primary cells such as neurons and glia. 
Introduction 
The developing of systems for investigation/intervention in cellular phenomena 
implies downsizing the components of the system to match the size of the cellular 
components. In the present work, we developed a nanocomposite Mesoporous Silica 
Nanosphere (MSN)-based system that is functioning as a cellular vehicle endowed with the 
ability of carrying exogenous molecules in the cytosol. The research performed in developing 
built-in delivery properties for pharmaceutical drugs is still relying on specialized synthesis 
for each particular group of molecules. Consequently, the development of delivery systems 
is as important as the development of the drugs. Several types of polymers were employed to 
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perform the intracellular delivery task. Often, polymeric system is too specialized on 
particular applications1 whereas supramolecular assemblies such as dendritic boxes are still 
suffering from lack of controlled release as well as limited loading capacity. In terms of silica 
mesoporous materials utilization, other than MSN, the application of such materials in the 
biological field, e.g. in drug delivery, was disappointing due to their low biocompatibility 
(irregular shape and size, out-ranging the biocompatible size). To respond to all prerequisites 
related to biotechnological applications, several modifications of mesoporous silica materials 
have been achieved by different research groups.2 Several organic-group modified 
mesoporous silica materials have been synthesized by in situ co-condensation of organosilane 
precursors and a silica source, e.g. tetraethyl orthosilicate (TEOS), in the presence of a 
templating surfactant. However, there were no morphological improvements reported, that 
would allow the successful of these materials use in drug delivery. In our recently published 
work,3 we have been reporting morphological as well surface modifications of mesoporous 
silica that lead to Mesoporous Silica Nanospheres (MSN). Herein we present a mesoporous 
silica nanospherical device that has ability to encapsulate and controlled release to HeLa 
cervical cancer cells an antineoplastic antibiotic—Doxorubicin—proving an incommensurable 
potential in applications in drug delivery to living systems. As therapeutic methods extend 
their field from simple drug molecules to polymeric proteins and genes, virtually, our system, 
with mesopores in the range of 2-4 nm,4 would not have the internal capacity necessary for 
encapsulating the drugs. However, the engineering of the surface with functionalities that 
enable it to electrostatically bind these aforementioned molecules allows the system to deliver 
their cargo. We demonstrated that HeLa human cancer cells, CHO murine cancer cells, and 
primary cells such as astroglia can be transfected and cotransfected by using MSNs as gene 
carriers. 
Materials and Methods 
Experimental Section 
Materials. 3-Aminopropyltrimethoxysilane (APTES), «-cetyltrimethylammonium bromide 
(CTAB), 3 -mercaptopropyltrimethoxysilane (MPTES), sodium sulfide, and tetraethoxylsilane 
(TEOS) were all obtained from Aldrich and used without further purification. Nanopure 
119 
water (18.1 MHz) prepared from a Barnstead E-pure water purification system was employed 
throughout. Fluorescein 5-isothiocyanate (FITC) and Texas Red sulfonyl chloride were 
purchased from Molecular Probe (Eugene, OR.). 
Synthesis of G2 -MSN5 
AL(3-triethoxysilylpropyl)-4,5-dihydroimidazole was purchased from Gelest, and all 
other chemicals were purchased from Aldrich. All chemicals were used as received without 
further purification. The role of imidazole group is associated with the ability of weak bases 
to confer the buffer capacity necessary for manipulating the endosomal pH. 
Hexagonally ordered IMI-MSN was prepared by the following procedure: N-
Cetyltrimethylammonium bromide (CTAB, 1.00 g, 2.74 x 10"3 mol) was dissolved in 480 mL 
of Nanopure water. NaOH (aq) (2.00 M, 3.50 mL) was added to CTAB solution and the 
solution temperature was adjusted to 353 K. At this temperature, TEOS (5.00 mL, 2.57 x 10"2 
mol) was introduced dropwise to the surfactant solution, followed by the dropwise addition 
of 7V-(3-triethoxysilylpropyl)-4,5-dihydroimidazole (0.928mL, 5.13 x 10"3 mol), both 
additions being performed under vigorous stirring. The mixture was allowed to stir for 2 h to 
give rise to a white precipitate: template-containing IMI-MSN. The solid product was 
filtered, washed with deionized water and methanol, and dried in air. To remove the 
surfactant template (CTAB), 1.50 g of as-synthesized IMI-MSN was refluxed for 24 h in a 
solution of 9.0 mL of HC1 (37.4%) and 160.00 mL of methanol followed by extensive wash 
with deionized water and methanol. The resulting surfactant-removed IMI-MSN material was 
placed under high vacuum to remove the remaining solvent from the mesopores. The 
surfactant-free IMI-MSN material was placed under high vacuum to remove the remaining 
solvent from the mesopores. IMI-MSN (1.00 g) was refluxed for 20 h in 80.00 mL of 
anhydrous toluene with 0.25 mL (1.00 mmol) of 3-isocyanatopropyltriethoxysilane to yield 
the 3-isocyanatopropyl-functionalized MSN (ICP-MSN) material. 
The purified ICP-MSN (0.15 g) was added to anhydrous ethanol (3.00 mL). A 
second-generation (G2) polyamidoamine dendrimer (PAMAM, 2.00 mL, 0.11 mmol) was 
then added to the ICP-MSN ethanol solution. The amino groups of the G2-PAMAM were 
allowed to react with the ICP functional groups present on the surface of MSN for 20 h at 
room temperature to yield the G2-PAMAM-capped MSN material (G2-MSN). The resulting 
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G2-MSN material was filtered and washed thoroughly with ethanol, methanol and acetone 
and dried under high vacuum. 
Synthesis of dye-Incorporated MSN (F-MSN and T-MSN)5 
For synthesizing dye incorporated MSNs, fluorescein isocyanate (3mL of 8 mM DMF 
solution to allow the fluorescent dye to be embedded inside the silica matrix, 2.4 x 10"5 mol, 
Molecular Probe) was first covalently attached to the coupling agent 3-
aminopropyltriethoxysilane (0.9 mL, 5.1 x 10"3 mol, APTES) by addition of the amine group 
to the FTIC group in anhydrous DMF solution. For Texas-Red doped MSNs, Sulforhodamine 
101 sulfonyl chloride solution (3mL of 8 mM DMF solution, 2.4 x 10"5 mol, Texas Red™, 
Molecular Probe) was added to 3-mercaptopropyltrimethoxysilane (0.97 mL, 5.13 x 10"3 mol, 
MPTES) to allow the reaction between the mercapto group and the sulfonyl chloride and both 
mixtures were stirred for 4 hours under nitrogen atmosphere. After 4 hour later, this mixture 
was added dropwise immediately after TEOS addition, the rest of conditions being identical 
with the aforementioned preparation. The resulting FTIC-MSN/Texas Red-MSN materials 
were filtered and washed thoroughly with ethanol, methanol and acetone and dried under 
high vacuum. To remove the surfactant template (CTAB), 1.50 g of as-synthesized FTIC-
MSN or Texas Red-MSN was refluxed for 24 h in a solution of 9.0 mL of HC1 (37.4%) and 
160.00 mL of methanol followed by extensive wash with deionized water and methanol. The 
resulting surfactant-removed FTIC-MSN or Texas Red-MSN material was placed under high 
vacuum to remove the remaining solvent from the mesopores. To ensure the complete 
removal of FTIC or Texas Red molecules physisorbed on the surface of MSN, a Soxhlet 
extraction in ethanol was performed for 20 h. The resulting solid was filtered and dried in 
air. 
Characterization of ICP-MSN and G2-MSN 5 
Powder X-Ray Diffraction 
Powder XRD experiments were performed on a Scintag XDS 2000 diffractometer 
using a Cu Kjx radiation source. Low angle diffraction with a 23 range of 1 to 10* was used 
to investigate the long-range order of the materials. 
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Nitrogen adsorption/desorption isotherms 
The surface area and median pore diameter were measured using N? 
adsorption/desorption measurements in a Micromeritics ASAP 2000 BET surface analyzer 
system. The data were evaluated using the Brunauer-Emmett-Teller (BET) and Barrett-
Joyner-Halenda (BJH) methods to calculate the surface area and pore volumes/pore size 
distributions, respectively. Samples were prepared by degassing at 90 ° C for 1 h and then at 
150 "Cfor4h.  
Solid-state 13C CP-MAS NMR 
Solid-state 13C CP-MAS NMR spectra were obtained at 75.47 MHz on a Bruker 
MSL300 spectrometer equipped with Bruker 4mm rotor MAS probe. Magic-angle sample 
spinning rate was maintained at 10 KHz for 13C in order to minimize the spin band due to the 
high anisotropic chemical shifts of aromatic carbons. The NMR spectra consisted of 5,000 to 
20,000 acquisitions with cross polarization times of 3 ms (13C) and pulse repetition times of 
15 s (13C). All chemical shifts reported are referenced to liquid Me4Si (TMS). 
Scanning and Transmission Electron Micrographs (SEM and TEM) of G2-MSN 
Particle morphology of these materials was determined by scanning electron 
microscopy (SEM) with 10 kV accelerating voltage and 0.005 nA of beam current for 
imaging. For transmission electron microscopy (TEM) studies, a small aliquot was taken 
from a suspension of methanol and placed in a lacey carbon-coated TEM grid, which was 
pulled through the suspension and allowed to dry in air. Thin sections of samples embedded 
in epoxy resin were obtained with ultramicrotomy (60-80 nm). The resulting sample was 
examined with a Philips model CM-30 TEM operated at 300 kV. The specimen was given no 
further treatment, as it appeared stable under beam bombardment. 
Cell Growth Studies 
To further demonstrate the in vitro biocompatibility of the G2-MSN, growth studies 
were performed for HeLa and CHO cells. Two series of experiments were designed for both 
types of cells: one series studied the natural cells growth (without MSNs) and the other was 
monitored after MSNs application. All experiments were performed in triplicate. To ensure 
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enough space and media for cell growing, the cells were seeded in T-25 flasks. In the 
experiments without MSNs, 18 flasks were loaded with the same amount of cells for each 
cell type. After allowing 24 h for cell adhesion, the cells were analyzed everyday (3 flasks 
per day) for 6 days. The cells were trypsinized and counted by using a Guava ViaCount® 
assay (Guava Technologies, Inc, USA). In the experiments with G2-MSNs, the cells were 
seeded for 24 h prior to the incubation with MSNs at O.lmg/mL concentration in DMEM + 
10% CS (calf serum) and antibiotics for 4 h. After the 4 h incubation, the cells were washed 
twice with PBS buffer and incubated for another 6 days. The aforementioned cell counting 
procedures were followed. All experiments were performed in triplicate (3 flasks /day). 
During the 6-day growth period, the cells were periodically examined under a phase contrast 
microscope. The cells were added with fresh media every other day or upon pH fluctuations 
(Phenol Red dye was used as pH indicator). The doubling times of the cell density of HeLa 
cells without and with MSNs were calculated from the semilog plots to be 20 h and 24 h, 
respectively. The doubling times of CHO cells without and with MSNs were calculated to be 
21 h and 24 h, respectively. (R2 > 97 % in the case of HeLa cells, whereas R2 > 97.6 % for 
CHO cells). 
Endocytosis Mapping of Cells 
For cell mapping studies, the cells were seeded with dye doped MSNs (such as FTIC-
MSN) at O.lmg/mL concentration in DMEM + 10% CS (calf serum) and antibiotics for 4 h. 
After the 4 h incubation, the cells were washed twice with PBS buffer and incubated for 
another 24 hours. Before imaging, the samples were washed three times with PBS buffer and 
fixed with formaldehyde in PBS (3.7 %). After washing again with PBS, images were 
captured by confocal microscope. 
Gene Transfection Experiments of DNA-coated G2-MSNs 5 
Experimental Section 
Human cervical cancer (HeLa) and Chinese Hamster Ovarian (CHO) cell lines were 
obtained from American Tissue Culture Collection (ATCC). Astrocyte Cells are donated 
from Dr. Srdija Jeftinija at Iowa State University. HeLa and CHO cells were maintained in 
T75 flasks using DMEM (Dulbbecco's modified Eagle's medium) supplemented with 10% 
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calf serum, 2 mM L-glutamine, 100 U/mL penicillin, 100 pg/pL streptomycin, and 1 jag/faL 
gentamycin. Astrocytes cells were in Eagle's minimum essential medium (EMEM) containing 
10% serum. All cells were passaged when its confluence is reaching 90% of the plates. 
pDsRedl-Nl and pEGFP-Cl plasmids (Clontech, Palo Alto, CA) were used as reporter 
proteins. All plasmids were amplified in the E. coli strain DH5a and purified according to 
the manufacturer's protocol (Qiagen, USA). The isolated DNA was resuspended in Tris-
EDTA (pH 8.0) at a concentration of 1 pg/pL. 
HeLa and CHO cells were first seeded onto 24-well plates (6 x 104 cells per well, in 
0.6 mL growth medium) 24 h prior to the experiment. Astrocytes were deposited on 24 wells 
(7 x 104 cells per well, in 1.0 mL growth medium). 
In a typical transfection experiment, 1 pg pEGFP-Cl and 1 pg pDsRedl-Nl (1 to 1 
ratio) were added to 10 jag of G2-MSN suspension obtained by dispersing the nanosphere 
material in 30 pL of HEPES buffer solution (10 mM HEPES, pH 7.4). The complex mixture 
was incubated for 2 h at 4 °C. To further compact the DNA bound to the G2-MSN for more 
gene transfection efficiency and protection of the DNA from enzymatic degradation, the G2-
MSN were incubated with 30 pL of 100 mM CaCl? aqueous solution for another 2 hours. The 
G2-MSN/DNA suspension was further added to the cells cultured on 24-well plates and 
incubated for 4 hours at 37 °C and each well contained 0.6 mL DMEM (free of Ca2+ and 
Mg2+) and consequently the addition of the complex resulted in a final CaClz concentration of 
4.5 mM. After 4 hours, the transfection mixture was removed by washing the transfected 
cells with PBS buffer and cultured with DMEM supplemented with 10% calf serum (CS) and 
antibiotics. The cultures were maintained for 2 days to monitor gene expression. 
To compare the transfection efficiency of our G2-MSN system with other 
commercially available transfection reagents, three different reagents, PolyFect® and 
SuperFect® (Qiagen, Valencia, California) were used to transfect the aforementioned cell 
types under the same experimental condition. First, 16 and 10 pL of the stock solutions of 
PolyFect® (2 mg/mL) and SuperFect® (3 mg/mL), respectively, were added to a 60 pL of 
serum-free medium (DMEM) containing 1 pg pEGFP-Cl and 1 pg pDsRedl-Nl (1 to 1 
ratio). The solutions were incubated at room temperature for 15 min to allow the formation 
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of stable complexes between DNA molecules and transfection reagents. The complexes were 
then added to a culture of cells in a 24 well plate with a cell density of 6 x 104 cells/well that 
contained 700 p.1 of pre-warmed DMEM + 10% CS medium and antibiotics. After 4 h of 
incubation, the transfection medium was discarded and replaced with fresh growth medium 
(DMEM + 10% CS medium and antibiotics). The cells were evaluated for expression of the 
GFP and RFP by flow cytometry after 48 h post-transfection. 
Flow Cytometric Analysis of transfected cells5 
Flow cytometric measurements were performed immediately after collection of 
cultured cells. All cells were trypsinized and resuspended in 0.5 mL of PBS before the F ACS 
analysis. Positive and negative control experiments utilizing cultures of untransfected cells 
(cells only) and "mock"-transfected cells (cells incubated with MSNs without DNA plasmid) 
were measured with an EPICS-ALTRA flow cytometer (Beckman Coulter, Miami, FL), using 
a 488 nm laser for GFP and RFP excitation. GFP fluorescence was detected using PMT2 in 
conjunction with a 525 nm band-pass filter and RFP fluorescence used PMT3 in conjunction 
with a 583 nm band-pass filter. An electronic gate was set around cells based on the forward 
and side scatter properties of the population and a minimum of 10,000 gated events per 
sample were collected and stored in list mode files. Data analysis was performed with 
Flow Jo software (Tree Star, Ashland, OR). All experiments were performed in quadruplicate. 
Untransfected cells were used for background calibration. The average transfection 
efficiencies of different transfection reagent systems on HeLa cells were summarized on 
Figure 8-13 and 8-15. 
Confocal Microscopy Imaging of Transfected Cells 5 
HeLa and CHO cells were grown on coverslips in a 24-well culture plate. All of the 
samples were washed three times with PBS buffer and fixed with formaldehyde in PBS (3.7 
%). After washing again with PBS, images were captured on an inverted Nikon Eclipse 
microscope connected to a Prairie Technologies (Middleton, WI) Scanning Laser Confocal 
Microscope controlled by Prairie Technologies software. Images were analyzed using 
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Metamorph software (Universal Imaging, West Chester, PA). The samples were imaged by 
FTIC channel for GFP and TRIC channel for Ds-Red. 
Transmission Electron Micrographs of G2-MSN transfected Cells 
To study the endocytosis of G2-MSN, cells were fixed 4 and 24 hours after a typical 
transfection experiment with 2% glutaraldehyde/2% paraformaldehyde in PBS buffer and 
incubated overnight at 4°C to visualize the location of MSNs. After washing with PBS, cells 
were dehydrated with graded ethanol and coated with 2% osmium tetroxide (Aldrich). TEM 
samples were sectioned in epoxy resin by microtome and developed using 2% uranyl acetate 
and 0.04% lead citrate. 
Results and Discussion 
MSNs biocompatibility study 
The application of our system directly to living cells involves two preliminary steps: 
successful derivatization of MSNs for the desired application and biocompatibility screening. 
To monitor the interaction of the MSN beads with the cellular environment we have prepared 
dye-doped particles, by incorporating fluorescent dyes inside the silica matrix. This 
embedding was performed in situ, during the synthesis of the material.6 As flow cytometry 
instruments are often using lasers Kr and Ar lasers, the fluorescent dyes of choice were 
derivatives of fluorescein and of Texas Red. The synthesis of the particles: fluorescein 
modified (F-MSN) and Texas Red modified (T-MSN), involve a slight modification 
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Figure 8-1. Schematic representation of Texas Red incorporated mesoporous silica nanospheres , T-MSN. 
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The synthetic pathway proposed in our previously published work resulted in 
morphological changes from polydisperse particles with irregular shape to nanospheres with 
high monodispersity (average diameter of 200 nm). The particles synthesized with 
fluorescent dyes were maintaining this morphology as suggested in Figure 8-1 and showed in 
the SEM images in Figure 8-2. 
Figure 8-2 Scanning electron micrographs (SEM) of the mesoporous silica nanospheres (MSN). Scale bars = 
100 nm (a) and 1.0 (im (b). 
The TEM micrographs in Figure 8-3 also show that the synthetic modifications of F-
MSN and T-MSN did not affect the well organized mesoporosity characteristic to non-
functionalized materials. The fluorescence of the materials was concluded by suspending 
aliquots of material in water and monitoring their fluorescent signal. A very high stability of 
the signal with time was observed, while the emission profile was similar with that belonging 
to the Texas Red monitored in water solution. Based on this observation we concluded that 
the covalent linkage between the fluorophores and the silica matrix prevented the undesired 
fluorophore-leaching problem. The biocompatibility screening was performed by applying 
the two fluorescent materials, F-MSN and T-MSN, to HeLa and CHO cancer cell lines. To 
evaluate the influence of fluorescent MSNs treatment on cells behavior, growth studies were 
performed for HeLa and CHO cells. The study concluded that after application of the MSNs, 
the cells followed their homeostatic behavior. 
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Figure 8-3. High-resolution transmission electron micrographs (TEM) of FTIC incorporated MCM-41 
mesoporous silica nanospheres with amine functionality (F-MSN). 
Furthermore, embedding a fluorescent dye within the matrix, although was designed 
for biocompatibility study, do not harm the mesostructure and consequently, the future 
applications for drug and gene can use this third dimension of the MSNs for tracking 
purposes.7 
The biocompatibility study is including the observation of cellular fate as a function 
of time and amount of material that was applied. Eventually, these observations are essential 
to decide the type and extent of the applications. There are two hypotheses in MSNs 
application to the cell: an extracellular attachment on the cell membrane or an endocytic 
uptake. Whereas the first hypothesis would not be of real interest, the practical applicability 
of the second: MSN uptake inside the cells—whether is related to analytical determinations or 
delivery applications—would be always dependent of the amount of the material that is 
engulfed by a specific cell, as well as to the period of time that is necessary for the MSN to be 
internalized by the cell. 
To investigate the aforementioned parameters, we performed a cellular uptake study 
of the material on HeLa and CHO cells. The dosage study experiments were designed to 
determine the maximum amount of material that can be incorporated by a cell. Fluorescein-
doped, F-MSNs, were used for the study, enabling flow-cytometry assessment of the 
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fluorescence. The cells at visual confluency were treated with incremental amounts of 
material. Flow cytometry measurements were performed for a predetermined population of 
cells. Each set of cell cultures contained increasing amounts of material. To establish which 
of the aforementioned hypotheses is true, after measuring the fluorescence coming from 
samples, we added a fluorescence quencher, Trypan Blue, to each sample test tube. In this 
way, by measuring the fluorescence before and after quencher addition we can assess the 
location of the material in respect with the cell membrane. The first hypothesis, that the 
MSNs are located on the outer side of the membrane of the cells, was easy eliminated 
because the cells kept the same fluorescence level after Trypan Blue addition (Figure 8-4). 
This observation allows us to conclude that the material is completely engulfed by the cells.8 
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Figure. 8-4. Cartoon Schematic representation of possible interaction of MSNs with HeLa cells: Hypothesis 1: 
MSNs are located primarily outside of the cell and the addition of Trypan Blue causes the fluorescence 
quenching a); Hypothesis 2: MSNs are located primarily inside of the cells resulting; no quenching 
The results, plotted in Figure 8-5, concluded that the maximum amount of MSNs 
engulfed by cells attained plateau at a dosage of 0.1 mg for 105 cells. As this uptake amount 
was observed after 12 hours of incubation, we further determined the minimum amount of 
time for incorporating the aforementioned dose (0.1 mg) for 105 cells. The kinetic study was 
performed for 12 hours and revealed that after the first 4 hours, the mean fluorescence 
became stationary. Together with the TEM micrographie evidence, this observations lead to 
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the final conclusion that the whole material was internalized in 4 hours, in the established 
conditions. 
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Figure 8-5. F-MSN internalization. Dosage study (a); Time dependence study (b) 
In the case of cancer cells, whose cell cycle is very short, the carrier particles have to 
be shared during mitosis, to ensure a continuum in delivery. In order to study if the MSNs 
own these characteristic, we treated HeLa and CHO cells with Fluorescein doped MSNs and 
monitor their evolution by confocal microscopy. We observed that the cells are able to 
distribute the material evenly and share between daughter cells following mitosis. 
Figure 8-6. Fluorescent MSNs after endocytosis and cell mitosis - a dividing HeLa cell 
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Drug Delivery As the biocompatibility of the MSNs was demonstrated, we directed 
our attention to intracellular delivery applications. Intracellular delivery presents three major 
challenges: 1. transmembrane trafficking, involving the ability of MSN to penetrate the 
membrane while carrying a loading; 2. release of the "cargo" and 3. drug action, 
encompassing the amount and effectiveness of release inside the cell. The first intracellular 
delivery application that we are proposing here is related to cancer therapy and involves the 
delivery of an antineoplastic antibiotic, Doxorubicin, to HeLa cancer cells. In current cancer 
therapy, Doxorubicin (Adriamycin®) is normally administered intravenously with dramatic 
side effects in the body. When pure Doxorubicin is released in the cells, the drug is 
accumulating inside their nuclei, triggering an apoptotic death mechanism. 
In our approach, Doxorubicin is encapsulated inside the mesopores of MSNs having 
the opening of the channels capped with bio-friendly PAMAM dendrimers of generation 
G4.5. The caps are covalently attached through a chemically cleavable disulfide linker. To 
demonstrate that this carrier has the ability to effectively deliver the drug to the cells we had 
to answer the three aforementioned challenges. The transmembrane trafficking of 
Doxorubicin loaded MSNs, Dox-MSNs, was monitored by TEM as showed in Figure 8-7. 
5(1(1 nm 
Figure 8-7. Cellular application of F-MSN (a) F-MSN engaged in endocytosis. (b) F-MSNs inside of a HeLa 
cell. 
In this way, besides the proof brought by earlier presented flow cytometry 
investigations, we evidenced that the MSN are not only engulfed by the cells but also that 
they are not disturbing cellular homeostasis. The ability of MSN to penetrate the membrane 
while carrying a loading does not make them yet a drug delivery carrier. The second problem 
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to be addressed is the release of the drug inside the cytosol. To achieve this goal, the 
dendrimer caps used for drug encapsulation were attached through a disulfide bond that can 
be cleaved in the intensely reducing environment inside the cells. The confocal image in 
Figure. 8-8 illustrated the red fluorescent nuclei of HeLa cells that are demonstrating that the 
doxorubicin has been released from the MSNs mesopores after 12 hours of incubation of the 
Dox-MSNs with the cells. As a benchmark, we performed the same experiment with a water 
solution of Doxorubicin that was deposited on the cells. Doxorubicin mechanism of action 
consists of DNA intercalation with blocking of replication. For this reason, any cell that is 
undergoes Doxorubicin uptake will show red fluorescent nuclei. After fixation, the cells were 
counterstained with DAPI - a fluorescent dye that is also a DNA intercalator. As showed in 
the confocal image, no nuclei were available for DAPI staining, the Doxorubicin having 
occupied the chromosome. The localization of the drug in the nuclei in both cases proves that 
our release followed the same killing mechanism as the direct administration. 
I'liasr Contrast 
Figure 8-8. Doxorubicin delivery: Free doxorubicin delivered to HeLa Cells (a); MSN Encapsulated 
doxorubicin delivery in HeLa Cells (b) 
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The release mechanism is not clear, however, the reducing media of the cytosol might 
be responsible of disulfide bond cleavage. To attest that the Doxorubicin release is originated 
from uncapped mesopores and not from any physiabsorbed drug, we performed a control 
experiment where the disulfide linker in Dox-MSN was replaced by a non-cleavable urea 
bond to give Dox-ISP-MSN. The urea bond was generated by reacting the carboxyl termini of 
generation G4.5 PAMAM dendrimers with MSN-surface-bounded amine groups. The 
Doxorubicin entrapped in the mesopores could be visualized by examining the confocal 
images of the cells after treatment with Dox-ISP-MSN where the red spots can be easily 
observed. The striking evidence is brought by nuclei staining (Figure. 8-9). 
Hwk Ctmlneet 
Figure. 8-9 Cleavable versus non-cleavable caps: Cells incubated with Dox-MSNs: release of Doxorubicin 
visualized by confocal microscopy (a); Cells incubated with Dox-Amine-MSNs: No release is observed, DAPI 
stain resides in the nuclei. 
By contrast with the Dox-MSNs, the noncleavable caps do not allow Doxorubicin 
release and consequently, the cells are surviving for many days, as showed in the 
biocompatibility section. Furthermore, the nuclei are stained with DAPI that demonstrates 
that the nuclear DNA was not interfered by any Doxorubicin. Any possibility of Doxorubicin 
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physiabsorbtion was eliminated by extensive washes of the loaded MSNs followed by a 
filtration and fluorescent examination of the supernatant for any residual Doxorubicin in both 
Dox-MSN and Dox-ISP-MSN. 
The third factor in evaluating a drug carrier is the drug action after release. This 
includes the amount and consequently the effectiveness of the release. To observe the fate of 
cells after dox-MSN application, a kinetic study was performed and confocal microscopy 
images were collected at intervals of four hours (Figure. 8-11). The cells started to change 
their shapes after 8 hours but at this stage only few of them had incorporated the Doxorubicin 
in the nuclei. After 12 hours, all cells had the drug in the nuclei. After another 12 hours, the 
culture was completely destoyed and only some debris coud be observed on light microscope. 
Althoug we have a visual proof of effectiveness of the release, the quantitative data are 
important for trying to evaluate the mechnism. The amount of potential drug release of MSNs 
was evaluated by high performance liquid chromatography (HPLC).10,11 The loaded Dox-
MSNs, after extensive wash, were suspended in phosphate buffer at physiological pH (7.4) 
and the release was triggerd using dithiothreitol, a well known disulfide reducing reagent. 
The release profile is represented in Figure. 8-10. The amount of released drug is evaluated as 
300 nmoles/mg MSNs.10'11 
Time ( Hours ) 
Figure 8-10. HPLC study of Doxorubicin releases from Dox-MSNs. 
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Figure 8-11. Kinetic study of Doxorubicin release: the Dox-MSNs were applied to cell cultures and monitored 
every four hours: after 4h (a); after 8h (b); after 12h (c) 
Transaction 
As described in the introductory part, the material can prove universal carrier 
properties by transporting molecules not only inside the mesoporous channels but also, for 
large molecules, on the outer surface. It was demonstrated in our previously published work 
that MSNs, after derivatization with a cationically charged molecule on the external surface, 
can complex and delivery plasmid DNA to cancer cells such as HeLa and CHO at a superior 
efficiency than commercially available vectors. As the modularity of our system permits 
multiple functionalities, Texas Red doped MSNs were used for transaction of HeLa cells 
following the same derivatization/complexation/delivery pathway used in our previous work. 
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Confocal imaging was used for analyzing the cells after gene expression. The visual 
inspection of the sections, recorded at a thickness of 0.5 jam, supplies a rapid method for 
investigating the internalization of the material. 
The application of MSNs in cancer gene therapy is important but there are many other 
diseases that can take advantage of gene therapy utilizing this nanocomposite. In the present 
work, we disclose a breakthrough in gene delivery, as the system is able to transfect primary 
cells such as neural glia (astrocytes) at an unprecedented efficiency. Our MSN-based gene 
delivery nanodevice was applied to living cells in vitro. The nanocomposite comprises the 
core module—MSN, an exterior surface module for DNA complexation and an internal pore 
surface module as buffer capacity enhancer. In our approach, the external surface of MSN 
materials was modified with G2-PAMAM dendrimers, covalently attached through a surface 
anchored linker. The interior surface of the mesopores is functionalized with imidazole 
group. The positive surface has ability to complex plasmid DNA as it was demonstrated in 
our previously work.3 As a proof of principle we condensed and transfected pEGFP-Cl— 
plasmid that is encoding for green fluorescent protein—to different types of cell lines as well 
as primary cells. The transfection of HeLa and CHO cells with pEGFP using MSNs was 
published elsewhere. However, the efficiency of the method was not satisfactory when 
applied to astrocytes and therefore required further optimization. One of the impediments in 
cells transfection is represented by endosomal escape of the DNA. The pH inside the 
endosome reaches values around 5, suggesting that by fine-tuning the pH one can manipulate 
the carrier fate. The concept of "proton sponge" was introduced by9 and is related to the 
buffer capacity of the carrier. This feature is enhancing the efficiency of gene transfection by 
causing endosomal burst and consequent escape of DNA. Because of the large surface area of 
the MSNs, they can be modified with functional groups to provide a strong buffer capacity to 
these gene carriers and thus enhancing endosomal escape thus increasing the efficacy of 
transfection. Anchoring dihydroimidazole functionality in the mesopores—via our previously 
published co-condensation reaction—proved to be the key of this optimization process. The 
transfection efficiency for astrocytes was considerably increased in this way from 1-2% to 
12.4% which is unprecedented for primary cells when using other non-viral vectors. 
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Figure 8-12. Transfection of neural glia (astrocytes) with pEGFP utilizing G2-MSN as a transfection vector 
Co-transfection of two different types of plasmids 
The transfection of different types of cells with plasmid pEGFP offers a proof of 
principle for applicability in MSN-based transfection for one particular gene. However, one 
of the major challenges for therapeutic gene transfection is to develop a method for fast 
response detection of the encoded protein expression. This is possible for a gene encoding a 
signal such as fluorescence (pEGFP) but most of therapeutic genes have as a single result, the 
protein that is expressed. One of the solutions of the problem is the engineering of a marker 
gene—such as the one encoding for GFP—inside the plasmid of choice. The expression of the 
marker is representing a benchmark for the expression of the desired gene. However, the 
genetic engineering is tedious; besides, as the size of the plasmid increases, eventually the 
whole transfection process can be compromised. The alternative is represented by 
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cotransfection of two plasmids: one encoding for the therapeutic gene and one encoding for 
the marker gene. For the later choice, the ideal gene carrier would be able to deliver both 
plasmids, in a known ratio, so that the expression of the marker can be correlated with the 
extent of the therapeutic gene expression. In order to test if our system can achieve the 
aforementioned task, we used two plasmids that encode for different gene fluorescent 
proteins: pEGFP-Cl and DsRed-Nl. The ratio between the two plasmids in the transfection 
experiments was 1:1 for all experiments. Since we have chosen plasmids that encode for 
fluorescent proteins, the level of expression could be monitored by flow cytometry. The most 
interesting finding was that within a cell culture there is no mixed population of transfected 
cells, i.e. there were no cells transfected only with one type of the two plasmids. The same 
observation is illustrated by the confocal images in Figure. 8-14. The efficiency of 
cotransfection is similar with the transfection efficiencies that we reported for transfection of 
pEGFP in HeLa and CHO cells in Figure 8-15. The TEM micrographs bring further evidence 
of particle internalization shown in Figure 8-13. 
Nuclear 
Figure. 8-13 TEM micrograph of cotransfected HeLa cells 
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Figure. 8-14. Confocal fluorescence images and phase contrast images of HeLa cells (a) and CHO cells (b). 
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Figure. 8-15. Relative transfection efficiencies between several transfection reagents: G2-MSN, Polyfect and 
Superfect. Mock transfection (beads without plasmids) was also performed to demonstrate that there is no 
fluorescent signal detected in the absence of DNA complexed MSNs. 
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Conclusions 
The potential of MSN in drug and gene delivery was demonstrated. Possible 
combinations of the two approaches can be easily envisioned. In future applications the 
MSNs can serve as gene carriers using the outer surface while carrying gene up- or down-
regulator molecules inside the mesopores. On the other hand, one of the methods proposed in 
the biocompatibility study was utilizing fluorescent doped MSNs in flow cytometry, 
demonstrating a possible utility in flow cytometry measurements. We can envision that by 
further outer surface derivatization of fluorescence MSN particles with cell targeting 
moieties, one can perform cellular sorting, the damaged cells being labeled and selected. In 
an extreme approach, all three elements of MSN: silica matrix, the nanochannels and the 
outer surface could be exploited at the same time, the device being endowed with both 
carrier and tracking abilities. 
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dispersed in 1.50 mL of PBS buffer (pH 7.4), followed by repeating 
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wash/sonication/centrifugation cycles for five times to remove physisorbed, uncapped 
Doxorubicin molecules on the exterior surface of the material. The purified 
MSN/drug composite was redispersed in 3.50 mL of PBS buffer (pH 7.4). Aliquots 
were taken every 4 h over a time period of 12 h from the MSN/PBS buffer suspension 
and injected to an analytical HPLC system (Hitachi LC/3DQMS with a reverse phase 
CI8 column (Vydac), 0.4 cm x 25 cm) to monitor the leaching of the mesoporous 
channel encapsulated Doxorubicin molecules.10 After 12 h, dithiothreitol (DTT, 18.50 
mM) was added to the suspension to cleave the disulfide linkage between the G4.5 
dendrimers and the MSN. The kinetic profiles of the DTT-induced release of 
Doxorubicin were monitored by following two literature-reported HPLC separation 
conditions.10 The peaks/areas at 254 nm were monitored/integrated for the 
quantitative analysis of amounts of released Doxorubicin.in of mixing, the suspension 
was centrifuged and the individual concentrations of dopamine and glutamic acid in 
the supernatant were analyzed by HPLC. Flow rate of mobile phase was 1 mL/min. 
separation was obtained with the following linear gradient of water (A)-acetonitrile 
(B), both containing 0.1% (v/v) CF3COOH: from 25% B to 30% B inlOmin, and then 
up to 80% B in 5min, finally elution was maintained isocratic for the next 15 min to 
return to the initial condition and re-equilibrate. The column temperature was set at 
room temperature and the injection volume of samples was 25 \xL for all analyses. 
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Chapter 9. General Conclusions 
In this dissertation, I presented my research accomplished in the past 5 years in 
chronological order. Each chapter discussed and demonstrated an application of pluripotent 
mesoporous silica nanospheres in three major areas. Throughout this dissertation they are 
presented as noninvasive, high sensitive, fast response and high resolution biosensors, as 
high selective and well-controlled drug delivery nano-devices and as de novo designed non-
viral transfection reagents -"The Trojan Horse reloaded ". 
Chapter 1 presented a general introduction of the dissertation, bringing a brief insight 
over each chapter. 
Chapter 2 have introduced a novel co-condensation method that can fine tune the 
amount of chemically accessible organic functional groups on the pores surface of MCM-41 
type mesoporous silica nanosphere (MSN) materials by matching the electrostatic 
interactions between surfactant head group and the organoalkoxysilane precursors at the 
micelle-water interface. 
Chapter 3 presented the design and synthesis of a well-defined, monodispersed 
mesoporous silica nanosphere (MSN) as a fluorescence sensory system which could serve as 
synthetic scaffold for selective molecular recognition of multifunctional molecules with 
similar sizes and functionalities. The sensing event can be achieved not by shape recognition 
but by creating a multifunctionalized mesopore as the "active site" with combinations of 
covalent (isoindole formation) and noncovalent interactions (hydrophobic and s - a 
interactions). 
Chapter 4 demonstrated the modification of a MSN coated with a poly(lactic acid) 
layer as a gatekeeper to regulate the penetration of molecules in and out of the nanoscale 
pores of PLA-MSN material. We successfully selected the molecular recognition events 
between several structurally simple neurotransmitters, i.e., dopamine, tyrosine, and glutamic 
acid and a pore surface-anchored o-phthalic hemithioacetal (OPTA) group. 
Chapter 5 presented the synthesis and characterization a of MCM-41 type 
mesoporous silica nanosphere-based (MSN) controlled-release delivery system using 
surface-derivatized cadmium sulfide (CdS) nanocrystals as chemically removable caps to 
143 
encapsulate several molecules inside the organically functionalized MSN mesoporous 
framework. The release profiles of several drugs as well as the delivery efficiencies for 
neuroglia cells demonstrated that the organically functionalized mesoporous silica 
nanosphere material can be used as a novel stimuli responsive controlled-release delivery 
carrier. 
In chaper 6, we applied a luciferase-catalyzed chemiluminescence technique to study 
the ATP release from mesoporous silica nanospheres end-capped either with CdS 
nanocrystals or with PAMAM dendrimers. By changing the capping molecules as well as the 
uncapping triggers, we concluded that the release profile of a drug of interest can be fine-
tuned depending on whether a high concentration, one-time drug release or a lower level, 
continuous drug release treatment is desired. 
Chapter 7 introduced a de novo designed gene shuttle. The nanocomposite consists of 
a polyamidoamine dendrimer-capped mesoporous silica nanosphere and a model gene-
pEGFP that is encoding for green fluorescent protein. The novel device is providing high 
transfection efficiencies in several types of cells. The cellular uptake behavior of capped 
MSNs envisioned the possibility of creating a universal transmembrane carrier for gene 
therapy, drug delivery and imaging applications. 
Chapter 8 presented the possible combination of intracellular applications of capped-
MSN, either drug delivery or multiple gene transfection, by proper engineering the inner 
surface or external surface. Fluorescent doped MSNs were used in flow cytometry, 
demonstrating a possible utility in flow cytometry measurements. In the future, we can apply 
this novel carrier on living cells in gene therapy and employ the channels to encapsulate up-
regulation or down-regulation molecules. 
Chapter 9 is concluding the dissertation with a final review of the entire work. 
